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SUMMARY 
I 
Three lines of Trichomonas vaginalisv one metronidazole- 
sensitive (clone G3) and several resistant lines, in particular 
line IR76 and line LRS (2.0). have been-studied with a view to 
elucidating the mode of metronidazole resistance exhibited by 
the latter lines. Drug resistance was found to be dependant upon 
aerobic conditions in all cases except in line LRS (2.0), suggesting 
that molecular oxygen plays a key role, possibly the inhibition 
of drug activation. Parasite cytoplasmic NADH and NADPH oxidases 
are thought to reduce the oxygen entering T. vaiLinalis, therefore 
maintaining the anaerobic natuxe of -the hydrogenosomes, in living 
cells. It is within these organelles that metronidazole is thought 
to be reduced and so activated. Parasite homogonates of clone G3, 
line IR78 and line LRS (2.0) had NADH and INADPH oxidase activities 
'570 ±8 0 -7,413 t 55,507 :t 153 aM 389 -± 101 1 &7 ± 4a 559 ± 
IQ 3 
rL rnoLes M"IL / rrL pn respecbve. ýj , suegesL, ,9 Lvi9 that drug resistance in IR78 is related to the parasites poor ability 
to handle moleculax oxygen. 
The medium used to culture T. vaginalis contained high levels 
of cysteine and ascorbate (12.7 mM and 21.0 mM respectively). In 
an attempt to confirm the poor ability of line IR78 to handle 
molecular oxygenv clone G3 and line IR78 were grown under aerobic 
and anaerobic conditions in medium containing loWered levels of 
cysteine and ascorbate. The adverse effects of such conditions 
upon growth of all lines of' T. vaFjnalis in the presence of oxygen 
support the suggestion that T. XaEiLnalis is an anaerobe. Under 
ii 
anaerobic conditions, in contrast, growth of the parasite 
occurred in media lacking both cysteine and ascorbate, although 
at a reduced rate. Using other reducing agents as cysteine 
substitutes enhanced growth, but it was still less than when 
cysteine was present. The effect of Idwering the c, ysteine 
and ascorbate Concentration's upon growth under aerobic conditions 
was g-reater with line IR78 than clone G3, and line IR78 was also 
more sensitive to oxygen than clone G3. These results correlate 
well-with line IR78's lower'NADII and NADPH oxidase activities. 
The results suggest that drug resistance in line IR76 may be due 
I 
to significant amounts of the oxygen entering the parasite 
permeating unmetabolised -to the hydrogenosomes where it would 
interfere with the reductive activation of the drug. 
'The lower metronidazole sen. siTtivity of line LRS (2.0) was 
found to be independant of oxygen. The rate of reduction of 
the nitro-group of metronidazole by homogenates of clone G3, line 
.. A IR78 and line LRS (2.0) were 65 1 9v 91 
± 18 and 19 +3 units 
(nmoles/min/mg protein) respectively. The low rate of metronidazole 
reduction exhibited by line LRS (2.0) could explain 4iy this line 
is less sen6itive to metronida, zole than clone G3 under both aerobic 
and anaerobic conditions. 
The reduction of nitro-compounds, such as 5-nitroimidazoles, 
by. T. vaginalis is well established. An attempt was made to 
assess the parasites ability to metabolise nitrobenzene and 
III 
azobenzene, compounds that are metabolised by aerobic cells through 
pathways involving oxygen. The results indicate that metabolism is 
mainly reductive, reduction of the nitrogroup of nitrobenzene and 
the azo-group of azobenzene probably takes place using the same 
ferredoxin-linked systemtý, %. i; reduces5-nitroimidazoles. High 
performance liquid chromatography (HPLC) identified hydrazobenzene 
as a major reductive metabolite of azobenzene in T. vaginalis. 
Oxidative metabolites such as nitrophenol were not detectable. 
Lactate and acetate at 5 mM were found to be antagonistic to 
, 
the killing action of metronidazole on T, va8inalis under aerobic 
conditionsp raising the aerobic MLC eightfold. This was not a pH 
eff--ct. Lactate and acetate had no effect on the growth rate of the 
parasites, oror%the rate of metronidazole reduction by, and the 
.. W -- 
activities of NADH and NADPH oxidases in, parasite homogenates. 
However, lactate dehydrogenase activity was enhanced on the addition 
of lactate to the growth medium, although this did not result in 
,, gareater amounts of lactate produced as an endproduct. These 
-nhenomena could have some bearing on the effectiveness of . X--- 
metronidazole in the treatment of trichomoniasis. 
There have been suggestions that DNA is the primary target 
of 5-nitroimidazoles, but no reports on the ability of T.. vaginalis 
to repcx-ir damaged DNA. Aminobenzomides have been shown to inhibit 
poly (ADP-ribose) polymerase, an enzyme implicated with DNA repair, 
and to potentiate the alkylating agent dimethyl slalphate (DMS) 
IV 
against mammalian cells. The trichomonacidal activity of DMS was 
increasedone hundred-fold by co-administration with benzamide or 
aminobenzamides. The trichomonacidal activity of metronidazole 
was not increased by these compounds. These results suggest that 
DNA repair is of some importance in T. vaginalis,, and that 
metronidazole does not effect DNA in a similar way to DMS. 
A rapid method has been developed for testing the in vitro 
trichomonacidal activity of compounds under aerobic and anaerobic 
conditions. A range of compounds have been tested using this 
system. 
Thiosemicarbazones containing disulphide bonds and able to 
form chelates with transition metals were found to be highly toxic 
to T., vaj2ftnalis. This trichomonacidal activity was antagonised by 
compounds containing thiol groups. cýielates were obtained by 
the addition of manganese, zinc and copper. The thiosemicarbazone 
bound to equimolar concentrations of these metal ions. A purified 
copper chelate was as effective against T. va nalis in vitro as 
the parent compound, and its activity was also antagonised by thiol 
gro-ups. Since thiosemicarbazones react with thiol groups, the 
possibility exists that they may inhibit enzymes with essential 
thiol groups. A tiosemicarbazone (TSC1 ) and its copper chelate 
(TSC2) were tested for inhibitory activity against parasite 
proteinases and glycolytic kinases. Antiproteinase activity was 
V 
detected with the chelate, but at concentrations significantly 
greater than those required to kill the parasite. TSC1 and 
TSC2 were tested for inhibitory activity against glycolytic 
Rcinases from T. vaginalis, mouse liver and yeast. The major 
effects were the inhibition of T. vaginalis hexokinase (55%) 
using 100 ; aM TSC1 and T. vaginalis pyrt&vate kinase (90%) using 
100 pT4 TSC2, The additions of TSC1 and TSC2 to cultures of 
T. vaginalis were found to cause a drop in the thiol content 
of -the parasite cultures, however this loss was transient, and 
did not correlate with parasite death. Although the primary 
target has not been elucidated, these studies suggest that 
binding to thiol groups plays a part in the activity of 
thiosemicarbozones. 
1.1 NTR0DUCT10N 
1 
1.1. THE TRICHOMONADS 
1.1.1. General Biology 
Trichomonads are members of the order Trichomonadida, family 
Trichomonadidae. They are flagellate protozoa. They are classified 
into three genera (Honigberg, 1963): genus Trichomonasr genus 
Pentatrichomonas and genus Tritrichomonas. The classification is 
based mainly on the number of anterior flagella, members of the 
genera Trichomonas, Pentatrichomonas and Tritrichomonas having 4,5 
and 3 anterior flagella respectively. Trichomonads are motile, 
ovoid or pear-shaped organisms with 3 to 5 anterior flagella and 
an undulating membrane with an accessory fibril along its outer 
margin (See Figure 1), giving it a double appearance. All flagella 
arise from basal bodies grouped at the anterior end, just in front 
of the single ovoid nucleus (Honigberg and King, 1964). Trichomonads 
also have a prominent skeletal axostyle which may protrude from the 
hind end of the body. 
Ultrastructural studies described an ordinary, three-layered 
nuclear membrane. The nucleus contains several large electron-dense 
granules, which either represent nucleoli or are simply clusters of 
chromatic material. The parabasal body lies in the anterior part 
of the cell, mostly dorsal to the nucleus, and is morphologically a 
Golgi zone, being composed of flattened cisternae. Vesicles have 
been seen which seem to have arisen from cisternae by a process of 
constriction or budding (Jirovec and Petru, 1968). The endoplasmic 
reticulum is found as a corona around the nucleus. Free ribosomes 
are distributed throuqhout the cytoplasm. Vesicles and vacuoles, 
Figure 
Diagram Trichomonas vaginalis Of 
anterior 
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some containing electron-dense material, are situated at the caudal 
end of the body. Most of them are food vacuoles. Paraxostyl4Lr 
bodies (hydrogenosomes) are found grouped round the axostyle 
Posterior to the nucleus. Mitochondria are not present in 
trichomonads. 
I All trichomonads reproduce by 6-. T nuclear division is 
mitotic. Multiple division is very unusual, but may be seen when 
in vitro culture conditions are poor. Whether trichomonads form 
cysts has been studied for many years. It is now thought that cysts 
are not formed by Trichomon_a_s_vaginalis. Some spherical, motionless 
trichomonads can be found in vaginal discharges, but these never 
have any flagella or a distinguishable cyst membrane, well known 
characteristics of amoebic cysts. These forms seem to be degenerate 
trichomonads which are dying. Cysts were reported by Holz (1953), 
but this was never confirmed, and he may have observed degefterate 
host cells. Other trichomonads develop into "pseudocysts" (Mattern 
and Wendell, 1980), forms lacking &-cyst wall but which appear to 
have internalised their locomotor organelles, including anterior 
flagella and the undulating membrane with its recurrent flagellum. 
These "pseudocysts" are viable upon incubation in culture medium 
and "excyst" and become fully mobile. However, it is yet to be 
shown whether they play a role in transmission or are simply 
degenerate forms. 
Many species T. vaginalis) lack a cytostome, but many 
can apparently take in solid food at the posterior region, whole 
leucocytes or bacteria being ingested. 
4 
All the members of the order are parasitic, in vertebrates or 
invertebrates. They parasitize the intestines of mammals, including 
man (Pentatrichomonas hominis), birds (Trichomonas gallinae), 
reptiles, amphibia, slugs and termites. Species are also found in 
the mouth of man and monkeys (T. tenax) and in the qrogenital tract 
of man and cattle (T. y 21inalis and Tritrichomonas foetus). 
trichomonads arelý>ýý rx, -, l 17 about their hosts. Trichomonas gallinae 
can be found in pigeons, chickens, turkeys and hawks, and 
Pentatrichomonas hominis in monkeys, rats and cats, as well as in 
man. 
1.1.2. Important parasitic species 
There are several species of trichomonads of medical or 
commercial importance to man, as they infect either man himself 
or his domestic animals. A diagram of trichomonads of medical 
or veterinary importance is given in Figure 2. 
Pentatrichomonas hominis is a parasite of the lower alimentary 
canal which infests a small percentage of people in temperate 
climates, but may affect more than 10% of children in the tropics. 
This species has been associated with persistant diarrhoea, especially 
in children. This parasite is easily separable from Trichomonas 
vaginalis since it has fiý-? anterior flagella and an undulating 
membrane which extends the full length of the body, the flagellum 
along its margin continuing free at the posterior end (see Figure 2). 
Transmission of the parasite is by the faecal-oral route. 
5 
Figure 2 
Trichomonads of medical or veterinary importance 
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Trichomonas tenax resembles T. vaginalis in most respects, but 
is smaller (6-10 pM in length). This parasite inhabits the gums 
and roots of the teeth and was initially regarded as uncommon, but 
is now thought to infest 10-25% of adults (Smyth, 1976). The 
parasite is often found associated with advanced inflammatory 
pyorrhea, although its pathogenicity has not been proven. However, 
it may play some role, along with Entamoeba gingivalis in this 
disease. is also occasionally found in bronchial and 
Pulmonary infections. Transmission is via mouth to mouth or hand 
to mouth contact. 
Trichomonas gallinae is mainly a parasite of young pigeons, but 
can also infest other birds. It is smaller than T. vaginal. is 
(6-18 pm in length) with four anterior flagella and a recurrent 
flagellum ending three-quarters of the way down the body. The 
parasite inhabits the mouth, pharynx, oesophagus and crop, causing 
a disease known as 'canker', Ifrouncel or Iroupl (avian 
trichomoniasis). This disease is often fatal in young pigeons, 
although nearly all adult birds are infested, but have no symptoms. 
Infection occurs by adult birds feeding the young by regurgitation. 
The organisms produce small, yellowish, spotty lesions in the 
anterior digestive tract which may-spread to the sinuses and organs 
such as the heart, lungs and liver. 
Tritrichomonas foetus has three anterior flagella and a 
recurrent flagellum which extends free for some distance beyond the 
hind end of the body. It is a common world-wide parasite of the 
7 
genital tract of cattle, which infests the vagina and uterus of 
the female and is found beneath the prepuce of the male. This is 
a venereal disease and infection is transmitted during coitus. In 
the female, the parasite attacks the mucous membrane of the vagina 
and invades the uterus, causing abortions and stillbirths. The 
infection is usually self-limiting as all the parasites are 
expelled with the aborted foetus and placenta. Bulls are infected 
for life and cannot be used for breeding unless successfully 
treated. 
Trichomonas vaginalis is the most important of the trichomonads 
as it is a world-wide, common human parasite. It was first described 
by Alfred Francis Donne in 1836 when he noted motile microorganisms 
in the leukorrhea of women with vaginal discharge and genital 
irritation. T. vaginalis is an ovoid organism, ranging from 10-30, um 
in length, and 5-15 pM in breadth. It has four anterior flagella and 
a recurrent flagellum and undulating membrane which ends about half- 
way down the body. T. vaginalis mainly infests the female vagina 
(Kean, 1955) , but also invades skenes glands in the urethra and is 
occasionally found in other parts of the female urogenital system 
(e. g. the cervical canal). In males it occurs in the urethra and 
prostate. The parasite is often non-pathogenic and indeed its 
pathogenicity was only slowly accepted. The parasite is almost 
always non-pathogenic in males, though mild urethral inflammation 
may resultC. In women the parasite is responsible for the condition 
known as 'trichomonal vaginitis'. 
8 
TRICHOMONAL VAGINITIS 
1.2.1. Transmission, symptoms and pathology 
Trichomonas vaginalis is the causative agent of trichomonal 
vaginitis. Infection rates of 20% of unselected women have been 
recorded; the incidence in women with a history of vaginal upsets 
is higher, up to 70%. Infection was at first considered rare in 
males, but is now thought as frequent as in women. A 
The parasite is normally transmitted during coitus. In the 
laboratory a single ý4, oculation of T. vag, nalis into the vaginal 
cavity of Golden Hamsters has given 20-31% infection; and repeated 
L4\ocula 80-90% infection (Schnitzer and Kelly, 1954), suggesting 
that transmission A occur, easily 
during coitus. 
This is indirect evidence that transmission between humans may be 
as easy. Transmission by methods other than coitus have been 
postulated to explain how young children become infected. Infection 
may occur .e during childbirth. Transmission may 
also perhaps occur via damp towels and toilet seats. This may be 
possible, as T. vaginalis is capable of surviving for 24 hrs on damp 
cloth. 
Trichomonal vaginitis may take one of two forms: - acute and 
chronic. The acute form of the disease is characterised by an acid, 
creamy-white, foul-smelling, frothy discharge from the vagina. This 
discharge may be very abundant. The vulva becomes red and chafed, 
and the mucosa of the vagina and cervix is congested, with a deep 
red mottling. Some patients complain of a severe itching or 
9 
irritation in the genital region. Inflammation of the vagina of 
experimentally infected guinea-pigs was expressed by a dilation 
and hyperaemia of the vaginal blood vessels, especially under the 
epithelium, and by an accumulation of masses of leucocytes, 
trichomonads and shed epithelial cells in the discharge. This is 
relevant to the human condition, as the patients inflammatory 
response and the discharge are similar, suggesting that a similar 
mechanism is responsible for symptoms in both humans and guinea-pigs. 
In the chronic form of the disease, women have few symptoms except 
for an atypical discharge. 
If T. vaginalis is cultured in vitro with other cells, they 
have adverse effects upon the other cells. T. vaginalis caused 
degenerative changes in HeLa cells and inhibited cell division in 
fibroblasts (Honigberg and King, 1964) in culture. It is not known 
why, but it may be due to toxins produced by T. vaginalis. 
Diagnosis 
Diagnosis of trichomonal vaginitis was originally based on the 
presence of trichomonads in a wet smear made of the vaginal discharge, 
but there has been dissatisfaction with the sensitivity of this 
procedure (Burch, Rees and Rearden, 1959). It has recently been 
shown by Fouts and Kraus (1980) that if this is the only diagnostic 
criterion, then over 80% of women infected with T. vaginalis, as 
diagnosed by the cultivation of trichomonads from a vaginal smear, 
will not be indePtified. Diaqnosis is usually confirmed by culturing A 
10 
trichomonads from a vaginal smear, although even this method is 
not 100% effective. The staining of epithelial smears of the 
cervix, 'Papnicolouls method' is also useful for diagnosis. The t 
chronic form of the disease however, can be diagnosed only by 
culture in the majority of cases. 
SerOtOSAe-vA identification using the complement 
fixation reaction have been attempted (Trussell, Wilson, Langwell 
and Laughlin, 1942) but was found to be less sensitive than the 
culture method. An intradermal test using prepared T. vaginalis 
antigen was also unsatisfactory as it gave false positive results 
(Adler and Sadowsky, 1947). More recently Ackers, Lumsden, 
Catterall and Coyle (1975) reported on antibodies to T. vaginalis, 
but these were not a practical diagnostic tool. Honigberg (1978) 
reported that a significant correlation between positive complement 
fixation reaction and T. vaginalis could be demonstrated, however 
false positive results occurred. It was concluded that this test 
could serve as a useful tool in epidemiological investigations, 
provided that the major antigenic types of T. vaginalis prevalent 
in the area being tested were employed as antigens. T. vaginalis 
haý- also been shown to attract polymorphonuclear leucocytes (Mason 
and Forman, 1980) and Gillin and Sher (1981) demonstrated that 
T. vaginalis activates the alternative complement pathway. 
These findings show that there is further scope for Skm - 
&ý-- identification systemse but as yet culturing of 
trichomonads gives the most reliable diagnosis in individual cases. 
11 
1.2.3. Changes in the vaginal environment 
The vaginal fluid from normal, healthy women is at pH 4-4.5 
(Stamey and Kaufman, 1975; Parsons, Lofland and Mullholland, 1977). 
The acid pH of the vagina may be due to the presence of pyruvate, 
glutamate (Hunter and Nicholls, 1959) and lactate (Stamey, Fair, 
Timothy and Chung, 1968) in the vaginal fluid. Lactate is a major 
I 
metabolic end product of the main bacterial species in the vagina 
(Doderlein's bacilli). 
The normal bacterial flora of the introitus, vagina and urethra 
of healthy women consists mainly of lactobacilli and staphylococci 
(Elkins and Cox, 1974; Pfau and Sacks, 1977). The former are also 
known as Doderlein's bacilli and are the major bacterial flora of 
the vagina. Gram-negative bacteria are also found in approximately 
25% of cases (Elkins and Cox, 1974) and Candida albicans is also 
present in many women (Goldacre, Watt, Milne, Louden and Vessey, 
1979) . 
Infestations of Trichomonas vaginalis are associated with a 
reduced vaginal acidity and a change in the bacterial flora of the 
vagina. The vaginal PH of women with trichomonal vaginitis is 
pH 5-6 (Parsons, Lofland and Mullholland, 1977) and the predominant 
microbial flora are gram-negative enteric bacteria, mainly Escherichia 
coli, with a heavier introital colonization by colonic organisms, 
such as Streptococcus faecalis, than normal women (Parsons, Lofland 
and Mullholland, 1977; Pfau and Sacks, 1981). Lactobacilli were 
rarely found (Thadepalli, Gorbach and Kieth, 1973). 
12 
Strang and Timothy (1975) suggested that the low vaginal 
pH in normal wo men (approximately pH 4) may be a significant 
defense mechanism. The change in vaginal pH is presumably 
correlated with the change in bacterial flora. Vaginal fluid from 
normal women was bactericidal to Escherichia coli, but when the pH 
was increased with NaOH, the same fluid supported bacterial growth. 
Also, Yeaw (1940) found that most bacteria grew well in urine at 
pH 5-7, but were killed below -pH 4.4. The acidification of urine 
as a means of treating urinary infections was used for many years. 
It was suggested that the presence of Trichomonas vaginalis in the 
vagina, and the concomitant decrease in acidity, may act as a trigger 
for the establishment of a predominantly gram-negative colonization 
I 
of the vagina. Tt has also been suggested that the bactericidal 
activity of vaginal fluid may be due to an antimicrobial factor, as 
has been found in prostatic fluid (Stamey, Fair, Timothy and Chung, 
1968), but it has never been identified. 
Although T. vaginalis is referred to as an anaerobic organism, 
it is likely that the tissues where it lives are not completely 
anaerobic. For instance, the epithelial cells will be well provided 
with oxygen in the blood. However, there is no detailed information 
available about the amount of oxygen present in the different parts 
of the urogenital tract. 
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PARASITE CULTIVATION 
Since the introduction of penicillin and streptomycin to 
inhibit bacterial growth, the cultivation in vitro of Trichomonas 
vaginalis (Adler and Pulvertaft, 1944; Johnson, Trussell and 
Jahn, 1945; Magara, Amino and Yokouti, 1953) has become relatively 
easy. Until recently all culture media have contained serum of 
one type or another. However, Linstead (1981) developed a serum- 
free defined medium which supported continuous growth. Most media 
areused at relatively low oxygen tensions and the redox potential 
of many culture media are decreased by adding cysteine HC1. The pH 
is usually adjusted to pH 5.5-6.0 and glucose or maltose used as a 
source of energy. Most media contain protein digests of some type. 
The media used most frequently are modifications of Johnsons CPLM 
(Johnson, 1947), Diamonds medium (Diamond, 1957) and Bushby's medium 
(Bushby and Copp, 1955). Other anaerobic protozoa can also be 
cultivated in vitro using similar media and conditions. Entamoeba 
histolytica is cultivated in the presence of low oxygen tensions 
(Diamond, 1968; Wittner, 1968) as is Giardia lamblia (Gillin and 
Diamond, 1980b). 
Although the axenic culturing of trichomonads is now routine, 
it has been reported that Trichomonas vaginalis and related 
organisms may become less virulent after prolonged in vitro 
cultivation (Lindgren and Ivey, 1964; Stabler, Honigberg and King, 
1964; Honigberg, Stabler, Livingston and Kulda, 1970; Dwyer and 
Honigberg, 1970). However, loss of virulence can be prevented by 
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storage of the organisms in liquid nitrogen, thus making possible 
long-term studies using strains of constant characteristics. 
T. vaginalis has been shown to retain its original virulence after 
two years storage in liquid nitrogen (Diamond et al., 1965) using a 
strain of parasites isolated several years previously, and Ivey 
(1965) has demonstrated this using a hceshly isolated strain. 
The growth of T. vaginalis in vivo has been attempted using 
a variety of hosts and locations within the host. Schnitzer and 
Kelly (1954) succeeded in infecting the vagina of Golden Hamsters. 
The infection persisted for over one year and was transmissable. 
The growth and transmission of T. vaginalis from the vagina of rats 
has also been attempted, the infections persisting and the number 
of parasites multiplying. Subcutaneous innoculation of trichomonads 
produced lesions containing large numbers of flagellates (Honigberg, 
1961), although infections of this type only persist for a few weeks. 
However, this type of culture has been used in many studies, including 
drug activity and parasite virulence. Intraperitoneal innoculation 
of trichomonads produced flagellate containing lesions, but again 
this type of infection only persists for a few weeks. 
In vivo methods of cultivation are neither as quick or as 
reliable as in vitroculltivation methods and are mainly used today 
for the testing of compounds for 
'in 
vivo trichomonacidal activity. 
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1.4. BIOCHEMISTRY OF TRICHOMONADS 
The biochemistry of trichomonads is not yet fully elucidated, 
although our knowledge has increased markedly over the last forty 
years. The first axenic cultures of Trichomonas vaginalis were 
isolated in 1944 by Adler and Pulvertaft. The use of the axenic 
culture method was followed by an upsurge in the interest shown 
about trichomonal biochemistry. 
1.4.1. Energy Metabolism 
1.4.1.1. Substrates 
The utilization of the sugars glucose, maltose and dextrin 
by Trichomas vaginalis was first reported by Trussell and Johnson 
(1941), despite the difficulty of the interpretation of data in 
a culture which was not axenic. However, this work was confirmed 
and expanded by Ninomiya and Suzuoki (1952) who demonstrated the 
rapid uptake of glucose and maltose, and a slower pyruvate uptake. 
These workers also reported a low level of lactate uptake. This has 
never been confirmed by other workers however, and it is now generally 
agreed that it does not occur. Succinate, citrater fumarate, acetate 
and several amino acids were shown not to be suitable substrates 
(Ninomiya and Suzuoki, 1952). Read (1957) confirmed the uptake of 
glucose and galactose in T. vaginalis and Doran (1958) reported the 
uptake of these sugars and of mannose, fructose, sucrose, trehalose, 
glycogen, starch and pyruvate by four strains of Tritrichomonas foetus. 
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It appears however, that the main substrates of Trichomonas 
vaginalis are glucose, maltose and glycogen and of Tritrichomonas 
foetus are glucose and glycogen (Muller, 1976). The substrates 
used by Trichomonas vaginalis correlate well with the parasites 
environment, as vaginal fluids have been shown to contain glucose, 
maltoser glycogen, lactose, pyruvate and a range of amino acids 
(Hunter and Nicholas, 1959). 
Intermediary Metabolism 
The uptake of glucose and glycogen, and the large reserves 
of glycogen in the cell (Manners and Ryley, 1955; Ryley, 1955; 
Wellerson and Kupferberg, 1962) suggested the existence of an 
Embden-Meyerhof system in trichomonads. Wellerson and Kupferberg 
(1962) were unable to detect phosphorylase (glycogen' 17 glucose-1-- 'g-- 
phosphate) in T. vaginalis, although it is now known to be present, 
and phosphoglucomutose, the enzyme mediating the conversion of 
glucose-l-phosphate to glucose-6-phosohate, has been demonstrated in 
both T. vaginalis (Wirtschafter and Jahn, 1956) and Tritrichomonas 
foetus (Lindblom, 1961). Hexokinase, glucose-phosphate-isomerase 
and phosphofructo kinase have been found in both Trichomonas 
vaginalis (Wirtschafter, 1954; Wirtschafter and Jahn, 1956) and in 
Tritrichomonas foett-us (Ryley, 1955; Lindblom, 1961). Aldolase was 
found in Trichomonas vaginalis in 1954, and this was confirmed by 
Baernstein (1955) who reported that this enzyme was soluble, and 
metal activated, ferrous or cobalt being the most effective. Enzyme 
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activity was enhanced by cysteine or thioglycolate and inhibited 
by EDTA. Aldolase in Tritrichomonas foetus and triose phosphate 
isomerase in both species have also been detected (Ryley, 1955; 
Lindblom, 1961; Wellerson and Kupferberg, 1962). Glyceraldehyde- 
3-phosphate dehydrogenase, 3-phosphoglycerate kinase, 3 phospho- 
glyceromutase, enolase and Pyruvate kinaser the enzymes responsible 
for completing the glycolytic pathway up to the production of. 
pyruvate, have all been demonstrated in Trichomonas vaginalis 
(Arese and Cappuccinelli, 1974). These enzymes are not attached 
to any membrane structure and are localised in the cytosol. 
Arese and Coppuccinelli (1974) also reported the presence 
of glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate 
dehydrogenase (6PGDH) and transaldolase, three of the enzymes of 
the pentose phosphate cycle, in T. vaginalis, and suggested that 
this cycle is functional in this organism. Although the low 
activities of G6PDH and 6PGDH and hence the capacity of the oxidative 
portion of the cycle were shown to be very low, the high activity of 
transaldolase points to the importance of the anaerobic portion, 
which provides the cell with pentoses and deoxypentoses for nucleic 
acid synthesis. 
All attempts to demonstrate the presence of a functional Krebs 
cycle have failed and only Kuntake, Stitt and Saltman (1962) indicated 
a possibility of the tricarboxylic acid cycle being operative. The 
absence of mitochondria (Smith and Stewart, 1966) and of detectable 
cytochromes (Inoki, Nakanishi and Nakabayashi, 1959; Ryley, 1955; 
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Loyd,, Lindmark and MU'ller, 1979) correlates well with the anaerobic 
nature of the parasite. 
In cultures of Tritrichomonas foetus the fermentation of sugars 
in the culture medium, or of endogenous glycogen if there are no 
sugars present, under aerobic conditions, leads to the production of 
succinate, acetate, carbon dioxide, ethanol and small amounts of 
pyruvate (Ryley, 1955; Lindblom, 1961). Under anaerobicconditions 
the same end products were excreted, and in addition there is 
hydrogen production (Suzuoki and Suzuokir 1951; Lindblom, 1961). 
The organic end produ-ts of Trichomonas vag nalis carbohydrate L 
metabolism are lactate (Kupferberg et al, 1953; Read and Rothman, 
1955; Wellerson, DoScher and Kupferberg, 1960)t acetate (Mack and 
Muller, 1980), small amounts of malate (Wellerson, Doscher and 
Kupferberg, 1959) and pyruvate (Kupferberg et al, 1953) under both 
aerobic and anaerobic conditions. Under anaerobic conditions H2 
and CO 2 are produced and under aerobic conditions 02 was consumed and 
CO 2 produced (Kupferberg et al, 1953; Read and Rothman, 
1955; Mack 
and Muller, 1980). 
1.4.1.3. Pyruvate catabolism in the hydrogenosome 
In the hydrogenosomes, pyruvate is catabolised to acetate, ATP, 
CO 2 and H 2* 
The mechanism of hydrogen formation in the hydrogeno- 
somes of trichomoads is of considerable interest as in fermentative 
prokaryotes there are two routes by which this can occur. 
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In the Enterobacteriace, formate is the proximal substrate 
of the Iformate hydrogenlyase' system, which produces hydrogen. 
HCOOH + fumarate ----> CO 2+ Succinate +H2 (After Gest, 1954). 
This system has been elucidated using cell-free preparations (Gest, 
1952; Barkulis and Gest, 1953) and in intact cells (Stephenson 
and Stickland, 1932). 
In Clostridia and many other strict anaerobes, the oxidation 
of pyruvate produces reducing equivalents leading to hydrogen 
production, a process that used to be known as lphosphoroclastic' 
pyruvate metabolism. The term 'phosphoroclastic' is actually a 
misnomer in this case, as acetyl phosphate is not a primary product, 
but the result of a subsequent reaction of acetyl CoA. The term 
'phosphoroclastic' was coined to describe the cleavage of pyruvate 
to acetyl phosphate and formate by colon-aerogenes bacteria. In 
Clostridia, however, the pathway involves the oxidative decarboxylation 
of pyruvate resulting in the formation of acetyl CoA (Koepsell and 
Johnson, 1942; Gest, 1954), (Figure 3). This results in the 
reduction of an electron carrier protein with a low redox potential 
(Mortenson, Valentine and Carnaham, 1962). This was found to contain 
iron, but no detectable haeme or flavin, and was named ferredoxin 
(Mortenson, Valentine and Carnaham, 1962). The role of ferredoxin 
was found to be the transfer of electrons from pyruvate: ferredoxin 
oxidoreductase to hydrogenase inthe formation of hydrogen from 
pyruvate (Mortenson, Valentine and Carnaham, 1962,1963; 'Valentine and 
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FIGURE 3 
THE ROLE OF FERREDOXIN IN CLOSTRIDIUM sp. 
'Coo 
Pyruvate + COA "z: z- Acetyl CoA 
Ferredoxin Ferredoxin 
(Oifidised) (reduced) 
2H 
U 
1, Fyruvate. o ferredoxin oxidoreductase 
Hydrogenase 
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Wolfe, 1963). Ferredoxin is the most electronegative electron 
carzier yet found in the oxidation-reduction chain in bacteria 
(Valentine, 1964). A diagramatic representation of the role of 
ferredoxin is given in Figure 
Methyl viologen was found to enhance the rate of activity 
of the reaction catalysed by cell-free extracts of Clostridium 
butyricum and to reactivate preparations that had lost activity 
(Mortlock, Valentine and Wolfe, 1959). It was suggested that it 
can substitute for ferredoxin in the catabolism of pyruvate as 
described. This pathway can also operate in the reverse direction, 
with the production of pyruvate. The enzyme catalysing this 
reaction was called pyruvate synthase, but probably is the same 
protein as pyruvate: ferredoxin oxidoreductase. 
The reaction catalysed by pyruvate: ferredoxin oxidoreductase 
requires coenzyme A, but not phosphate. Hydrogenase could be 
replaced by oxygen, but under these conditions, of coursepyruvate 
oxidation did not result in hydrogen production. Carbon monoxide 
inhibited the formation of H2 and the oxidation of reduced ferredoxin 
by hydrogenase, but did not. inhibit the oxidation of reduced 
ferredoxin by oxygen. Both pyruvate: ferredoxin oxidoreductase and 
hydrogenase were found to be sensitive to oxygen, although ferredoxin 
protected pyruvate: ferredoxin oxidoreductase when present (Mortenson, 
Valentine and Carnaham, 1963). 
The above pathways differ from the oxidative decarboxylation of 
pyruvate in mitochondria and in many microorganisms. In these cases 
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NAD + is the final electron acceptor and the enzyme cannot donate 
electrons to ferredoxin or to some other similar electron transoort 
protein. The reoxidation of NADH usually occurs in the electron 
transport chain with 02 as the terminal electron acceptor. 
The nature of the hydrogen producing system in trichomonads 
has been under investigation for some time. The formate hydroqenlyase 
System has not been detected in Trichomonas vaginalis (Ninomiya 
and Suzuoki, 1952; Edwards and Mathison, 1970) or in Tritrichomonas 
foetus (Bauchop, 1971). However, a hydrogenoso7---, ký' "phosphoroclastic- 
type" system, similar to that observed in Clostridia and utilizing 
hydrogenase has been observed (Edwards and Mathison, 1970; Bauchop, 
1971; Lindmark and Muller, 1973a). Pyruvate: ferredoxin oxidoreductase 
and hydrogenase have been found in all the species of trichomonads 
studied to date; in Trichomonas vaginalis (Lindmarkt Muller and Shio, 
1975), in Tritrichomonas foetus (Lindmark and Muller, 1973a) and also 
in Monocercomonads (Lindmark and Muller, 1974). Lindmark, Muller and 
Shio (1975) noted that both enzymes function with exogenous 
clostridial ferredoxin or methyl viologen as electron acceptors, 
but not NAD or NADP and that these enzymes were sensitive to oxygen 
and required thiol compounds for their activity. The electron 
transport protein linked to this system has not yet been identified, 
however, the ability of the enzymes to function with ferredoxin, 
and the overall similarity of the pathway to that found in Clostridia, 
suggests that a ferredoxin-like protein participates in this process 
in trichomonads (Cerkasova, 1970; Lindmark and M611er, 1973b). In 
ad(ýition, the presence of iron-sulphur proteins and flavoproteins 
have been suggested in Tritrichomonas foetus (m6ller, 1980). 
23 
The enzyme associated with the formation of acetyl CoA from pyruvate 
in trichomonads has been named pyruvate: ferredoxin oxidoreductase in 
the expectation that the electron transport molecule involved will 
be found to be a ferredoxin. 
1.4.1.4. Hydroqenosomes and carbohydrate metabolisril in other 
anaerobic protozoa 
The biochemical characteristics of hydrogenosomes suggested 
that if they are present in organisms other than trichomonadst 
they will be most likely to occur in protozoa from anaerobic habitats. 
One such group is the Holotrich ciliates of the rumen (Anderson 
and Dumont, 1966). The absence of mitochondria and presence of 
microbody-like organelles have also been reported in ciliates from 
the bottom sediments of oceans (Fenchel, Perry and Thane, 1977). 
In neither of these cases, howeverroAs there biochemical evidence 
for the identification of organelles as hydrogenosomes. However, 
it was recently reported that hydrogenosomes had been identified in 
Dasytricha, (Yarlett,, Hann, Loyd and Williams, 1981 ; Yarlett, Loyd 
and Williams, 1982). 
In some protozoa both mitochondria and hydrogenosome-like 
structures are lacking. Entamoeba histolytica is the causative 
orcanism of amoebic dysentery and is an aerotolerant anaerobe 
(Band and Cirrito, 1979) lacking cytochromes. The end products of 
the catabolism of glucose by E. histolytica are CO 2' acetate and 
ethanol. (Montalvo, Reeves and Warren, 1971). There is evidence that 
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this organism utilizes the glycolytic pathway to metabolise glucose 
to pyruvate (Reeves, 1972) and metabolises pyruvate to acetate in a 
process involving an electron transfer protein (Weinbach, Diamond 
and Claggett, 1976). The proposed enzyme system is similar to the 
pyruvate: ferredoxin oxidoreductase system present in Trichomonas. 
Howeverr this system is localised in the cytoplasm (Reeves, Warren, 
Susskind and Lo. 1977; Lindmark, 1976b) and there is no evidence of 
hydrogenosomes. 
Giardia lamblia is a flagellate parasite of the order 
Diptomonadida, which inhabits the human intestinal tract and causes 
'traveller's diarrhoea' (Giardiasis). G. lamblia is another 
aerotolerant anaerobe which lacks mitochondria (Friend, 1966). The 
end products of glucose metabolism by G. lamblia are CO 2' acetate 
and ethanol (Lindmark, 1990). The initial steps of carbohydrate 
metabolism in this organism are those of classical glycolysis 
(Lindmark, 1980). Pyruvate is formed from phosphoenol pyruvate (PEP) 
by two pathways; pyruvate kinase forms pyruvate from PEP with the 
phosphorylation of ADP; or the oxaloacetate formed from PEP by PEP 
carboxy kinase can be reduced to malate and then to pyruvate by the 
sequential action of malate dehydrogenase and a decarboxylating 
malate dehydrogenase. The pyruvate formed is oxidised to acetyl 
CoA, a step involving a ferredoxin-like protein (Lindmark, 1980; 
Weinbachr Claggett Keister and Diamondr 1980) and acetate is formed 
from acetyl CoA by acetyl CoA synthetase (Lindmark, 1980). This 
system is similar to that proposed for Entamoeba histolytica, and is 
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localised in the cytoplasm, again there being no evidence of 
hydrogenosomes. 
Thus, in trichomonads, Entamoeba sop. and Giardia lamblia, 
the production of acetate is accomplished by similar pathways, 
however it is only in Trichomonas spp. that the production of 
acetate from pyruvate occurs in hydrogenosomes. 
Endproducts 
The endproducts of the energy metabolism of Trichomonas 
vaginalis and Tritrichomonas foetus have been extensively 
investigated and have been found to differ, although in both species 
the carbon originating from the utilized carbohydrates are excreted 
in the form of organic acids (Honigberg, 1978). 
1. Acetate production 
In prokaryotes such as Clostfldia, acetyl phosphate is an 
intermediate in acetate priduction (See Figure 4). However, acetyl 
phosphate and this pathway have not been found in Tritrichomonas 
foetus (Lindmark, 1976a), the most studied trichomonad to date. 
In eukaryotes it has been postulated that acetate production 
is by way of acetyl-CoA synthetase working in the reverse direction, 
that is towards acetate production (Saz, 1970). but this enzyme has 
not been detected in trichomonads. 
Lindmark (1976a) reported two methods of acetate formation in 
T. foetus. Firstly the direct production of acetate from acetyl 
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CoA by acetate thiokinase, involving a substrate level phosphorylation 
2+ 
Of ADP or GDP, and requiring Mg Secondly, the sequential action 
of two enzymes; acetyl CoA: succinate transferaser producing succinyl 
CoA and acetate, and succinate thiokinase, converting succinyl CoA 
to succinate with the simultaneous phosphorylation of ADP or GDP 
(See Figure 5). 
2. Malate production 
The production of malate by Trichomonas vaginalis does not 
involve the "phosphoroclastic" system. In this case, oxaloacetate 
is formed from PEP by CO 2 
fixation involving PEP carboxy kinase, 
and the phosphorylation of GDP (Arese and Cappuccinelli, 1974). 
Oxaloacetate is then reduced to malate by malate dehydrogenase. In 
T. vaginalis the malate produced by this pathway is either excreted, 
or transported into the hydrogenosomes and converted to pyruvate 
by NAD(P) linked decarboxylating malate dehydrogenase (Brugerolle 
and Metenier, 1973). 
3. Succinate production 
The production of succinate by Tritrichomonas foetus involves 
the production of malate by an identical pathway to that reported 
for Trichomonas vaginalis. Succinate is formed from malate by 
fumarate hydratase and fumarate reductase (Muller and Lindmark, 1974). 
This takes place in the cytosol. T. vaginalis does not produce 
succinate. 
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Figure 
Acetate production in. Clostridia sp. 
1 2 
Acetyl CoA Acetyl phosphate -t- Acetate 
pi CoA ADP ATP 
1. Phosphotransacetylase 
2. Acetate kinase 
Fi gure 
The fomation of acetate in Trichomonads 
Acetyl CoA 
A-DP GDP) 
I- 
Succinate ATP(GTP) 
ATIP 
ý 
GTP Succi, nyl CoA > ADP(GDP) 
Acetate 
1. Acetyl CoA: Succinate transferase 
2. Succinate thiokinase 
28 
4. Lactate production 
Lactate is produced from pyruvate by T. vaginalis in a 
reaction catalysed by Lactate dehydrogenase (Wirtschafter and 
Jahn, 1956; Wellerson and Kupferberg, 1962). Lactate is not 
produced by Tritrichomonas foetus. 
5. Ethanol production 
The production of ethanol by T. foetus involves the decarboxy- 
lation of pyruvate to acetaldehyde and a subsequent reduction 
catý-ilysed by alcohol dehydrogenase. Trichomonas vaginalis does not 
produce ethanol. 
6. H2 and CO 2 production 
The pathways involved in the production of these gases are 
dealt with in detail in section 1.4.1.3. 
A summary diagram of the energy metabolism of Trichomonas 
vaginalis is given in Figure 6. 
Aerobic metabolism 
It has been shown that under aerobic conditions trichomonads 
show intense respiration (Kupferberg et al, 1953; Read and Rothman, 
1955- Muller and Lindmark, 1978) and that exogenous carbohydrates p 
stimulate respiration Cerkasov, Cerkasovova, Kulda and Vilhelmova, 
1978). Cell respiration is insensitive to cyanide, amytal, rotenone, 
iodoacetate and several other inhibitors (Ryley, 1955). It was shown 
by Ryley (1955) that under anaerobic conditions all of the carbon 
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of utilised carbohydrate can be accounted for in the acetate and 
succinate which is produced in equimolar quantities by Tritrichomonas 
foetus. However, under aerobic conditions, Ryley (1955) found that 
there was a greater release of carbon as acetate and a decrease in 
succinate production, and that hydrogen production ceased. It was 
suggested by M51ler (1976) that this would occur if 02 served as an 
electron acceptor, diverting the flow of reducing equivalents, 
suppressing the reduction of oxaloacetate to malate and stimulating 
the conversion of pyruvate to acetate. Since electrons from reduced 
ferredoxin are transferred to oxygen instead of to protons, hydrogen 
production would not take place. As acetate formation from PEP yields 
two moles of ATP and succinate formation yields only one, the shift 
in metabolism under aerobic conditions is advantageous in terms of 
energy yield (Cerkasova, 1970). However, the parasite does not 
benefit from this higher energy yield as one might expect, that is, 
by growing faster. Under aerobic conditions trichomonads grow more 
slowly than under anaerobic conditions. This suggests that growth 
may be limited by something other than energy availability, and 
that the detoxification of oxygen metabolites may require energy. 
Indeed, oxygen detoxification may require more energy than the extra 
produced under aerobic conditions, and may explain why the cells grow 
more slowly under aerobic conditions. 
The hydrogenosomal membrane has been shown to be impermeable to 
vv 
NADH (CerkasovovS and Cerkasov, 1976) and although hydrogenosomes 
'0, w .1 
are able to oxidise NADH at a low rate (Cerkasov, Cerkasovova, Kulda 
and Vilhelmova, 1978)f the predominant NADH oxidase is localised 
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*5 1 in the cytoplasm (Brugerolle and Metenier, 1973; Cerkasovova and 
V 
Cerkasov, 1974; Tanabe, Asami and Kobayashi, 1977; Tanabe, 1979). 
It was reported by Tanabe (1979) that one reaction product of NADH 
oxidase was NAD 
+, 
and that ratio of oxygen uptake to NADH oxidation 
was approximately 
. 
1: 2. The enzyme was substrate specific for NADH 
and would not accept NADPH. Catalase effected neither NAD 
+ 
formation nor NADH oxidation and hydrogen peroxide was not produced 
during the reaction. Tanabe (1979) suggested that the following 
reaction takes place (See Pigure 7). 
Figure 7. The action of NADH oxidase 
1 
NADH + li 
++ý02 
----* NAD 
++H201. 
NADH oxidase 
That NADH oxidase has as one of its products H20 is of interest. 
As Trichomonas, vaginalis has no catalase, peroxidase or NADH 
peroxidase (Tanabe, Asami and Kobayashi, 1977), it is necessary for 
this parasite to produce H20 and not H202 as a product of oxygen 
metabolism. NADPH oxidase has also been found in trichomonads and 
is thought to catalyse a reaction similar to that catalysed by NADH 
oxidase, but probably producing H20 2* 
It has been postulated that NADH oxidase and NADPH oxidase are 
involved in the removal of oxygen from the cytoplasm of the parasite 
1. 
(MUller, 1982). Under aerobic conditions oxygen entering the cell may 
be reduced by NADH oxidase and NADPH oxidase in the cytoplasm, 
therefore maintaining the anaerobic integrity of the hydrogenosomes. 
32 
These enzymes probably account for the major part of the trichomonal 
02 consumption under aerobic conditions. Their operation would lead 
to a lowering in the NAD(P)H concentration in the cell and hence tend 
to push the metabolism of PEP away from malate production to acetate 
production. 
It is not unusual for a supposedly anaerobic organism to 
tolerate and even utilise oxygen when it is present. Other anaerobic 
protozoa have been shown to be tolerant to oxygen. Entamoeba 
histolytica and related species are aerotolerantr and often infect 
aerobic tissues (e. g liver). It has been reported that E. histolytica 
has a limited ability to detoxify products of oxygen (Band and Cirrito, 
1979) and that it is capable of growth in vitro under low oxygen 
tensions (Gillin and Diamond, 1980a). Giardia lamblia is another 
protozoan which is supposedly anaerobic, but it is known to consume 
oxygen if present (Weinbach, Claggett, Keister and Diamond, 1980). 
Protein metabolism 
The mechanisms of mammalian and bacterial protein synthesis 
have been studied extensively. The mechanisms are similar in the 
two groups, differing only in detail. However, these differences 
constitute the basis of activity of many antibacterial drugs. 
Protein synthesis in parasitic protozoa has been investigated very 
little despite its potent$. al importance. Available evidence 
suggests it is more similaf to the eukaryotic process than that of 
prokaryotes. Little has been reported on Trichomonads. 
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Protein breakdown is carried out, in part, by enzymes most 
broadly referred to as 'proteases' or 'proteinases'. the two terms 
often being considered interchangeable. Proteinases are grouped 
into four classes: Serine, Thiol, Aspartic and Metallic (Hartley, 
1960). The activity of the thiol or Icysteinel proteinases is 
dependant upon the thiol group of a cysteine residue at the active 
site (Light, Frater, Kimmel and Smith, 1964). There are few, if 
any drugs of proven value that undoubtably act by proteinase 
inhibition, however there are clear indications that proteinases 
mediate a range of processes that may be poten&i. al targets for 
rational chemotherapy (Barretý, 1980). 
number of pathogenic organisms have been shown to make use 
of proteinases in entering the host body or living there (Barre&, 
1980), and thiol proteinases are numbered amongst the proteinases so 
used. Thiol proteinases may be involved in the prc>cessing of the 
precursors of proteolytic proteins in Rhinoviruses (Korant, 1975; 
Dittmar and Moelling, 1978). and have been reported in adult 
schistosomes (Timms and Bueding, 1959; Dresden, Rutledge and Chappell, 
1981). Thiol proteinases have been reported to be present in a range 
of protozoan parasites. In Leishmania mexicana mexicana amastigotes 
and promastigotes (Coombs, 1982), in the promastigotes of L. donovani 
and L. braziliensis (Camargo, Itow and Alfieri, 1978; Steiger, Van 
Hoof, Bontemps, Nyssens-Jadin and Druetz, 1979), in Trypanosoma 
brucei (Sieger et al. 1979). Trypanosoma cruzi (Bongeretz and 
Hungerer, 1978), in Entamoeba histql_ytica (McLaughlin and Faubert, 
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1977) and from the free-living ciliate Tetrahymena pyriformis 
(Viswanatha and Liener, 1956; Dickie and Liener, 1962; Levy, 
Sisskin and McConkey, 1976). The presence of more than one thiol 
proteinase has been suggested for this orgon-ism (Dickie and Liener, 
A 
1962). In malaria parasites, only acid (Levy and Chou, 1974) and 
EDTA-sensitive alkaline proteinases (Cook, Grant and Kermack, 1961) 
have been reported, however, and therefore thiol proteinases may not 
be present in all protozoan species. 
Thiol proteinase activity has been reported for Tritrichomonas 
foetus (McLaughlin and Muller, 1979) and Trichomonas vaginalis 
(Coombs, 1982). The proteinase isolated from Tritrichomonas foetus 
resembled the mammalian intracellular thiol proteinase cathepsin B. 
However, the T. foetus enzyme had a pH optimum at oH 7.0. while 
the optimum for cathepsin B is in the range of pH 3.5 to pH 5.0 
(Otto, 1971). In addition, the T. foetus enzyme was not labile on 
exposure to pH values above pH 7.0, unlike mammalian cathepsin B 
(de lumen and Tappel, 1972). Cell fractionation studies demonstrated 
that T. foetus proteinase was associated with a population of large 
subcellular particles, containing other neutral hydrolases (McLaughlin 
and Mu'ller, 1979), that are located posteriorly in the parasite. 
These structures are closely related to lysosomes, differinq only in 
the neutral pH optima of their hydrolases. Thiol proteinases activity 
has also been located in a similar fraction of Trichomonas vaginalis 
(Wink, unpublished data), suggesting a similar location to that 
found in Tritrichomonas foetus. The part played by the trichomonal 
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ý thiol proteinases are yet to be fully elucidated. 
Xenobiotic metabolism 
The ability of trichomonads to metabolise potentially toxic 
compounds other than nitro-compounds has been little studied. 
Since the most successful antitrichomonal compound to date 
(metronidazole) is a nitroimidazole, the metabolism of nitro- 
compounds has been studied extensively (Stambaugh, Feo and Manthei, 
Ings and McFadzean, 1975; Perez-Reyes, Kalyanaraman and 
Mason, 1980). The metabolism of metronidazole is reductive in 
trichomonads. Trichomonads are anaerobes that grow optimally in 
the absence of oxygen and so it was of interest to investigate the 
metabolic capabilities of trichomonads with respect to compounds 
whose metabolism in the mammal involves oxidative steps. Any 
inability of the parasite to utilise such oxidative pathways could 
perhaps be exploited in the design and development of new anti- 
tritrichomonal agents. 
Two compounds whose metabolism in the mammal involves 
hydroxylation and reductive steps are nitrobenzene and azobenzene. 
Both compounds have been extensively studied in the mammal, but have 
not- been previously investigated with Trichomonas vaginalis. 
Nitrobenzene 
Nitrobenzene was originally used under the name 'oil of mirbanel 
or 'artificial oil of bitter almonds' for flavouring and perfuming 
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purposes, although its use today is in the industrial manufacture 
of aniline and benzidine. 
The older literature suggests that the main metabolite of 
nitrobenzene found in mammalian urine (Crowdle and Sherwin, 1923) 
is p-aminophenol and its conjugates. A more recent investigation 
of the fate of nitrobenzene in the mammal was undertaken by Robinson, 
Smith and Williams (1951a) who reported that nitrobenzene undergoes 
both reductive and oxidative steps in vivo, and that both amino- 
and nitro-compounds are excreted as metabolites, although the 
authors could only account for approximately 55% of the nitrobenzene 
in the urine. They reported that nitrobenzene and o-nitrophenol 
occurred in small quantitites in the urine, and that m- and p- 
nitrophenol, and p-nitrocatechol occurred in relatively large amounts. 
Thev also showed that the production of p-nitrocatechol resulted 
from the oxidation of nitrophenols in the mammal (Robinson, Smith 
and Williams, 1951b). Nitroquinol could be similarly formed, 
however they were unable to detect the presence of nitroquinol as a 
metabolite of nitrobenzene. Small amounts of aniline, and o- and 
m-aminophenol were detected (Robinson et al. 1951a) but p-aminophenol 
was the main metabolite. It was suggested that as the urine from 
nitrobenzene-fed animals was not highly reducing, unlike the urine 
produced by aniline-fed animals (Smith and Williams, 1949), and 
aniline was not produced in large amounts, that the formation of 
p-aminophenol did not arise via aniline or p-nitrophenol. This was 
refuted by Parke (1956) who accounted for over 85% of the nitrobenzene 
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taken by the mammal. 58% of this was found in the urine, the rest 
being in the faeces (9%) and in the tissues (15-20%) of the animal. 
Parke (1956) confirmed the presence of the metabolites previously 
reported and also noted two additional urinary metabolites, 
nitroquinol and p-nitrophenolmercaptic acid, as well as a yield 
Of CO 2 (See Table 1). The denitration products, phenol and catechol 
were not detected in the urine, neither were nitrosobenzene, 
azoxybenzene, azobenzene and benzidine, suggesting that nitroso- 
benzene and pheny1hydroxylamine were not intermediates in the 
formation of the p-aminophenol produced. A diagram of the main 
steps in the mammalian metabolism of nitrobenzene is given in 
Figure 8. 
The metabolism of nitrobenzene and related nitrocompounds has 
been investigated in organisms other than mammals. Douch and Blair 
(1975) demonstrated nitroreductase activity in the cestode 
Moniezia expansa and the nematode Ascaris lumbricoides var suum. 
Both species readily reduced a variety of compounds to their 
corresponding amines. Oxidative products were not found. Douch 
also reported on the effect of various inhibitors and activators, 
and gave the pH optima and cofactor requirements, for the nitro- 
reductases of both species (Douch, 1975a; 1975b; 1975c; 1976). The 
results suggested that the worms were able only to reductively 
metabolise the nitro-compounds and that the enzymes involved were 
similar to those in mammals. 
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TABLE 1* The metabolic fate of an oral dose of 
14C-nitrobenzene 
in the rabbit 4-5 days after dosing. 
Metabolite 
Respiratory 00 
Nitrobenzene 
Aniline 
0-nitropheiaol 
M-n, itrophenol 
P-nitrophenol 
of dose Metabolite 
1.0 O-aminophýnol 
o. 6 M-amino-phenol 
0.4 P-aminophenol 
0.1 Nitrocatechol 
9.0 Nitroquinol 
I 
9.0 P-nitrophenylnogstic acid 
Modified after Parke (1956) 
Yo of dose 
3-0 
4.0 
31-0 
0.7 
0.1 
0-3 
Figure 8. Diagram of the mammalian metaboli 8f nitrobenzene, NO NO 2 N02 22 
7 
ý7 
OH 
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A 
V 
NH NH NH NH 222 
y2 
OH 
H 
OH 
Aniline P-aminophenol 0-aminophenol M-aminophenol 
A. Reductive step 
B. Oxidative step 
Only the main metabolic products are given. 
Modified from Williams (1959, P. ). 
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1.4.3.2. Azobenzene 
The metabolism of azocompounds in the mammal is of great 
interest, as it was through the realisation that the azodye 
Prontosil broke down in vivo to sulphonilamide, that the sulpho- 
nilamides were discovered and used for the treatment of bacterial in- 
fections (Williamse 1959b). Azobenzene is the simplest azo derivative. 
It has been shown that the azo linkage can be broken (Elson and 
Warren, 1944) and this was confirmed by Bray, Clowes and Thorpe 
(1951) who showed, using paper chromatography, that azobenzene is 
metabolised to yield o- and p-hydroxyazobenzene, benzidine, o- and 
p-acetamidophenols, o- and p-aminophenols and hydrazobenzene, some 
of these being conjugated with glucuronic or sulphuric acid. The 
p-hydroxy-compounds were the major metabolites. Figure 9 summarises 
the major pathway of azobenzene metabolism in the mammal. 
A variety of azocompounds have now been shown to be reduced 
in vivo by enzymes localised mainly in the microsomal fraction of 
the liver (Mueller and Miller, 1948; 1949; 1950). Studies in vitro 
revealed that the enzyme localised in the microsomal fraction was a 
flavoprotein (Hernandez, Gillette and Mazel, 1967). 
Azoreduction has also been reported in the cestode, Moniezia 
expansa, and in the nematode Ascaris lumbricoides var suum (Douch 
and Blair, 1975; Douch, 1975a; 1975b; 1976). The enzyme responsible 
for azoreduction was detected only in the distal cytoplasm of the 
cestode proglottids. No oxidative products of azobenzene were 
detected. 
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1.5. CHEMOTHERAPY OF TRICHOMONAS VAGINALIS 
1.5.1. Methods of assessing antitrichomonal activity 
The conventional method for the determination of the 
susceptibility of Trichomonas vaginalis to compounds in vitro 
involved growth in tubes of media containing serial twofold 
dilutions of drug, and incubation for a set period of time, usually 
one to three days (Forsgren and Wallin, 1974). Usually the drug's 
activity was tabulated as the minimum inhibitory concentration (MIC), 
the minimum concentration of the drug that stopped the flagellar 
movement and motility of the organism. This technique was simplified 
by Meingassner and Thurner (1979) by using microtitre plates in place 
of test tubes; thus facilitating the measurement of the MIC under 
both aerobic and anaerobic conditions. Another method of measuring 
the compound susceptibility of T. vaqinalis using discs containing 
set concentrations of a compound was reported by Smith and Domenico 
(1980). It was reported that all three methods gave comparable 
results (Smith and Domenico 1980). 
Determination of susceptibility of T. vaginalis to compounds 
in vivolisually has been assessed using a subcutaneous infection 
of T. vaginalis in mice or rats. Such a subcutaenous lesion contains 
large numbers of flagellates (Honigberg, 1961). Doubling dilutions 
of drug are given to the animals and lesions are studied at various 
times after dosing for the presence of live parasites. Drug activity 
was. expressed as the MIC, the lowest concentration of the drug which 
killed all the parasites in the lesion. More recently, in vivo drug 
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activity has been assessed by measuring its effect on parasites 
growing intravaginally in hamsters or mice. This method has the 
advantage of measuring the drugs effect on parsites in situ. 
History 
The treatment of trichomonal vaginitis has become more 
sophisticated over the last hundred years. Early treatment 
included efforts to restore the acidity of the vagina as well as 
kill the trichomonads. Treatments of this type involved the initial 
drying of the vaginal mucosa with warm air and then the application 
of douches of dilute vinegar. Powders containing boric acid, or 
acid creams and jellies I were also found useful, often in conjunction 
with the application of lactose to stimulate the growth of acid- 
producing bacteria. Insufflations of acetarsone powder (acetylamino 
hydroxylphenylarsonic acid) or local application of silver picrate 
were found to be moderately successful (Buxton and Shelanski, 1937; 
A 
Strain, 1945). However, the local application of chemicals was not 
a satisfactory treatment, as foci of infection often remained in 
neighbouring structures and glands. The simultaneous application of 
various agents to vagina, bladder and rectum only partly overcame this 
obstacle. An ideal trichomonacidal agent should exert its effect 
systemically, to ensure its distribution to all the affected parts 
of the body. 
In the 1950's and early 1960's several classes of compounds were 
known which were systemically active in experimentally induced 
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ext,, avaginal trichomona4 infections in micer and intravaginal 
infections in hamsters and rats. These included 2-substituted 
5-nitrothiazoles (Bushby and Copp, 1955), 2-substituted nitro- 
pyridines (Michaels and Strube, 1961), 2-substituted 5-nitro- 
pyrimidines (Michaels and Strube, 1961) and 1.2 substituted 
5-nitroimidazole (Cosar and Julou, 1959). It is noteworthy that 
these classes of compounds were all nitroheterocyclics. In clinical 
trials, nitropyridines and nitropyrimidines were found to be too 
toxic for general use, and nitrothiazoles were found to have little 
trichomonacidal effect (Michaels, 1968). The nitroimidazoles, 
however, were promising. 
In 1955, French scientists had observed the growth inhibitory 
effect of an extract of streptomyces 6670 on Trichomonas vaginalis 
(See Jolles, 1977). This extract was purified and 2-nitroimidazole 
isolated as the active compound. A range of nitroimidazole compounds 
were then synthesized and their trichomonacidal activity was 
investigated. 2-nitroimidazoles and 4-nitroimidazoles were found 
to be less active and more toxic than 5-nitroimidazoles (Michaels, 
1968). Of the range of 5-nitroimidazoles tested, such as 
dimetridazole (1,2-di. methyl-5-nitroimidazole) and chlomizol (I- 
methyl-4-chloro-5-nitroimidazole)I metronidazole (1-hydroxyethyl- 
2-methyl-5-nitroimidazole), Figure 10), was the most effective 
trichomonacide and was selected for the treatment of T. vaginalis in 
man. The trichomonacidal activity of metronidazole was reported by 
Cosar and Julou (1959) and the drug was launched onto the market in 
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Figure 10. The structure of metronidazole 
2 
N 
JCH 
1.111 2 CH 2 OH 
1960 for the treatment of T. vaginalis infections. Subsequently 
similar 5-nitroimidazoles have been developed (See section 1.5.3.1. ). 
Other compounds such as nitrofurans, nitropyrroles and bis (thiosemi- 
carbazones) have also been tested for antitrichomonal activity 
(Michaels, 1968), but the 5-nitroimidazoles such as metronidazole 
are,, to date, the most effective antitrichomonal compounds discovered 
and are used extensively throughout the world. 
Metronidazole 
Spectrum of activity 
The most widely used and effective antitrichomonal compound 
discovered to date is metronidazoler although several other 
5-n-itroimidazole derivatives are also very effective in the 
treatment of infections caused by prokoyotic and eukaryotic 
anaerobes (See Figure 11). 
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Figure 11. Metronidazole and other 5-nitroimidazole derivatives 
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The antitrichomonal activity of metronidazole was first reported 
by Cosar and Jolou (1959), since then metronidazole has been used 
very successfully in the treatment of trichomonal vaginitis (Rees, 
1960; Doyle and Bruce, 1964; Porapakkham, 1967; Howes, Lynch and 
Kivlin, 1969). Metronidazole was found to be effective in over 
95% of cases (Pereyra and Lansing, 1964; Parapakkham, 1967) and to 
have few side effects (Watt and Jennison, 1960). An oral dose of 
500 mg metronidazole per day for 7-10 days was found to be effective 
(Doyle and Bruce, 1964) and the insertion of metronidazole into the 
vagina was found to be unnecessary. Several different regimens are 
now used routinely, e. g. 200 mg metronidazole, three times daily 
for 7 days; 800 mg in the morning and 1.2 g at night for 2 days; a 
single 2g dose. All have been reported to give satisfactory results 
(British National Formulary, 1982). 
Laboratory studies have shown that stains of Trichomonas 
vaginalis were killed in vitro in three days by concentrations of 
0.6 to 1.0 jug metronidazole per ml. culture medium 
(Jennison, 
Stenton and Watt, 1961). Blood and urine estimations show that 
metronidazole is rapidly absorbed from the intestiner and excreted 
by the kidney. Even with the 7 day metronidazole regimen, however, 
blood and urine metronidazole levels are maintained at a level high 
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enough to cause parasite death throughout the complete treatment 
period (Jennison, Stenton and Watt, 1961). 
Metronidazole and other 5-nitroimidazoles are also active 
against a range of protozoa other than T. vaginalis, such as 
Entamoeba histolytica (Powell, McLeod, Wilmot and Elsdon-Drew, 
1966; Tanowitz, Wittner, Kress and Rosenbaum, 1973; Everett, 1974; 
WittnerpRosenbaum and Kress, 1975), Giardia lamblia (Felix and 
Ouryoux, 1962; Rambatta, 1971; Andersson, Forsell and Sterner, 1972; 
Wolfe, 1975; Jokipii and Jokipii, 1980), Histomonas (Lucas, 1961) 
and Balantidium (Garcia-Leverde and de Bonilla, 1975). 
In recent years 5-nitroimidazoles, especially metronidazole, 
have been found to have activity against Bacteroides spp. (Nastro 
and Finegold, 1972) and have been used in the treatment (Ingham, 
Rich,, Selkon, Hale, Roxby, Betty, Johnson and Uldall, 1975; 
Feldman, 1976) as well as in the prophylaxis of anaerobic infections 
(Gillespie and McNaught, 1978). In colon surgery, metronidazole 
prophylaxis has been used, reducing the incidence of postoperative 
infections (Fiddion, 1978). The killing activity of metronidazole 
has been found to occur against a wide range of anaerobic bacteria 
(Rissing, Moore, Newmanp Crockett, Buxton and Edmonsonp 1980). 
Other 5-nitroimidazole compounds, such as tinidazole and 
nimorazole, have a broadly similar spectrum of activity, but none 
have supplanted metronidazole from its role as the drug of choice 
for a wide range of bacterial and protozoal diseases. 
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1.5.3.2. Basis of selective toxicity 
A variety of infections of man and of his domestic animals can 
be treated successfully with 5-nitroimidazole derivatives. 
common feature of the infectious agents is that they are anaerobes. 
This suggested that similarities in the metabolism of these organisms 
are responsible for their susceptibility to these compounds. 
It has been shown that the addition of metronidazole or 
other nitroimidazoles to cultures of Trichomonas vaginalis (Edwards 
and Mathison, 1970; Edwards, Dye and Carne, 1973; Muller, Lindmark and 
Mack, 1978) and of Clostridia spp (O'Brien and Morris, 1972; Coombs, 
19-j -J) caused a cessation of hydrogen production, indicating that 
the action of these compounds could be related to metabolic processes 
dependant on ferredoxin-linked reactions, and therefore localised 
in the hydrogenosomes of trichomonads. Both O'Brien and Morris 
(1972) and Coombs (1976) showed that the inhibition of hydrogen 
production was for a finite period of time, which was directly 
proportional to the concentration of drug present. This demonstrates 
that metronidazole does not act by directly inhibiting hydrogenase, 
but rather by utilizing the electrons normally consumed in hydrogen 
production. It has been shown that interferance with hydrogen 
production is not responsible as such for the toxicity of nitro- 
imidazoles in trichomonads. Other nitroderivatives, such as 2,4- 
dinitrophenol (MLler, Nseka, Mack and Lindmark, 1979) and nitrofurans 
(Edwards, Dye and Carne, 1973) can also act as electron acceptors 
and do not have the same toxic effects. 
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Carbon dioxide production was not inhibited by metronidazole 
(Coombs, 1976) under a nitrogen atmosphere. Indeed, under a carbon 
monoxide atmosphere, CO 2 production wasenhanced, for a period 
directly proportional to the concentration of the drug added. This 
su(ý-jested that, directly or indirectly, metronidazole was acting 
as an electron acceptor for the pyruvate: ferredoxin oxidoreductase 
system responsible for the production of CO 2' However,, metronidazole 
did not stimulate CO 2 production if oxygen was present, suggesting 
that oxygen stopped the drug acting as an electron acceptor. 
Edwards and Mathison (1970) reported that metronidazole has no 
effect on the production of acetyl CoA in Trichomonas vaginalis 
and this was confirmed using Clostridiumpasteurianum by Coombs 
. r- 
(1976) , although the latter noted that acetyl CoA production was 
enhanced under a carbon monoxide atmosphere. 
Edwards, Dye and Carne (1972) suggested that if nitroimidazoles 
act as electron acceptors, there would be an accumulation of 
hydrogen ions within the parasite, unless the nitro-group of the 
compound was reduced. No accumulation of hydrogen ions has been 
detected. It has been shown that metronidazole can be reduced by 
sodium dithionite (Edwards, Dye and Carne, 1972; Coombs, 1976), by 
cell-free extracts of Clostridia. spp. (Coombs, 1973; MUOller, 
Lindmark and McLaughlin, 1976; Coombs, 1976) and by trichomonads 
(Lindmark and Muller, 1974; 1976; Muller, Lindmark and McLaughlin, 
19761 with a concomitant loss of its 320 nm absorbance maximum. 
This absorbance is due to the nitro-group, which indicates that 
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reduction involves this group. 
The metabolism of metronidazole within the cell maintains a 
concentration gradient of unreduced parent drug for its continued 
diffusion into the cell. This would explain the rapid uptake of the 
large quantities of radiolabelled metronidazole that it absorbs 
(Ings, McFadzean and Ormerod, 1974; MU"ller, Lindmark and McLaughlin, 
1976). 
Metronidazole was not reduced by ferredoxin-free Clostridium 
pasteurianum unless ferredoxin or methyl viologen was added (Coombs, 
1976), and then the rate of reduction was proportional to the 
concentration of electron acceptor added. This author suggested 
that the reduction of metronidazole was dependant upon pyruvate: 
ferredoxin oxidoreductase, ferredoxin and anaerobic conditions. 
to Mullerp Lindmark and McLaughlin (1976) showed that the reoxidation 
of reduced ferredoxin by metronidazole occurred under aerobic 
conditions. Metronidazole has a redox (half-wave) potential of 
-0.56v and can therefore act as a better electron acceptor than 
ferredoxin (Edwards and Mathison, 1970), both the nitro-group and 
the imidazole ring of the drug conferring the properties of an 
efficient electron sink. Competition for electrons generated by 
the production of acetyl-CoA would occur and this would inhibit the 
hydrogenase system. Muller and Lindmark, (1976) reported that 
metronidazole was probably reduced by reduced ferredoxin in a 
purely chemical reaction. 
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The proposed mechanism of action of metronidazole is given 
t 
in Figure 12. Reduced ferredoxin can be reoxidised by three 
mechanisms. Hydrogenase (1) is the pathway in normal cells. In 
the presence of metronidazole, hydrogenase is inhibited and 
metronidazole is reduced (2). If oxygen is present, (1) and (2) 
cease, probably due to the greater electronegativity of oxygen for 
electrons. Reaction (4) is catalysed by pyruvate: ferredoxin 
oxidoreductase. The reduction of metronidazole is the key to its 
antimicrobial activity, and it is postulated that it is a reduced 
metabolite that is the agent that causes cell death. 
The specificity of action of metronidazole to anaerobic 
organisms is thought to be due to their possession of the metabolic 
capability to reduce the nitro-group of the drug. Aerobic cells 
are apparently unable to do so. It has been shown that drug 
sensitive organisms grown in the presence of oxygen are less 
sensitive to metronidazole (Mullerr 1982). This is related to the 
inhibition by Oxygen of metronidazole reduction, and probably 
involves the reoxidisation of reduced ferredoxin by oxygen, removing 
the means of reducing the metronidazole. A second possible explana- 
tion for this finding is that 02 may reoxidise reduced metronidazole 
within the cell. 
Studies of the reduction of metronidazole by sodium dithionite 
and the inhibition of hydrogen production by the drug, by cell-free 
homogenate, indicated that metronidazole reduction was a four electron 
process (Coombs, 1976: Muller, 1976). A four electron reduction 
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Figure 12 
The mechanism of action of metronidazole 
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indicates that a hydroxylamine derivative was produced (See Figure 13), 
although this has never been confirmed by isolation. More recently 
it has been suggested that the reduction of metronidazole occurs in 
one electron steps (Muller, 1983), assumed to lead firstly to the 
formation of a free radical aniQn which can be reoxidised by oxygen 
to the original compound with the production of superoxide, a toxic 
derivative of oxygen (Perez-Reyesp Kalyanaraman and Mason, 1979). 
Further reduction gives a nitroso derivative, a nitroso-free radical 
and a hydroxylamine derivative (See Figure 13). It is assumed that 
one or more of these intermediates represents the cytotoxic species, 
although none of these transient compounds have been isolated and 
only the existence of the one electron reduction free-radical anion 
has been shown by electron paramagnetic resonance spectroscopy 
(Perez-Reyes, Kalyanaraman and Mason, 1979). 
The complete reduction of metronidazole to acetamide was 
reported by Beaulieu, McLafferty, Koch and Goldman (1981), who used 
acetamide production from cultures of Trichomonas vaginalis and 
Entamoeba histolytica containing metronidazole as a chemical 
indicator of the production of the intermediate thought to exert a 
killing effect on the cell. 
Site of action 
How the parasite is killed has not yet been elucidated, but 
it is thought that certain short lived derivatives or free-radicals 
are responsible for the toxic action (Mu'ller, Lindmark and McLaughlin, 
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Figure 13 
The reduction of metronidazole 
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1977) and that specific intracellular sites are damaged. Micrographs 
of Prichomonas vaginalis cells exposed to high concentrations of 
5-nitroimidazoles showed a reduction in number of, and structural 
damage to, the hydrogenosomes (Buchner and Edwards, 1975; Carosi, 
Filice,, Suter and Dei Cas, 1977). The former authors also noted 
some damage to the nuclear membrane, although this occurred less 
quickly, however the latter authors were unable to detect any damage 
to the nucleus. 
in-. 1974, Ings et al., suggested that DNA might be the major 
site of action of nitroimidazoles when they reported that radio- 
activity from 
14 
C-metronidazole bound to T. vaginalis was released 
on the addition of DNAase, but not RNAase, and that chemically 
reduced metronidazole inhibited nucleic acid synthesis. Unreduced 
metronidazole had no effect on nucleic acid synthesis. Plant and 
Edwards (1976) reported that reduced metronidazole and tinidazole 
inhibited DNA synthesis and degraded the existing DNA. RNA synthesis 
was unaffected. The binding of metronidazole to nucleic acids was 
also demonstrated by La Russo, Tomasz, Muller and Lipman (1977) who 
suggested that metronidazole reduced by dithionite in vitro yields 
a short lived, activated compound or compounds which covalently 
binds to the guanine and cytosine of mammalian, bacterial and 
phage DNA. This work was complemented by Edwards (1977) who reported 
that dithionite reduced metronidazole caused strand breaks in phage 
and mammalian DNA. However, results indicating DNA strand breakage 
with dithionite-reduced metronidazole are not reliable, as dithionite 
itself induces strand breaks in DNA (Cone, Hasan, Lowen and Morgan, 1976). 
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The interaction of electrolytically reduced metronidazole and 
DNA was studied by Knight, Skolimowski and Edwards (1978), who 
reported that this resulted in a loss of helix content and strand 
breakage. It was reported that reduced 5-nitroimidazol. e-induced 
damage to DNA was related to its base composition (Rowleyf Knightf 
Skolimowski and Edwards, 1980) and was associated with the release 
of thymidine phosphates from DNA (Knox, Knight and Edwards, 1981a). 
These authors reported that misonidazole causes cleavage of the 
phosphodiester bonds around thymine residues in DNA, and that 
approximately 5-6% of the total thymidine is released irrespective 
of the total thymidine content of the DNA. This work was extended 
by Knox, Knight and Edwards (1981b) who showed a correlation between 
drug-induced damage and electron affinity in a range of nitroimidazoles, 
and that this correlation arises as a result of the different rates of 
reduction of the drugs, which are themselves a direct function of 
their relative electron affinity. La Russo, Tomasz, Kaplan and 
MLler (1978), however, were unable to detect strand breaks or loss 
of helix content by reduced metronidazole, with mammalian, phage and 
bacterial DNA. Weight was added to this by Mitelman, Strombeck and 
Ursing (1980) who were unable to detect chromosomal aberrations in 
patients on long-term metronidazole treatement. 
There is good evidence that In vitro reduced metronidazole can 
damage DNA in some way. However, it is not possible from the evidence 
available to make firm conclusions on the site of action in vivo of 
the active metabolite of metronidazole. There could be differences 
between prokaryotes, in which evidence for DNA damage is reasonable, 
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and eukaryotes such as T. vaginalis, in which the situation is 
complicated by the physical separation between the DNA in the 
nucleus and drug activation in the hydrogenosomes. 
1.5-3.4. Resistance to metronidazole 
In the 1960's there were reports of Trichomonas vaginalis 
infections refractory to treatment (Robinson, 1962; Squires and 
McFadzean, 1962; Diddle, 1967)f although the parasites isolated 
from these refractory patients were not found to be resistant 
to metronidazole in vitro (Squires and McFadzean, 1962). It was 
suggested that failure to respond to treatment was due to 
metronidazole inactivating organisms in the vagina (Nicol, Evans, 
McFadzean and Squires, 1966; McFadzean, Pugh, Squires and Whelan, 
1969; Edwards, Thompson, Tomusange and Hanson, 1979). failure to 
complete the treatment course (Keighley, 1971) or to reinfection 
(Roe, 1977). 
In the laboratory, lines of Tritrichomonas foetus were developed 
by in vivo exposure to metronidazole, that exhibited resistance to 
several nitroimidazoles as tested both in vivo and in vitro (Actor, 
Ziv and Pagano, 1969; Meingassner and Mieth, 1976). Meingassner, 
Mieth, Czok, Lindmark and MU'ller (1978) reported the existence of a 
strain of T. foetus which had been grown in sublethal concentrations 
of metronidazole and which showed in vitro resistance to metronidazole 
under aerobic, but not anaerobic conditions. Lines of Trichomonas 
vaginalis resistant to metronidazole in vivo have also been induced 
by in vivo exposure to metronidazole, however in these cases no 
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significant in vitro resistance was observed (de Carneri, Achilli, 
Montiand Traner 1969; Benazet and Guillaume, 1971). Jennison, 
Stenton and Watt (1961) were unable to induce resistance to 
metronidazole in T. vaginalis in vitro, as were other workers 
(Squires and McFadzean, 1962). However, Coombs (1976) developed a 
line of T. vagin. aliS by growth in the presence of sublethal concen- 
trations of metronidazole, which showed a slight decrease in 
sensitivity to the drug. 
In 1978, Thurner and meingassner isolated a strain of T. vaginalis 
with a decreased metronidazole sensitivity, from a patient who had 
not responded to several courses of treatment. This strain showed 
resistance to metronidazole, tinidazole and nimorazole both in vivo 
and in vitro. In vitro the resistance to metronidazole and the 
other nitroimidazoles only occurred under aerobic conditions. 
Subsequently, three metronidazole resistant strains of T. vaginalis 
were isolated from patients in the United States of America in 1978 
and 1979. These isolates showed resistance to metronidazole both 
in vivo and in vitro. In vitro, however, the resistance again could 
be detected under aerobic conditions only (M61ler, Meingassner, Miller 
and Ledger, 1980; MUller, 1982). Heyworth, Simpson,, McNeillage, 
Robertson and Young (1980) also reported the isolation of a strain 
of T. vaginalis, resistant in vitro to metronidazole, from a 
natiL&nt who had not responded to metronidazole treatment. 
In all lines of metronidazole resistant T. vaginalis isolated 
from patients to date, in vitro metronidazole resistance has only 
been detected under aerobic conditions. Since it is necessary for 
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oxygen to be present for the in vitro expression of resistance, and 
that the presence of ascorbate, a strong reducing agent, in the 
culture medium (Meingassner, Mieth, Czokr Lindmark and Muller, 1978) 
suppresses this resistance', it suggests that oxygen is involved in 
some way. It appeared possible that oxygen may be entering the 
hydrogenosomes of these parasites under aerobic conditions and 
inhibiting the reductive activation of metronidazole. 
Metronidazole resistance has also been reported for bacteria. 
Metronidazole-resistant mutants of Bacteroides fra2ilis were isolated 
after treatment of the bacteria with N-methyl-Nl-nitro-N-nitroguanidine 
and ethyl methane sulfonate (Britz and Wilkinson, 1979). All. the 
metronidazole resistant strains had lowered levels of pyruvate 
dehydrogenase compared with parent cultures. A consequence of this 
would be lowered rates of ferredoxin reduction, and therefore of 
metronidazole reduction in these strains, causing lowered metroni- 
dazole sensitivity (Britz, 1981). This metronidazole resistance was 
found under both aerobic and anaerobic conditions. This suggested 
that the mode of resistance to metronidazole exhibited by these 
organisms was different from that exhibited by clinical isolates 
of Trichomonas vaginalis and Tritrichomonas foetus. 
1.5.4. Thiosemicarbazones 
Thiosemicarbazones (See Figure 14) containing highly varied 
substituents have been found to possess chemotherapeutic properties 
against a wide range of microorganisms and diseases (Levinson, 1980). 
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Figure 14 
Basic Structure of a thiosemicarbazone 
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In addition to other activities, these compounds, often in chelation 
with transition metalst appear to inhibit the function of nucleic 
acids and related enzymes. 
1.5.4.1. Antitumor activity and mode of action 
Several thiosemicarbazones have been found to have antitumor 
activity (Brockman, Thomson, Bell and Skipper, 1956; French and 
Freedlander, 1958; Barry, Conalty and O'Sullivan, 1966). However, 
these compounds are apparently ineffective unless transition metal 
ions are present (Booth and Sartorelli, 1966; Petering, Buskirk and 
Crim, 1967; Van Giessen, Crim, Petering and Petering, 1973). It 
has been shown (Van Giessen, Crim and Petering, 1968) that 
thiosemicarbazones can form stable chelates with transition metals 
(Crim and Petering, 1967; Kessel and McElhinney, 1975) and the effect 
of the copper chelate of a thiosemicarbazone on various metabolic 
processes has been studied (Kessel and McElhinney, 1975), showing 
a correlation between chelation and an ability to inhibit DNA synthesis. 
Booth and Sartorelli (1966) showed that a combination of cupric 
chloride and a thiosemicarbazone inhib; ted the synthesis of. DNA, RNA 
and proteins in sarcoma 180 ascites cells, although little or no 
inhibition was CcLLsed by the cupric chloride or thiosemicarbazone 
alone. Subsequently, many authors have reported that DNA synthesis 
was inhibited by thiosemicarboazones and their chelates (Booth and 
Sartorelli, 1967; Kessel and McElhinney, 1975; Minkel and Petering, 
1978). Inhibition of RNA and protein synthesis also occurred, but 
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to a much smaller extent. 
In 1970, Moore, Zedeck, Agrawal and Sartorelli showed that 
the interferance of DNA synthesis by a thiosemicarbazone was due 
to the inhibition of ribonucleoside diphosphate reductase, an 
enzyme responsible for the conversion of ribonucleotides to 
deoxyribonucleotides. They also noted that dithiothreitol (DTT) 
and dithioerythritol (DTE) were partially competitive with the 
inhibitor, and that ferrous ions enhanced the inhibitory effect of 
the compound. A relationship between the inhibition of ribonucleoside 
diphosphate reductase by a thiosemicarbazone and the concentration 
of DTT and DTE was reported by Sartorelli, Agrawal, Tsiftsoglou and 
Moore (1977) who noted that the inhibition was more pronounced at 
a low thiol concentration than at a higher one. They suggested that 
the thiosemicarbazone binds at or near to the site on the enzyme 
normally occupied by the thiols. The inhibitory effect of 
thiosemicarbazones, and their transition metal chelates on ribonucleo- 
tide reductase in tumor ce, ls has been confirmed by a number of 
authors (Chang and Cheng, 1978; Cory and Fleischer, 1980; Preidecker, 
agrawal, Sartorelli and Moore, 1980; Sato and Cory, 1981). 
The reaction mechanism of the ribonucleotide reductase from 
Escherichiacoli has been investigated (Thelander, 1974; Thelander, 
Larsson, Hobbs and Eckstein, 1976) and is probably as follows 
(See Figure 15). 
The antagonism of thiosemicarbazone inhibition by the addition 
of thiol groups noted by Moore et al. (1970) and Sartorelli et al. 
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(1978) could be explained by the competition of these thiols with 
those associated with the enzyme for binding to the thiosemicarba- 
zone, and therefore inhibiting the amount of enzyme associated with 
the thiosemicarbazone. 
More recently? another mechanism of action has been postulated 
for thiosemicarbazones; the inhibition of amino acyl t-RNA 
synthetase activity (Rhode, Cordell, Webster and Levinson, 1977). 
It was found that thiosemicarbazone: copper complexes, but not the 
thiosemicarbazone or copper alone, bind to tRNA (Mikelens, 
Woodson and Levinson, 1976). Rhode et al. (1977) proposed that 
tRNA synthetase inhibition was due to such an interaction between 
tRNA and the copper: thiosemicarbazone complex. Since the binding 
of tRNA by amino acyl. tRNA synthetases is sensitive to changes in 
the overall shape of the tRNA, they suggested that the binding of 
the thiosemicarbazone: copper complex to the tRNA induced a 
conformational change, adversely affecting its substrate properties, 
and therefore inhibiting tRNA synthetase. 
Since the thiosemicarbazones contain compounds with such varied 
substitutents, it is very likely that different compounds could have 
activity at different sites. 
1.5.4.2. Antiviral and antibacterial activity 
The antiviral activity of thiosemicarbazones was first 
reported by Hamare, Bernstein and Donovik (1950) who found that 
benzaldehyde thiosemicarbazone derivatives were active against 
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vaccinial infection in mice when given orally. Isatin /3-thiosemicar- 
bazone was shown to be a potent inhibitor of pox virus replication in 
cultured animal cells (Sheffieldr Bauer and Stephenson, 1960), 
affecting the late stages of the virus growth cycle (woodson and 
Joklik, 1965). This was confirmed by Cooper, Moss and Katz (1979), 
who reuorted a 95% inhibition of viral protein synthesis. In 1969, 
Sidewell, Arnett? Dixon and Schabel demonstrated that purine-6- 
carboxaldehyde thiosemicarbazone was effective in suppressing both 
the cytopathic effect and the titres of human megalovirus. Activity 
against Herpes Simplex virus was reported by Shipman, Smith, Drach 
and Klayman (1931) who showed that the thiosemicarbazones inhibited 
viral replication to a greater extent than cellular DNA and protein 
synthesis. 
It is only recently that thiosemicarbazones have been reported 
to have antibacterial activity. 2-Acetylpyridine thiosemicarbazones 
have been shown to be very active against Neisseria gonorrhoeae and 
N. meningitides (Dobek, Klayman, Dickenson, Scovill and Tramont, 1980). 
Inhibition of gram-negative bacilli, namely Pseudomonas, Shigella, 
Proteus and Escherichia coli also occurred, but only at such high 
concentrations as to rule out their use as chemotherapeutic agents. 
However, the sensitivity of Neisseria spp. to thiosemicarbazones was 
so great (mIC: 0.002-0.008 ug/ml) with the drugs above, against both 
penicillin-susceptible and -resistant strains, that these compounds 
are of continuing interest as possible anti-bacterial agents. Little 
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is known of the basis of the antibacterial activity of thiosemi- 
carbazones, although DNA synthesis has been implicated (See section 
1.5.4.1. ). It is not yet clear whether any of these compounds will 
have clinical use as antibacterial agents. 
1.5.4.3. Antiprotozoal activity 
The potential of thiosemicarbazones as antiprotozoal agents 
has only been reported over the last few years. Klayman, Bartosevich, 
Griffin, Mason and Scovill (1979) showed that a wide range of 2- 
acetylpyridine thiosemicarbazones have antimalarial activity. This 
work was continued on a small range of compounds in an attempt to 
elucidate which of the substitutents of the compound gave the greatest 
antimalarial activity (Klayman, Scovill, Bartosevich and Mason, 1979). 
Thiosemicarbazones, in particular the 2-acetylpyridine 
thiosemicarbazones, have also been shown to have activity against 
Trypanosoma cruzi (Wilson, Revankar and Tolman,, 1976), both in vivo 
and in vitro, and against Trypanosoma rhodesiense in vitro (Casero, 
Klayman Childs, Scovill and Desjardins, 1980). In the latter case, 
the authors suggested that a potential site for activity may be 
the iron-containing parasite-specific enzyme, glycerol-3-phosphate 
oxidase, which is essential for energy producing metabolism in the 
blood-form of the trypanosome. They support this by noting that 
thiosemicarbazones are avid chelators of transition metals, and 
that a structurally similar thiosemicarbazone is thought to form a 
liqand with iron within its target organism (French, Blanz, 
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DoAmaral and Frencht 1970). This thiosemicarbazone has also been 
shown to inhibit the growth and suppress RNA synthesis in, Escherichia 
coli (Brown, Stancato and Wolfe, 1981). DNA and protein synthesis 
were also inhibited, but this could be a consequence of the suppression 
of RNA synthesis. This compound apparently does not require an 
exogenous transition element. E. coli RNA polymerase and DNA 
polymerase, however, contain zinc (Scrutton, Wu and Goldthwaiter 
1971; Slater, Mildvan and Loeb, 1971), which may form part of the 
drugs target. The activity of thiosemicarbazones against other 
parasitic protozoa, including Trichomonas vaginalis, has not been 
reported. It seemed feasible, however, that the biochemical pathways 
unique to anaerobic protozoa may be possible targets for these 
compounds, especially as it was known that transition metals are 
important constituents of these parasites. 
COMPOUNDS AFFECTING DNA REPAIR 
There have been no reports on the ability of T. vaginalis to 
repair damaged DNA or the enzymes involved in the process. However, 
there have been suggestions that DNA is the primary target of the 
main antitrichomonal drugs, 5-nitroimidazoles such as metronidazole 
(Knight, Skolimowski and Edwards, 1978). 
In 1978, Knight, Skolimowski and Edwards reported that reduced 
metronidazole caused DNA strand breaks, although La Russo, Tomasz, 
Kaplan and Muller (1978) were unable to detect any strand breaks. 
Olive (1979) reported an increase of breaks in the DNA of mouse L929 
cells in the presence of metronidazole. To date, the ability of 
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metronidazole to cause DNA strand breaks in vivo has not been 
assessed. 
Dimethyl sulphate (DMO) is a well known alkylating agent, 
which alkylates oxygen atoms in DNA (Newbold, Warrenr Medcalf and 
Amos, 1980) and thus interferes with DNA base-pair hydrogen bonding. 
This may be the major DNA modification responsible for the induction 
of GC -*AT transition mutations in bacterio-phages by alkylating 
agents (Lawley and Martin, 1975). DMS has also been used in previous 
studies involving poly (ADP-ribose) polymerase (Durkacz, Omidijii, 
Gray and Shall, 1980) as a DNA-damaging agent. 
Ethidium bromide is a compound which intercalates between 
DNA bases causing transcription errors and helix loss. It has been 
shown to inhibit DNA supercoiling (Benyajati and Worcel, 1976) and 
to inhibit the incorporation of titrated dTMP into DNA (Mattern and 
Painter, 1979) in permeabilised Chinese hamster ovary cells. 
A group of thiosemicarbazones (2-acetylpyridine thiosemicarbazones) 
have been found to inhibit DNA synthesis (Booth and Sartorelli, 1966). 
Other thiosemicarbazones have been shown to inhibit ribonucleotide 
diphosphate reductase (Moore, Zadeck, Agrawal and Sartorelli, 1970). 
It has been postulated that some thiosemicarbazones may inhibit 
tRNA synthetase (Rhode, Cordell, Webster and Levinson, 1977). Poly 
(ADP-ribose) polymerase has not been postulated as a target for 
thiosemicarbazone activity, but the envolvement of these compounds in 
the inhibition of DNA synthesis suggested that thiosemicarbazones 
might be of interest in this experiment. 
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AIMS OF THE PROJECT 
The main purpose of this project was to increase our knowledge 
of the metabolism of Trichomonas vaginalis and how this can be 
disrupted by drug action. It was hoped that this would indicate 
ways in which to selectively kill the parasites with new drugs. To 
these ends, several approaches were followed. Firstly, to compare 
metronidazole-resistant and metronidazole-sensitive lines of 
1. vaginalis in an attempt to understand the mechanism or mechanisms 
of drug resistance and other factors that affect the parasite's 
susceptibility to metronidazole. Secondly to develop an in vitro 
drug-screening system to test the sensitivity of T. vaginalis to 
potential antitrichomonal compounds and drug combinations, and to 
elucidate the mode of action of compounds with potent antitrichomonal 
activity. Thirdly, to investigate the ability of T. vaginalis to 
metabolise xenobiotics, which are metabolised in the mammal by both 
reductive and oxidative steps, and so to discover more about the 
anaerobic nature of the parasite and the restrictions this imposes 
upon it. 
MATERIALSANDMETH0D 
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2.1. PARASITES AND GROWTH CONDITIONS 
2.1.1. Parasite lines 
Seven lines of 11'richomonas vaginalis were used: Clone G3, a 
clone isolated in this laboratory from a line originally obtained 
in 1973 from The Wellcome Research Laboratoriesq Beckenham, Kent 
(Coombs, 1976); Line IR78, a metronidazole-resistant line isolated 
from the vagina of a patient after three unsuccessful courses of 
treatment with metronidazole (Meingassner and Thurner), and 
obtained from Dr. J. G. Meingassner (Sandoz Forschungsinstitutt 
Vienna, Austria) in 1978; Lines LRS (0.6) and LRS (2.0), developed 
in this laboratory from clone G3 by growth in vitro under increas- 
ing drug pressure, until they were grown in medium containing 
metronidazole at 0.6 and 2.0 ýig/ml respectively; Line 965691, 
obtained from May and Baker Ltd., Dagenham, Essex, England; Lines 
Albany, Boston and Fall Rivert isolated from patients after unsuc- 
cessful metronidazole treatment (Mttller, Meingassner, Miller and 
Ledger, 1980) and obtained from Dr. J. G. Meingassner. The line 
of Leishmania mexicana mexicana used had been isolated in 1962 and 
was obtained from Dr. R. A. Neal (The Wellcome Research Laboratories, 
Beckenham, Kent) in 1972. Promastigotes were obtalned by trans- 
formation of isolated amastigotes. 
2.1.2. Growth of Parasites 
Clone G3 and lines LRS (0.6), LRS (2.0), IR78, Albany, Boston 
and Fall River of. Trichomonas vaLnalis were usually grown axenically 
at 37 
0C in sterile, screw-capped, bijou bottles containing approxi- 
matelY 5 ml GTM medium (Table 1). 
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Table 1. Constituents of GTM culture medium 
L-ascorbic acid 3-7 9/1 Panmede 1.0 g/1 
Tj-cysteine-Ml 2-5 9/1 Bactopeptone 5.0 9/1 
D-glucose 10.0 g1l I*, 6, lemco powder 3.0 9/1 
Distilled deionised water 1 litre 
The medi-um was adjusted to PH5.8, autoclaved for 10 minutes at 
15 lbs/in 2 and stored for up to two weeks at 40C. Newborn calf 
serum, heat inactivated bY 30 minutes incubation at 56 0C) was added 
to 109/0 (v/v), just prior to use. The parasites were cultured 
stationary with air as the gas phase (Coombs, 1976). Lines G3 and 
LRS were subcultured every 24 and 48 hrs respectively, and lines 
IR78, Albany, Boston and Fall River everY 72 hrs, -trj the addition 
of 0.2 mls of late log-phase cialture (abaut 2x 105 parasites) into 
approximatelY 4.8 mls of fresh culture medium. 
Line 965691 was maintained in a similar manner using modified 
'Bushby's medium (Bushby and Copp, 1955)v (Table 2). 
Table 2. Constituents of modified Bushby's medium 
Try-ptone broth 30 9/1 Calcium pantothonate 
0.05% soln. 
Dextrose 20 9/1 
1 ml /I 
Neutralised liver digest 18 g1l Distilled deionised water 1 litre 
The medium was adjusted to pH6.0, autoclaved for 10 minutes 
at 15 lbs/in 
2 
and stored for up to two weeks at 40C. Heat inacti- 
vated horse serum was added to 201/6 (v/v) just prior to use. 
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Leishmania promastigotes were obtained by transfo: rmation of 
isolated amastigotes and grown at 26 
0C in HOMEM medium (Berens, 
Bmm and Krassnerl, 1976) with 10yo Poetal Calf Serm. OnlY 
promastigotes that had been subpassaged 3-8 times were used in 
-this investigation. Parasites were subpassaged every 96 hrs. 
'DO-A 
larasite numbers were determined using an improved Neubauer 
Haemocytometer. Checks for contaminating organisms were made by 
microscopic observation using a Leitz phase-contrast microscope 
at the time of each subculture. Contaminated cultures were 
subcultured with 500 units of Crystamycin/ml culture medium. If 
the contamination was present at the next subaulturing then the 
contaminated cultures were discarded and a fresh culture taken from 
the stabilate. 
Variations in growth conditions 
Growth studies of clone G3 and line IR78 in media containing 
a range of concentrations of acetate, L-lactate, L-cysteine, L- 
ascorbate, L-methionine, gliatalhione and dithiothreitoll at a 
range of pH's,, and under different oxygen, nitrogen and carbon 
dioxide tensions, were carried out at 37 
0C using 20 ml universal 
bottles containing 5 ml of GTM medium and fitted with a tight 
fitting suba-seal (Gallenkamp and Co. . Ltd., London, England). 
Appropriate gaseous conditions were attained by gassing cultures 
(i litre/min) with mixtures of nitrogen, oxygen and carbon dioxide 
for 3 minutes initially, and for 2 minutes every subsequent 12 hrs. 
s mixtures were obtained using a gas mixing apparatus in which 
r the gas flow rates are controlled by needle valves ýNegretti and 
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Zambra, Southampton, England), and the appý: '&atus was calibrated by A 
monitoring gas flow rates using measuring cylinders (Hart and 
Coombs, 1981), (See Agure 1. ). 
'Itie gas flow from each of the gas cylinders was calibrated 
in the following manner. The flow rate was firstly standardised 
using the calibrated regulators (R) to give gas pressures of 
29 lbs/in 2 (nitrogen and oxygen) or 5 lbs/in 
2 (carbon dioxide)* 
With the rate of gas issuing from each gas cylinder standardised, 
the gas passed through a calibrated needle valve (CV) and the flow 
rate through the valve at each setting was measured by use of a 
measuring cylinder, the bottom of which was fitted with a teat 
containing detergent. With gas passing through the measuming 
cylinder, the teat was squeezed, the detergent level was raised 
above that of the gas inlet and a bubble was formed. The time 
taken (in minutes) for the bubble to reach the top of the one 
litre cylinder gave the rate of gas flow in litres/minute. The 
g. as flow from each gas cylinder was calibrated individually using j- 
the needle valve settings. The flow -rate of each gas could 
then 
be set at the required rate and the gases mixed in the mixing 
chamber. This apparatus was designed and constructed by Dr. A. C. 
Taylor of this department. Gas mixtures are given throughout as 
the percentage (v/v) in the ga& phase. 
Routine drug screening of all drugs, under aerobic and 
anaerobic conditions (without the use of gas mixing apparatus), 
was carTied out using microlitre plates. The use of these 
multiwell plates is disaussed in section 2.2.1. 
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ýnalis Cryopreservation of Trichomonas ya 
ml of culture medium containing 5Y6 (v/v) IRSO was added to 
ml of axenic, late lo6ýýphase culture, containing approximately 
5x 105 parasites/ml, bY 3 additions at 15 minute intervals. This 
mixture was aseptically transferred into 1 ml stabilate tubes and 
frozen using liquid nitrogen and methanol, at a rate of 3-4 0 C/ 
minute from room temperature to 00C and at 10 C/minute from OOC to 
-400C. At -400C the stabilate tubes were transferred into liquid 
nitrogen for storage. PaA'ites stored in this way maintained A 
viability for several years. The parasite lines were reinitiated 
from stored parýs'ites at least every 6 months, to minimise the A 
effect of changes -that occurred on continuous subculture. 
Materials 
Metronidazole (1-hydroxy ethyl-2-methyl-5-nitroimidazole) was 
provided by May and Baker Ltd., Dagenham, Essext aigland. Other 
compounds were obtained from the following sources: 1-ascorbate, 
1-acetateý L-lactatep D-glucoseq D-dextrose,, BDH laboratory 
Chemical Division, Poole, Dorset, England; "Lab. lemcoll powder, 
tr:; - ptone broth, neutralised liver digest, Oxoid Ltd., London, 
England; parmedet Paines and Byrne Ltd., Greenford, Middlesex, 
England; newborn calf serumt horse serumq Gibco-Biocult, Paisley, 
Scotland. All other chemicals were of analar grade and were 
obtained from Sigma Chemical Co. . Ltd.. Poole, Dorset, England. 
Deionised and distilled water was used in all solutions. 
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2.2. METHODS OF ASSESSING IN VITRO ANTITRICHOMONAL ACTIVITY 
2.2.1. In vitro drug screening methods 
Trichomonas vaginalis were incubated in round-bottomed, 
multiwell plates, containing 96 wells (Flow laboratories Ltd., 
Ayrshire, Scotland) in 300 )al GTM medium with added drug (0-580tuM) W 
at 37 0C under both aerobic and anaerobic conditions. The latter 
conditions were produced by a BBL Gas Pak 150 hydrogen and carbon 
dioxide generating system (Becton, Dickinson U. K. Ltd., Wembley, 
Middl esex, England). The aerobic experimental plates were incubated 
in the incubator inside a large (25 x 15 x 12 cm) plastic sealed 
container, along with a beaker containing 25 ml water, so that the 
wells would not dry out. The effect of cysteine on the killing 
activity of the thiosemicarbazones (TSC1 and TSC2) on Leishmania 
mexicana mexicana promastigotes was carried out in multiwell plates 
under aerobic conditions, in Homem, medium, with and without the 
addition of 12.7 MM cysteine H61. Any pH change caused by the 
addition of the cysteine was countered by the addition of 0.1 M 
NaCH. These cultures were incubated at 26 0C and 
parasite number and condition assessed .. Incubation 
usually was for 24 hr. and the number and condition of parasites 
at the end of incubation was assessed using a Leitz inverted phase 
coLtrast microscope. Parasite number was assessed using a three 
level scheme, -'++' indicating similar numberp of live cells as in 
the control well; 1+1 indicating live cells, but fewer than in the 
,r control, and 
1-1 indicating no live cells present. Iack of flagella 
and body motility was taken to mean that the parasite was dead. Drug 
activity was expressed as the minimum inhibitory concentration (MIC), 
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the lowest concentration in which no motile parasites were observed 
at the end of the experiment. All drugs were dissolved in water 
where possible, or in amalar methanol diluted in water. In the 
experiments, only methanol concentrations of 2% or less were used, 
concentrations shown to have no inhilitory effect on the growth of 
the parasite. All drugs were filter sterilised, using a millipore 
filter (pore diameter 20 um) prior to lase# 
The drugs assessed using this method were: metronidazole,, 
nitrofurans (nitrofurantoin and comPound 4)v 4-nitrodiazoles 
(compounds 1,2 and 3)v isothiazoles (compounds 5,6 and 7). 
th io s emicarbaz ones (TSC1 92 and 3), quinone compounds 
(compounds 
8 and 9). non-nitro heterocyctics (compounds 10 and 11)0 6. bl%idium 
bromide, dimethyl sulphate, benzamide, 2-, 3- and 4-aminobe W7-ide, 
le-apeptin, antipain. The structure of metronidazole, nitrofurantoin, 
compounds I to 11 and TSC1 to 3 are given in section 3-1- 
In experiments to measure the antitrichomonal activity of 
thiosemicarbozones on Trichomonas vaginalis', cysteine and ascorbate 
excy6okm morawna 
were omitted from the medium. Expeximents involving dimethyl A 
sulphate were carried out in a fume cupboard. 
In some experiments T., vaginalis was incubated in 10 ml test-7 
tubes, in 5 ml of Bushby's medium with added drug (0-100 ug/ml- in 
doubling dilutions) at 370C, under aerobic conditions. The compounds 
tested by this method were: aniline, nitrobenzene, 4-nitrophenol and 
azobenzene. The number and condition of parasites was assessed by 
the microscopic examination of a wet preparation of parasite cultuxe 
using the scheme outlined above. 
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The production of -thiosemicarbazone killing curves was carried 
out using an axenic 100 ml culture containing approximately 2.7 x 
10 
6 
cells per ml which was dispensed equally into five sterile 
20 ml universal bottlesp Thiosemicarbazones (TSCI and TSC2) were 
added, at concentrations of 1 ), iM and 5 )iM eacho to frour of the 
cultures, the fifth 20 ml culture,, without added thiosemicarbazoneý 
was used as a control. The cultures were incubated at 37 0 C. Small 
samples were removed from each culture using a sterile pipette 
after Oi, 30,60,1209180924Ot3OO and 360 minutes. The samples were 
used to determine-the parasite density in each aulture, using an 
improved Neubauer haemocytometer. 
2.2.2. Procedure in experiments involving acetate and lactate 
Experiments involving the effect of acetate, lactate or pH 
-In '... ange on the killing effect of metronidazole were performed by 
adding metronidazole (0-120 pM in do-abling concentrations) to GTM 
medium containing a range of acetate or lactate concentrations 
(0-10 mM in doubling concentrations) or to medium adjusted to pH 
5.2 or pH 4.6, the pH obtained upon the addition of 10 mM acetate 
and 10 mM lactate respectively to GTH medim (usually pH 6.0). 
'Parasites were incubated at 37 
0C under aerobic and anaerobic con- 
ditions as in section 2.2.1. Their number and condition was 
assessed using a Leitz inverted phase contrast microscope, and 
drug activity was assessed as in section 2.2.1. 
2.2-3- Materials 
The compounds assessed using the drug screening methods were 
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provided either by May and Baker Ltd., Dagenham, Essex, England, 
or by BIE Laboratory Chemical 2ivisiong Poole, Dorset, England. 
2.3. PRODUCTION OF CELL-FREE HOMOGENATES 
Trichomonas vaginalis 
Axenic 200 ml aulturc-, containing approximately 5x 1()5 
parasites per ml were harvested by centrifugation at 1430 g for 
20 minutes at 40C. Parasites were washed three times in a solution 
containing 0.11 M NaCl. 2.8 mM D-glucose and 0.19 M sodium phosphate, 
pH 7.4. resuspended to a cell density of approximately 1x 10 
8 
cells/ml in a solution containing 0.25 M sucrose, 0.025 M kCl, 
5 MM MgC129 5 ml"I EDTAP 30 mM mereaptoethanol, 0,05 M tris-EC1P 
'PH 7-5 and gassed with argon (1 litre/minute) over the surface of 
the solution, so Ihat the surface was agitated, for 3.5 minutes. 
The tube containing the parasite suspension was sealed with a tight 
fitting suba-seal and gassed again for a further 2 minutes. Cell 
breakage was achieved by three cycles of freezing (-800C) and 
thawing (3700- In most cases, homogenates were assayed immediately, 
but some were immediately frozen to -70 
0C 
and assayed within 96 hrs. 
2.3.2. Mouse liver 
The liver was excised from a freshly killed female NIH mouse 
(Hacking and Churchillp Huntingdon, Cambridge), cut up into small 
pieces, rinsed twice in 10 volumes of 0.1 M tris-HCl, pH 7-3 buffer, 
resuspended in 3 volumes of the same buffer and homogenised with 
20 strokes of a tight fitting pottor homogeniser at a speed of 
10 revolutions per second. The resultant cell-free homogenate was 
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centrifuged at 1430 9 fOr 10 minutes at 40C using an MSE Chillspin 
centrifuge. The supernatant was removed and centrifuged at 24000 9 
for 60 minutes at 40C using an MSE Prepspin 50 centrifuge, to 
rer-ove the rema=**ng cell debris. The supernatant was removed 
and either assayed immediately or frozen at -70 
0C for-up to 4 days 
prior to use. 
2.3-3. Materials 
auba-seal caps were obtained from A. Gallenkampand Co. 1, Ltd., 
Braeview Place, Nerston, East Kilbride, Glasgowl Scotland. EDTA 
and mercaptoethanol were obtained from Sigma Chemical Co., Ltd., 
Poolev Dorset, England. All other chemicals were of analar grade 
and were obtained from BBH Laboratory Chemical Division, Poole, 
JDA-Prset, England, 
2.4. STU-DIES ON THE XENOBIOTIC METABOLISH OF TRICHOMONAS 
VAGINALIS 
Two methods of investigating the potential of T.. vaainalis 
to metabolise azobenzene and nitrobenzene were used. (a) Using 
living parasites, (b) Using cell-free homogenates. 
2.4-1. Inaubation conditions and extraction proced'are 
a) Whole cells 
Axenic aaltures of T. vaginalis were grown in 100 mls of 
modified Bushby's medium at 37 
0C for 24 hrs, alone or in the 
presence of nitrobenzene or azobenzene at 25 ; ig/ml. At -the end of 
the incubation the complete 100 ml culture,, both cells and medium, 
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was subjected to 3 cycles of freezing (-800C) and thawing (370C) 
to break the cells, and the resultant homogenate was extracted 
three times into equal vol-umes of chloroform to which 0.1 M NaOH 
had been added, to raise the pH to pH 8.0. The extracts were 
evaporated to dryness in a vacu-um oven at 50 0C and resuspended 
either in 1-2 mls of chloroform, if they were to be analysed 
using thin layer chromatography, or in 1 ml of methanolo if they 
were to be subjected to high performance liquid chromatography 
(HPLC). 
b) Cell-free homogenates 
Azobenzene or nitrobenzene (25 ug) was incubated at 370C 
with 500 ;A of T. vaginalis cell-free homogenate, for 30 minutes 
under aerobic or anaerobic conditions. Two control phials, one 
containing homogenate but no parent compound, and the other parent 
compound but no homogenate, were incubated anaerobically at 37 0C 
for 30 minutes. Anaerobic conditions were attained using a 
0C -Forma Scientific anaerobe system, model 1024, containing a 37 
incubator. All incubations were conducted both with and without 
the addition of pyravate f\)-50 mmoles), coenzyme A (5 mmoles) and 
methyl viologen (100 mmoles). At the end of the inciabation the 
mixtures were extracted using the same system that was used for 
whole cell incubates. 
2.4.2. Thin layer chromatography 
The compounds in the samples were separated by ascending thin 
layer chromatography (Williams and Kirby, 1948)- 10-40 ý11 samples 
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of the extracts, and 5 lig of the standards of the parent compounds 
and their mammalian metabolites, were spotted onto Camlab polyga-am 
Sil G/U. V. 254 thin 
layer chromatography plates. These were then 
placed upright in solvent tanks containing solvent to a depth of 
approximately 1 cm. The tanks were sealed and the solvent was 
seen to move -up the plate over a period of hours, The plates 
were removed when the solvent front was approximately 1 cm from 
the top of the plate, the position of the solvent front was marked 
and the plates allowed to dry in air. The run was complete after 
apProximatelY 5.5 hr using solvents I and II, and after 1-5 hr 
using solvent III. 
After drying, the plates were examined under a 254 rim U-V. 
light source. The plates fluoresced under light of this wavelength 
and samples and standards showed up as dark spots on the fluorescing 
background. The samples and standards were examined by comparing 
the distance they and the solvent had migrated. This was expressed 
as the Rf value (i. e. distance of a sample spot from the origin/ 
distance of solvent front from the origin). An identical Rf valae 
of a sample and a standard was taken as a positive identification 
of the sample. The standards used in this way were nitrobenzene, 
aniline, o-, m- and p-aminophenol, o-, m- and p-nitropheriol, 
azobenzene, hydrazobenzene. Three solvents were used: - 
I. Butan-1-ol: acetic acid: H 20 
(4: 1: 5 v/v) (Robinson, Smith and 
Williams,, 1951 ). 
II. Propan-l-ol: a=onia (7: 3 v/v). 
III. Methanol: toluene: acetic acid (8: 45: 4 v/v). 
al 
2-4-3. High performance liqiaid chromatography 
Chromatography of standards and extracted samples was performed 
on a 25 cm, reverse phase column packed with ODS hypersealo D5 um 
diameter beads, using a Waters Associates inc. chromatography PumPo 
solvent delivery systemg model 600OA9 equipped with a Pye-Unicam 
LO-U. V. detector set at 290 ran. The mobile phase consisted of 
methanol: water (1 :1 v/v). 
The apparatus was calibrated for each standard compoland by 
measuring the heights of absorbance peak obtained with a range of 
different concentrations of each compound, and comparing them with 
that of an added internal standard. The results were used to give 
standard curves of compound concentration vs. peak height ratio for 
each standard. The time taken from the injection of a compound to 
a peak registering is known as the retention time. The compounds 
in the extracted samples were identified by compaxing the retention 
time and shape of the peak produced with peaks obtained on the 
injection of standards. 10 ýils of extract was injected into the 
system each time, and replicate analyses of each extract was 
carried out. 
2.4-4. Assessment of extraction efficiency 
100 pg/ml standards of nitrobenzene, 3-aminophenol and aniline I 
were extracted three times into chloroform at pH 8.0 as in section 
The final 1 ml sample obtained was then used for HPLC in 
order to elucidate the efficiency of the extraction procedure. 
This was done by measuring the absorbance peak height of two equal 
concentrations of each compound, one of which was fresh, the other 
had been processed through the extraction procedure. Identical 
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peak heights for the two samples would indicate that the extrac- 
tion procedure was 100% efficient. 
2.4-5. Materials 
PyrUvate,, coenzyme A and methyl viologen were obtained from a; 
Sigma Chemical Co., Ltd., Poole, Dorset,, Ihgland. All other 
compounds were provided by May and Baker Ltd., Dagenham, Essext 
and supplied by BDR Laboratory (3aemical Division,, Poole, Dorset, 
England, 
2.5. ENZYKE ASSAYS 
Metronidazole reduction 
The reduction of the nitro-group of metronidazole was followed 
by measuring the decrease in absorbance at 320 nm using a Pye Unicam 
SP8000 spectrophotometer. The absorbance peak at 320 nm is due to 
the 5--nitro group of the compound, and this disappears on reduction, 
of the graup. The reduction was followed at 37 0C under anaerobic 
conditions. The standard reaction mixutre containe'd 100 ýmol 
metronidazole, 12.5 mmol pyruvate, 8 mmol methyl viologen, 250 ýmol 
cOenzyme A9,125 umol mercaptoethanol, 50 ý19 cell-free homogenate 
protein in 600 ul, 0.1 M phosphate buffert pH 7.0. Anaerobic 
conditions were achieved by gassing the reaction mixture prior to 
the addition of cell-free homogenate, in a2 mm path length cell, 
fitted with a suba-seal, with argon for 2 minutes. The cell-free 
homogenatev was prepared under anaerobic conditions (section 2.3-1. ). 
withdrawn from its anaerobic storage tube by microsyringe, and 
injected into the sealed cell to start the reaction. 
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2.5.2. Nitrobenzene and azobenzene reduction 
The absorbance spectrum of nitrobenzene has a peak at 315 nm 
due to the nitro-group. Upon reduction of this group the absorbance 
disappears. Therefore, the reduction of the nitro-group of 
nitrobenzene was monitored by following the decrease in absorbance 
at 315 nm. The reduction was followed at 37 0C under anaerobic 
conditions. The reaction mixture contained 0.12 mM nitrobenzeneo 
1.25 mmol coenzyme A, 62.5 mmol pyruvate, 40 mmol methyl vioTogen, 
250 ý19 cell-free homogogenate protein in 3.4 ml, 0.1 M potassium 
phosphate buffer, pH 7.2. The reaction solutions were dissolved 
and then agitated for 10 minutes in an anaerobic environment 
produced in a Forma Scientific anaerobic hood system, model 1024, 
and then allowed to stand on ice, in this anaerobic environment 
for a further 10 minutes, to ensare that they contained no oxygen. 
The conptituents of the reaction were then added to the cell which 
was then sealed. The cell was then taken out of the anaerobic 
chamber and the reaction followed in a Pye Unicam, SP800 spectro- 
photometer. 
In a similar way, the red-action of the azo-group of azobenzene 
was followed by measuring the decrease in absorbance, due to the 
azo-group,, at 440 nm. 0.08 mM azobenzene was added to the 
reaction mix in place of nitrobenzene. 
In both nitrobenzene and azobenzene reductions, the reaction 
was started by the addition of coenzyme A. 
2.5-3. NAM oxidase (E. C. 1.6.99.3. ) and NADPH oxidase (E. C. 
1.6.99.1. ) 
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NAIII and NADPH both : ave absorbance maxima at 340 nm, 
whereas NAD 
+ and NADP74' do not. The oxidation of NADH and NADPH 
at 370C were followed by monitoring the decrease in absorbance 
at 340 rm. The reaction mixture contained 0.12 ýamol NAM or 
NADPH9 50 ý. ig. cell-free homogenate protein, and 0.1 M phosphate 
buffer, pH 7.2. to 1 ml total volume. Ibr the NADPH oxidase 
assay 100 ýzmol MIN was added. In both assays the reaction mixtures 
were open to the atmosphere and cell-free homogenate was added to 
start the reaction (Tanabe, 1979). 
2-5-4. Lactate dehydrogenase (E. C. 1.1.1.27. ) 
The activity of lactate dehydrogenase was followed at 37 0C 
by measuring the decrease in absorbance at 340 rm due to the 
oxidation of NADH. The reaction mixture contained 0.6, umol NADH, 
7-5 =01 pyruvate, 25 ýxg cell-free homogenate protein in 600 1); Ll, 
0-1 M tris-HClv PH, 7.6. Anaerobic conditions were achieved by 
gassing the reaction mixture, in a cell. fitted with a suba-seal, 
I 
with argon for 2 min-ates. A similar method was previously 
reported in use with T., vaginalis by Arese and Cappuccinelli 
(1974)o 
2-5-5. Hexokinase (E. C. 2.7-lo'le) 
The activity of trichomonal hexokinase was followed at 37 
0C 
by linking it with glucose-6-phosphate dehydrogenase (E. C. 1-1-1-49-) 
and measuring the increase in absorbance at 340 nm due to the 
formation of NADPH. The reaction mixutre contained 100 nmol 
NADP +y 400 nmol EDTA,, 12 ýmol MgCl 2t 300 runol ATP 9 ýMol D-glucose, 
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33C m units of glucose-6-phosphate dehydrogenase (Grade II) from 
yeast, 50 )ig j. va nalis cell-free homogenate protein in 600 IUl, 
0.1 M tris-HC1, PH 7-3- Anaerobic conditions were achieved by 
gassing the reaction mixt-are, in a cell fitted with a suba-sealv 
with argon for 2 minutes. 
The activities of purified yeast hexokinase and the isofunc- 
tional enzyme in mouse liver were measured aerobically using a 
similar reaction mixture as with T. vaginalis, but using a volume 
of 1.5 ml. Either 27 m units of hexokinase from yeast or 50 119 
protein from mouse liver cell-free homogenate supernatant were 
added. This method was previcusly reported by Wellerson and 
Kupferberg (1962)o 
2.5.6. Phosphofractokinase (E. C. 2.7-1-11. ) 
The activity of phosphofructokinase at 37 0C was followed -asing 
a modification of the method of Makkada, Schaeferv Simon and Neu 
(1974),, by linking the enzyme to aldolase (E. C. 4-1.2.13- ), triose- 
phosphate isomerase (E. C. 5- 3- 1-1-) and glycerol-3-phosphate 
dehydrogenase (E. C. 1.1.1.8. ) and following the decrease in 
^1ý absorbance at 340 nm due to the oxidation of NADH. The reaction 
mixture contained 400 rMol fructose-6-phosphatet 360 nmole ATP, 
300 nmol NABH, 1.3 ýmol MgC'29 9 ýmol KC1,1.8 ýmol DTT, 200 )ig 
aldolase from rabbit muscle, 4 units glyceraldehydE-,, i--phosphate 
dehydrogenase/triose phosphate isomerase from yeast, 50 ý19 
T. va nalis cell-free homogenate protein in 600 112 0.1 M tris-HC1, I 
pH 7-3- Anaerobic conditions were achieved by gassing the reaction 
86 
mixture in a cell fitted with a suba-seal, with argon for 2 minutes. 
Phosphofructokinase assays using purified enzyme from rabbit muscle 
were performed aerobically using 1.5 ml total assay volume, the 
reaction mix components being proportionately increasedp with 0.42 
units of phosphofractokinase being added. 
added last, to start the reaction. 
2.5-7- Py: ruvate kinase (E. C. 2.7-1-40. ) 
In each case the ATP was 
The activity of pyruvate kinase at 37 0C was followed using a 
modification of the method used by Valentine and Tanaka (1966). 
by linking the enzyme to lactate dehydrogenase (E. C. 1.1.1.27. ) 
and following the decrease in absorbance at 340 nm dae to the 
oxidation of NAIE. The reaction mixture contained 240 nmole ATP, 
1.35 umol PEP, 60 nmol NAIE, 4 ýMol MgC'29 45 =01 KC19 19 units 
of lactate dehydrogenase from pig heart, 50 ý19 1- vajýjnalis cell- 
free homogenate protein in 600 ýil, 0.1 M tris-HC1, pH 7.3. Anaerobic 
conditions were achieved as in the other enzyme assays. Pyruvate 
kinase assays using purified enzyme from rabbit muscle or mouse 
liver homogenate supernatants were performed aerobically using 1.5 ml 
total volume, the reaction mix components being proportionately 
increased. 2 Výx6 of pyravate kinase or 50 ýig of protein from 
mouse liver cell-free homogenate snapernatant were added. 
2.5-8. Effect of inhibitors on enzyme activity 
The effect of a range of compounds on enzyme activity was 
assessed by comparing the rate of activity of each enzyme in the 
presence and absence of each compound. The inhibitory effect of 
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each compound was expressed as the percentage inhibition of the 
enzyme activity at a given inhibitor concentration. 
2.5.9. Proteinase 
Proteinase activity was assessed using azocasein as the 
substrate,, by the method described by Coombs (1982). The reaction 
mixture contained 10 mg azoeasein and approximatelY 500, ug 
T. vaginalis cell-free homogenate protein to a total volume of 
750 Al with a buffered solution consisting of 0.25 M sucrose,, 
25 mMKC1,5 MM M9C129 5 mM EDTA, 50 mm tris-HCl. pH 6.0 or pH 7.5. 
Proteinase activity was assessed both in the presence and absence 
of 1.3 mM dithiothreitol (DTT). Several compounds were tested for 
proteinase inhibition, these were leupeptin, antipain and the 
thio semi carbazone s TSC1 and TSC2. 
The effect of an inhibitor was assessed by preincubating it 
with cell-free homogenate for 1 hr at 37 0C at 3 times the final 
concentration before the reaction was started by the additions 
of 500,,. ul substrate. Inhibitors were dissolved in buffer where 
possible, or in methanol. In the latter case the inhibitory 
activity was assessed by comparison with the appropriate methanol 
control. 
Activity was also assessed at a range of pH's, from PH 5.0 
to pH 8.0 using the above buffered solution adjusted to the 
appropriate pH by the addition of 1M HC1 or 1M NaOH- 
The reaction was stopped by the addition of 750 ý11 of 5% (v/v) 
trf. chloroacetic acid which had been cooled to 40C. The precipitate 
was pelleted by centrifVgation at 10,000 g at room temperature (180C) 
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for 3 minutes using an Elppendorf centrifugeg and the absorbax. Lce 
at 366 rim of the supernatant fluid was measured using an MSE 
Spectro-plus spectrophotometer. One unit (U) of activity was 
defined as that which caused hydrolysis of 1.0 Mg azocasein/ 
minute under assay conditions. 
0 
The Elyo Of azoeasejn was taken 366 
as 32. 
2-5-10- Materials 
Metronidazolel azobenzene and nitrobenzene were provided by 
May and Baker Ltd.,, Dagenhamp Essex, England. Aldolase, from 
rabbit muscle (4-1.2.13) (9 U/mg at 250C, fructose as substrate); 
glncose-6-phosphate dehydrogenase (grade II), from yeast (1-1-1,49-) 
(140 U/mg at 25 0 C, glucose-6-phosphate as substrate); glycerol- 
phosphate dehyd-rogenase/triose phosphate isomerase, from yeast 
hexokinase, from yeast (2-7-1-l-) (140 U/ing 
at 370C, ATP and glucose as substrates); pyruvate kin. ase, from 
rabbit muscle (2-7.1-40. ) (500 U/mg at 370C, PIT as subst: mte); 
phosphofructokinase, from rabbit muscle (2-7-1-11-) (130 U/mg at 
37 0 Cl, f-ructose-6-phosphate and ATP as substrates); Iactate 
dehydrogenase, from pig heart (1.1.1.27. )(1100 U/mg at 370C. 
py-xuvate as substrate); and sodium pyruvate were obtained from 
Boehringer Co., (London) Ltd., Lewes, Ehgland. All other compounds 
were of analar grade and were obtained from either BDH Laboratory 
Chemical Division, Poole, Dorset, England, or Sigma Chemical Co., 
Ltd., Poole, Dorset, England. 
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2.6., DETEENINATION OF COMPOUND CONCENTRATIONS 
Lactate 
The concentrations of lactate in media in which T. vaginalis 
had been growing were determined by a modification of the method 
of Gutman and Wahlefeld (1974). The reaction mixture contained 
4 pmol NAIýv 50 units of lactate dehydrogenase, from pig heart, 
20, als of samplet glycine (0-4 M) and hydrazine (0-5 M) buffer, 
pH 9.0, to 1-5 mls. 20 umol of perchloric acid was added to 
control solutions to stop any reaction occurring. The lactate 
concentration was assessed by monitoring the increase in absorbance 
at 340 nm due to NADH formation. This was produced from lactate 
in the reaction: Iactate + NAIý 'ýPyruvate + NADH + H+. Thus 
the total amount of NADH formed was directly proportional to the 
concentration of lactate initially present. The reaction at 37 0C 
was followed -using an SPSOOO U. V. recording spectrophotometer and 
the total change that occurred measured. A range of standard 
lactate concentrations in culture medium, were assayed using this 
method, and a calibration curve of medium lactate concentration vs. 
change in absorbance at 340 nm was constructed. Samples of media 
which had been used to grow cultures of T. vaeftnalis were then 
assayed, and the lactate concentrations estimated. 
2.6.2. Cell preparation for glutathione or thiol determinations 
50 ml samples of late log phase T., vaE2, ýjalis culture were 
harvested as in section 2-3-1. and washed 3 times in 0.1 M phosphate 
buffer,, pH 8.0 containing 0.005 M EDTA, and resuspended in a total 
of 2.0 mls of this buffer and 0.42 mls 25Yo (v/v) phosphoric acid. 
go 
Cell breakage was achieved by 3 cycles of freezing (-800C) and 
thawing (37 0 C). The resultant homogenate was centrifuged at 
20tOIDO 9 for 30 minutes at 40C in an MSE prepspin ultracentrifuge. 
The supernatant was removed and stored at -70 
0C until the gluta- 
thione or thiol determinations were carried out. 
To assess the effect of thiosemicarbazones on glutathione and 
thiol levels, four parallpI cultures (approximatelY 5x 10 
5 
organisms 
/ml) were incubated for 3-5 hr at 370C in the presence of thiosemi- 
carbazone (TSC1 or TSC2) at concentrations of either 1 um or 5 PM- 
A fifth culture with no added drug acted as a control. At points 
throughout the incubation period 10 ml samples were removed from 
each culture and processed as described above, until thiol and 
glutathione determinations were carried out as described in sections 
2.6-3. and 2.6-4- 
2.6-3. Glutathione 
Glutathione (GSH) was determined by the method of Hissin and 
Hilf (1976). 100 )il of T. va&lnalis, homogenate supernatant, 
prepared as described in section 2.6.2., was made up to 2.9 nil with 
0.1 M sodium phosphate buffer, pH 8.0, containing 5 mM EDTA. A 
series of standards (0-1.5 ýig reduced glutathione in 100 )al buffer) 
were treated similarly. 100 ýil of 0.1% (w/v) orthophthaldehyde 
(OPT) in absolute methanol was added to form a fluorescent compound. 
Some samples were spiked with an internal standard of 0.5 ý29 GSH9 
and GSH was estimated as above. After 20 minutes incubation at 
-room 
temperatureq fluoresence was measured using a Perkin Elmer 
fluoresence spectrophotometer, model MPF4, excitation waveleng-th 
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350 rm, emission wavelength 420 nm. 
Concentrations of sample of glutathione were calculated by 
comparison with GSH stand42ds. All standards and samples were 
assayed in d-uplicate. Both GSH standards and OPT were prepared 
just prior to use. 
2.6-4. Thiol 
The non-protein thiol content of T. vaginalis homogenate 
supernatant was determined by using Ellmants reagent (Ellmano 1959)- 
30, ul samples, prepared as in section 2.6.2., were made up to 3-0 ml 
with 0-05 M potassium phosphate buffer, PH 7.4, and the absorbaxice 
at 412 nm measured, using buffer as a blank. 20, ul 5,51-dithiobis- 
2-nitrobenzoic acid (DTNB) was added and the mixture left at room 
temperature for 10 minutes. The absorbance at 412 nm was measured 
again, using buffer as a blank, and the change in absorbarice (, 6 E) 
at 412 nm calculated. The total concentration of thiol was estimated 
by comparison with GSH standards in the range 0-20 nmole/ml in buffer. 
Some samples were spiked with an internal GSH standard. All samples 
were assayed in duplicate. 
2.6-5. Protein 
Protein ooncentration was estimated by the method of Lowry, 
Rosebrough, Farr and Randall (1951). To 0.2 ml sample was added 
1.0 ml reagent 1 (2% (w/v) Na2 CO 3 in 0.1 M NaOH, lyo 
(w/v) copper 
sulphate solution, 2yo (w/v) NaK tartrate; 98; 1; 1 v/v) and the 
mixture incubated for 10 minutes at room temperature (180C). 
0.1 ml of reagent 2 (2N Fblin and Ciocalten's phenol reagent; 
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distilled water; 1; 1 v/v) was added and the mixture incubated 
for a further 30 minutes at room temperature. The absorbance at 
750 ram was measured. By comparison with a standard curve, 
constructed using standards containing 0-50 pg bovine serum 
albumen, increasing bY 5 )19 stepsq sample protein concentration 
was calculated. 
2.6.6. Materials 
EEJDJJTA9 NAb+ and Folin's reagent were supplied by Sigma Chemical 
Co., Ltd., Poole, Dorsetv lhgland. Copper sulphate, sodium 
potassium tartrate, glycine, hydrazine, 1-lactate and phosphoric 
acid were supplied by BDH Laboratory Chemical Division, Poole, 
I-D"Orset, England. All other compounds were supplied by May and 
Baker Ltd.,, Dagenham, Essex, Brigland. 
2. ', '. THIOSEMICARBAZONE CHELATE PRODUCTION 
Chelate formation 
Possible Ihiosemicarbazone chelate formation was followed by 
continuously monitoring the spectrum of TSC1 , from 300-700 nm, 
upon the addition of solutions of MnSO 4' 1'1ý21 ZnS04 , NaCl. KCI-, 
and CaCl 2* All compounds were dissolved 
in 50% Methanol and moni- 
toring was carried out at room temperature. In an attempt to 
elucidate the molar ratio of TSC1 to metal in the chelates, 10 ýmq 
100, uM and 500 uM concentrations of TSC1 were titrated against 
solutions of MhSO 4' znSO 4 and CuSO 4 at concentrations of 15- 
2000 p14. Measurements were made of the change in absorbance at 
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480 nm -upon addition of each amount of CaSO 4' and at 460 nm and 
345 rm with MnSO 4 and ZnSO 4 respectively. These were the wavelengths 
at which the difference in absorbance between TSC1 and respective 
chelates had been found to be maximal. When all the TSC1 had been 
cl, -,, elated, the addition of excess metal did not cause any further 
change in absorbance. 
The effect of 5 MM concentrations of compounds containing thiol 
0-" UP S 5.0 
(cysteine, DTT, glutathione, homocysteine) on the stability 
of the chelate was also investigated. This was done by monitoring 
the spectrum of a chelate upon addition of thiol compounds and for 
30 minutes subsequently. It was anticipated that the spectrum would 
alter if the chelate was disrupted. 
2-7.2. Materials 
The thiosemicarbazone (TSC1) was supplied by May and Baker Ltd., 
Dagenham, Essex, Digland. CYsteine, DTT9 glutathione and homocystei-ne 
were obtained from Sigma Chemical Co., Ltd., Poole, Dorset, England. 
. 
Ul other compounds were obtained from BDH Iaboratory Chemical 
Divisiong Poole, Dorset, England. 
Drugs and So6kants 
Metronidazole and the nitrofurons (nitrofurantoin and compound 
4) were dissolved in distilled water. Dimethyl sulphate and 
ethidium bromide were dissolved in 100% ethanol. All other drugs 
were dissolved in 100% methanol. 
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Abbreviations 
ATP, Adenine 5'triphosphate; DM, 5,51-dithiobis-2-nitrobenzoic 
acid; DTT,, dithiothreitol; EDTAO ethylenediaminetetra acetate; 
RAN, flavin mononucleotide; GSHO glutathione; HPLC, high-performance 
liquid chromatography; LRSt laboratory developed resistant strain; 
MIC, minimum inhibitory concentration; NAIý, nicotinamide adenine 
d-inucleotide (oxidised form); NAIFI, nicotinamide adenine dinucleotide 
(reduced form); NADPý+, nicotinamide adenine dinucleotide phosphate 
(oxidised form); NADRIO nicotinamide adenine dinucleotide phosphate 
(reduced form); OPT9 orthophthaldehyde; PEP, phosphoenol py-, -avate; 
U. V., ultra-violet. 
SUL 
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SENSITIVITY OF TRICHOMONAS VAGINALIS TO A RANGE OF 
COMPOUNDS: VARIATIONS WITH CULTURE CONDITIONS 
The sensitivity of three lines of T., vagýnalis to a range of 
compounds -under aerobic and anaerobic conditions, using the methods 
given in section 2.2.1., are given in Table 1. It was found that 
each of the nitroheterocyclic compounds tested (5-nitroimidazole, 
4-nitrodiazoles and nitrofurans) were active against T. vaginalLsq 
clone G3. The 4-nitrodiazoles however, were relatively inactive 
against line IR78 under both aerobic and anaerobic conditions, 
whereas the 5-nitroimidazole (metronidazole) was inactive only 
under aerobic conditions. In contrast, the nitrofurans were 
active against all three parasite lines under aerobic and anaerobic 
conditions. Line LRS (0.6), the parasite line grown in the labora- 
tory under in vitro drug (metronidazole) pressure, and at"he time 
of these experiments grown routinely in medium containing 0.6; ag 
metronidazole/ml, was affected by by nitro-compounds differently 
to line IR78. Metronidazole was active against this line under 
both aerobic and anaerobic conditionsv although higher concentrations 
were required to kill all the cells than with clone (ý3. The 
nitrodiazoles, although relatively effective against it and clone 
G3, differed with individual compounds. The thiosemicarbazones had 
poor activity against all three parasite lines in comparison to 
.L meý, ronidazole when tested -using this method. All other compounds 
tested were inactive against all three parasite lines at concentra- 
tions of 100, uM. The structures of these compounds are given in 
Diagram 1. 
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The sensitivity of T. vaginalis,, line 965691, to all the 
above compoundsv except metronidazole and nitrofurantoin, was 
tested using the test-tube screening method described in section 
2.2-1. The results of this method are. given in Table II. They 
show that the minimum inhibitory concentrations (IMIC) obtained 
lasing this method were, in most cases, similar to those produced 
by the microtitre plate method. Using the test-tube methodv howeverg v 
the thiosemicarbazones (TSC1 and TSC10) and the isothiazoles were 
found to be much more active. To test if the differences in 
Mý 
activity were dependant upon the parAsite strain, the culture medium, 
or the assessment method, the sensitivities of clone G3 and line 
965691 to a thiosemicarbazone (TSC10) and to an isothiazole 
(compound 7) were measured using both the methods outlined in 
sekAion 2.2.1., using both GTM and Bushby's medium. The results 
obtained are given in Table III. They show that for each compound 
the DUC was lower using Bushby's medium than with GTM medium. 
The sensitivities of line 965691 to both of the above compounds 
(compound 7 and TSC10) were tested in GIM medium, Bushby's medium, 
and in Bushby's medium with added ascorbate (12.7 mM and 2.7 mm) 
or added cysteine (12-7 mM or 2.7 mM), using the aerobic microtitre 
plate method. 12-7 MM cysteine or ascorbate was used as this is 
the concentration noxmally present in GTM medium, 2-7 mm concen- 
trations were used to study the effect of lower levels of the two 
compounds. The results are given in Table IV. The addition of 
12.7 mm cysteine to Bushby's medium raised the MIC of TSC10 to 
20, uM,, a point between the MIC's found using GTM (100, uM) and 
Bushby's medium without additives (45 jiM). The addition of 
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2.7 mM eysteine or either concentration of ascorbate had no 
discernable effect. The addition of cysteine or ascorbate raised 
the MIC of compound 7 to a lesser extent, but not to that using 
GTM medium. The addition of 2.7 mM asQorbate had a greater effect 
than that of 12.7 mM ascorbate. This result suggests that high 
concentrations of ascorbate may not inhibit the activity of this 
compound. Me addition of 12.7 mM eysteine and 12.7 mM ascorbate 
together to Bushby's medium had a similar effect to the addition 
of 12-7 inM cysteine alone on the MIC of TSC10, but had a greater 
effect on the MIC of compound 7 than using either compound by 
itself. 
3.2. ANTITRICHOMONAL ACTIVITY OF METRONIDAZOLE 
The sensitivities of clone G3 and lines LRS (2.0), Boston, 
-Fh. 11 River and Albany to metronidazole measured under aerobic and 
anaerobic conditions are given in Table V. It was fo-und that lines 
IR78, Boston, Fall River and Albany were resistant to metronidazole, 
but only under aerobic conditions, whereas line LRS (2.0) was less 
sensitive to the drug than clone G3 under both aerobic and anaerobic 
conditions. 
3.3. STUDIES ON METRONIDAZOLE RESISTANT T., VAGINALIS 
Reduction of metroridazole by homogenates of T. vaginalis 
Metronidazole was reduced by cell-free homogenates of 
. 
1. vaainalis only if all the assay constituents given in section 
2.5.1. were present, with the single exception of methyl viologen. 
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Reduction occurred in the absence of methyl viologen, but at a 
much lower rate, about one twentieth, than when methyl viologen 
was present. If oxygen was present the reduction did not occur. 
The addition of NAIE, NADPH or FMN did not enhance the reaction 
or replace the requirement for any of the assay constituents. 
The metronidazole reducing activity decreased by approximately 
20% over 5 hr, when the cell-free homogenate was kept on ice under 
a flow of argon. If the homogenate was not kept on ice under 
areon the activity decreased by approximately 50Yo in 1 hr. The 
rates at which metronidazole was reduced by cell-free homogenates 
of three lines of T. vaginalis (clone G3. lines LRS (2.0) and IR78) 
are given in Table VI. The results show that homogenates of line 
LRS (2.0) reduced the drug much more slowly than those of either 
clone G3 or line IR78. 
3.3.2. NAIE oxidase and NADPH oxidase activities 
NAIE oxidation catalysed by cell-free trichomonal homogenate 
took place under aerobic conditions only, and the addition of CoA 
or FMN did not enhance the reaction. The enzyme was stable at 
0C for a three hour period, but after 6 hr activity had decreased 
by 20%. NADPH oxidation took place under aerobic conditions only, 
and was enhanced by R4NL. Withaut INN present the NADPH oxidase 
activity of T. vajýjnalis clone G3 homogenate was approximately 
20 nmoles/min/mg cell-free homogenate protein i. e. 20 fold less 
than in the presence of YMN. Ibr this reason FM was added to all 
NADPH oxidase assays to enhance the reaction. The NADH oxidase 
and NADPH oxidase activities of cell-free homogenates of the three 
101 
lines are given in Table VI. The two activities of lineIR78 
were found to be significantly lower than those of clone G3, and 
the NADPH oxidase activity was also found to be significantly lower 
than that of line LRS (2.0). The enzyme activities of clone G3 
and line LRS (2.0) were not significantly different. 
3.3-3. Growth studies 
The growth of clone G3 and line IR76 in GTM medium under 
anaerobic and aerobic conditions, and in media containing lower 
concentrations of cysteine and ascorbate are given in Figures 1-4. 
It was found that with clone G3 under anaerobic conditions, 
reduced concentrations of cysteine and ascorbate resulted in a 
lower growth rate and a lower maximum parasite density. The 
reduction in growth rate was much greater with line IR7B (Fig. 
than that with clone G3 (Fig. 1). Under aerobic conditions the 
lowering of cysteine and ascorbate concentrations similarly 
resulted in lower growth rates and lower maximum parasite 
densities, but under these conditions the effect was much more 
marked. With line IR78 rapid cell death occurred in the absence 
of added cysteine and ascorbate and when they were present at 1.3 mm 
and 2.1 mM respectively. With clone G3, there was parasite growth 
even in the absence of added cysteine. 
Although high concentrations of both cysteine and ascorbate 
were required for optimal growth under aerobic conditions, the 
parasites were more sensitive to changes in the cysteine concen- 
tration (Table VII). When the cysteine concentration was varied 
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the ascrobate concentration was constant at 21 mM and when the 
ascorbate concentration was varied the cy-steiieconcentration was 
constant at 12.7 mm. Since the effects of cysteinewere most 
obvious under aerobic conditions, other thiol-containing compounds 
were tested for their effect on growth under these conditions. 
The results are given in Table VIII. The replacement of cysteine 
by other agents resulted in reduced growth, however growth was 
still greater than if there were no thiol compounds added. Perhaps 
surprisinglyt methionine was the most effective replacement for cysteine. 
The growth of clone G3 and line IR78 in the medium without cysteine 
or ascorbate under various oxygen, nitrogen and carbon dioxide tensions 
is shown in Figures 5 and 6 respectively. It was found with both 
strains that as the oxygen tension was increased then growth was 
lessened. Premature death of all the parasites was caused at oxygen 
tensions of 15yo and 20% with clone G3, although only after an initial 
increase in parasite numbers, and growth rate and maximum density 
achieved were reduced at lower oxygen tensions compared with the 
anaerobic cultures. With line IR78 those effects were more marked, 
premature cell death occurring at oxygen tensions of 10% and above, 
and with no initial increase in parasite numbers. In this experiment 
the growth rate of line IR78 under an argon atmosphere was rather 
less than that found in some other experiments using similar condi- 
tions e. g. Figure 3. The possible explanation for this co-uld be 
thc-, 
-4w 
despite flushing with argon, a level of oxygen was present 
in the incubation vesselp and this was sufficient to slightly 
inhibit parasite growth. 
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A 5Y6 carbon dioxide concentration was found to enhance 
slightly growth of both lines compared with growth under an argon 
atmosphere, 
3-3-4. Effect of acetate and lactate on the sensitivity of 
. 
1. vaginalis to metronidazole 
The sensitivities of T. vaginalis clone G3 to metronidazole 
under aerobic and anaerobic conditions, in GTM medium with added 
mM L-lactate, I-acetate, L-pyruvate and L-succinate, and at 
different pH Is. are given in Table IX. Parasites grown in medium 
containing 5 mM lactate or acetate were less sensitive to metroni- 
dazole under aerobic, but not under anaerobic conditions, than 
those grown in medium without the added salts. Neither succinate 
nor pyruvate had any effect on parasite sensitivity to metroni- 
dazole. PH had no effect. The effect of different concentrations 
of lactate and acetate on metronidazole sensitivity is given in 
Table X. Increasing the lactate or acetate concentrations to 10 mM 
did not enhance the inhibition, and the addition of 0.5 mM lactate 
or acetate to cultures had no detectable effecto whereas 2 mM 
lactate or acetate raised the aerobic MIC to approximately half 
that found in the presence of a5 mM concentration. 
It was feasible that the effects of additions of lactate and 
acetate upon the sensitivity of the parasite to metronidazole may 
be due to the lower pH which they produced, however this was not 
the case (Table IX). 
Metronidazole reduction by, and NADH oxidase and NADPH 
oxidase activities in, parasite homogenates were not affected by 
the addition of 5 mM lactate or 5 mM acetate to the assay mixtures. 
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The addition of 5 mM lactate or acetate to the gTowth medium did 
not affect parasite growth sigrifficantly under aerobic conditions, 
although it was reduced appreciably by 10 mM of the compounds 
(Figuxes 7 and 8), nor did it affect the specific activities of 
NAIE oxidase or NADPH oxidase in parasite homogenates, or the 
rate at which the homogenates catalysed the reduction of metroni- 
dazole (Table XI). 
As lactate is a major excretory prod-act of T. vaEinalis, 
the effect of growth in 5 mM lactate was investigated by studying 
the activity of parasite lactate dehydrogenase. It was found that 
the activity (5.1 ý 0-3 umoles/min/mg protein, mean of four 
experiments 
± 
one standard deviation) of lactate dehydrogenase in 
cell-free homogenates of parasites (clone G3) grown in culture 
medium with 5 mM lactate added was significantly greater than the 
activity (3-8 ý 0.3 umoles/min/mg protein) in cell-free homogenates 
of parasites grown in GTM medium alone. In addition, the concen- 
tration of lactate produced by the parasite growing for 24 hr in 
GTM medium which 5 mM lactate added was significantly less than 
that prodlaced from cells growing in GTM medium alone (Table XII). 
3.4. SYNERGISTIC ANTITRICHOMONAL DRUG COMBINATIONS 
The sensitivities of T. vaLnalis clone G3 to metronidazole, 
a thiosemicarbazone (TSC1), ethidium bromide, dimethyl sulphate 
(DMS) and various benzamides, under both aerobic and anaerobic 
conditions, are given in Table XIII. The thiosemicarbazone (TSC1) 
was highly active against T. vaginalis. Dimethyl sulphate was 
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more active than metronidazole, but less active than TSC1. 
Ethidium bromide and the benzamides did not kill all the parasites, 
even at 1 mM and 5 mM respectively. The results were similar under 
both aerobic and anaerobic conditions. The trichomonacidal 
concentrations of metronidazole, TSC1, ethidium bromide and 
dimethyl sulphate in combination with sub-inhibitory concentrations 
of the benzamides are given in Table XIII. It was found that the 
addition of benzamide or the aminobenzamides to cultures contain- 
ing dimethyl sulphate reduced the MIC of BMS approximatelY one 
hundred f old. This effect was independant of oicygen. The 
benzamides, however, did not alter the effectiveness of metroni- 
clazole or TSC1. Ethidium bromide was no more effective in 
combination with benzamide and aminobenzamides than by itself. 
3.5. THD, XMOBIOTIC METABOLISM OF AZOBENZENE AND NITROBENZENE 
BY TRICHOMONAS VAGINALIS 
Antitrichomonal activity of azobenzene and nitrobenzene 
The sensitivities of T. vaLnalis to azobenzene, nitrobenzene 
and two of their mammalian metabolitesp aniline and p-nitrophenol, 
are given in Table XIV. All four compounds killed the parasite, 
but high concentrations were required compared with metronidazole. 
3.5-1.1. Reduction of azobenzene and nitrobenzene by : L. vaginalis 
As one of the mammalian metabolites (aniline) of both compounds 
is a reductive metabolite, the production of which involves the 
reduction of the nitro-group of nitrobenzene or the azo-group, of 
azobenzene, the ability of T. vaginalis cell-free homogenate to 
reduce these compounds was investigated. 
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The reduction was followed at 440 nm with azobenzene and at 
315, m with nitrobenzene, wavelengths at which the azo-gro-ap 
and nitro-group absorb maximally. These absorbance maxima 
disappear on reduction. The addition of pyruvate and coenzyme A 
to T. ZaLinalis cell-free homogenate and the compound, was 
necessary for the reduction to occur. Reduction took place under 
anaerobic conditions only. The addition of NADH to the assay mix 
had no effect, but the addition of 40 mmoles methyl viologen 
enhanced the rate of redw-5ion approximately five fold. 
3-15.2. Detection of metabolites by Thin Layer Chromatography 
Possible metabolites of nitrobenzene and azobenzene metabolism 
in T. ZaLnalis were looked for using thin layer chromatography 
(TLC). Since nitrobenzene and azobenzene were reduced by cell- 
free homogenates of the parasite, reductive metabolites were 
coT-sidered good candidates as metabolic products. 
The Rf values of 5 ý; Lg standards of nitrobenzene and azobenzene, 
and their main mammalian metabolites were elucidated using the 
solvents and methods given in section 2.4.2. The Rf values of 
these compounds are given in Table XV. The Rf values show that 
it is possible to distinguish between azobenzene and two of its main 
mammalian metabolites, benzidine and 4-aminophenol, using solvents 
I or III. However, hydrazobenzene could not be distinguished from 
azobenzene in this manner, whereas aniline was not detected using any 
of the three solvents. Nitrobenzene and its main mammalian metabolites, 
the aminophenols and the nitrophenols, were found to be separated 
using solvent III, and to a lesser extent with solvent I. Separation 
of the different species of these grou. 15s of compounds was not 
possible, except in the case of 4-aminophenol which had a much 
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lower Rf value than 2- or 3-aminophenol with solvent III. Using 
solvents I and III, 2-nitrophenol could not be detected. Solvent 
II was tile least useful solvent. With this solvent it was not 
possible to separate aminophenols and nitrophenols, although 
detection of 2-nitrophenol was possible. This method was very 
sensitive, a 0.1jig sample of 4-aminophenol cauld be detected 
using solvent I. 
rk_ 
Ciromatography of extracts of parasites grown in the presence 
of azobenzene produced spots with Rf values identical to that of 
the parent compound. These spots could have been due to the 
parent compound, to hydrazobenzene, or to a mixture of both, as 
it was not possible to separate these two compounds using these 
solvents. No other metabolites could be positively identified. 
Similarly chromatography of extracts of T. ya nalis grown in the IEL_ 
presence of nitrobenzene demonstrated the presence of nitrobenzene 
itself, but no metabolites. A function of this method was the 
inability to detect aniline. This is the major purely reductive 
metabolite of both nitrobenzene and azobenzene, but its production 
by T. vaginalis could not be detected by this method. 
3.5-3- Detection of metabolites by High Performance Liquid 
Chromatography 
The metabolism of nitrobenzene and azobenzene by 1. vaginalis 
was investigated using HPLC. This method is more sensitive than 
TLC, giving greater separation of compounds, and quantification is 
much more precise. 
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Standards of azobenzenet nitrobenzene, and their main mammalian 
metabolites were injected into the column and the retention time 
of each compound and the shape of its absorbance at 290 nm was 
studied. The retention time of all the compounds are given in 
Table XVI. The results show that using compound standards, 
azobenzene and its mammalian metabolites, hydrazobenzenev benzidine, 
aniline, 2-aminophenol and 4-aminophenol can be separated and 
detected using this method, as can nitrobenzene and its mammalian 
metaboliteso 3-nitrophenolv aniline and the ami-nophenols. HPLC 
can be used to detect much smaller quantities of a compound than 
TLC. The detection limit of the TLC method given in section 2.5.2. 
was 0.1 )ag of a 4-aminophenol standard. Using HPLC the same 
compound was detected usiri- a 0.01 ug standard. The other stand- 
ards had detection limits in the range 0.005-0.05 )19- In this 
series of experiments cell-free homogenates of the parasite had 
been incubated with 25 )19 of the parent compound. If extraction 
was 100yo efficient, then the 1 ml extraction sample would contain 
25). ig parent compound and metabolites, well within the limits of 
Z-'-ý4e 
detection. -, ý-Ajarasites 29500 319 of parent 
compound and detection would be easier in these cases. 
No azobenzene or nitrobenzene metabolites were detected by 
HPLC in whole-cell incubates (section 2.4.1. (a)). Parent compound 
recovery rates were approximately 90% (azobenzene) and 70% 
(nitrobenzene) in both control (incubates lacking parasites) 
and experimental incubates. 
Using incubates of cell-free homogenates and parent compounds 
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alone, no metabolites were detected, and parent compound recovery 
rates were similar to those given above. In incubates with added 
pyruvate, coenzyme A, methyl viologen, as well as nitrobenzene 
and cell-free homogenate, onlY 30% of the parent compound was 
recovered. Tn appropriate control incubates (lacking homogenate), 
70% of the parent compound was recovered. However, no metabolites 
were detected in the experimental sample. In incubates containing 
pyruvate, coenzyme A., methyl viologen, azobenzene and cell-free 
homogenate, hydrazobenzene was detected by cochromatography. 
Approximately 15% of the azobenzene was reduced to hydrazobenzene 
and approximatelY 409'o of the parent compound was recovered. In 
control inc-abates (lacking homogenate) approximatelY 75Yo of the 
parent compound was recovered. X, -- 
In an attempt to elucidate the efficiency of the extraction 
proceduret the extraction of nitrobenzenet 3-aminophenol and aniline 
standards was carried out, and the compounds detected by HPLC. 
ApproximatelY 70Yo of the nitrobenzene and 3-aminophenol was w 
recovered, but aniline was not detected. Unextracted aniline 
samples were detected. A quantitative U. V. analysis of an aniline 
chloroform extract and its aqueous remains showed that the aniline 
was extracted into the chloroform, The next step in the extraction 
procedure was the evaporation of the chloroform to dryness, and 
resuspension in methanol. The aniline was not present in the 
methanol however, and must have been lost in the evaporation 
procedure, presumably due to its highly volatile nature. 
0 
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3.6. ANTITHICHOMONAL ACTIVITY OF THIOSEMICARBAZONES 
Sensitivity of T., vaginalis to thiosemicarbazones 
The sensitivity of T. vaeinalis to three thiosemicarbazone 
compounds (TSC1, TSC2 and TSC3) and of, Leishmania mexicana mexicana 
promastigotes to TSC1, both with and without the addition to the 
media of compounds containing thiol groups, is given in Table XVII. 
The presence of cysteine in the media of cultures of Trichomonas 
vaginalis appreciably raised the MIC of TSC1 and TSC2. but had 
no effect on the trichomonacidal activity. of TSC3. and in the 
media of cultures of Leishmania mexicana mexicana promastigotes 
raised the MIC of TSC1. The addition of DTT, glutathione or 
homocysteine also antagonised the trichomonacidal activity of 
TSC1 and TSC2, whereas the addition of methionine or thioglycolate 
had no effect on the activity of TSC1. 
3.6.2. Formation of thiosemicarbazone chelates 
Thiosemicarbazones are avid chelators of metals, and their 
chelates have been implicated in antitumor activity (Minkel and 
Petering, 1978). Chelates of TSC1 were formed by the method given 
in section 2.7.1. Only transition metals formed chelates with TSC1. 
Chelates of TSC1 formed on the addition of MhSO 4 and CuSO 4 had 
absorbance maxima at 460 rm and 480 nm, and the chelate of TSC1 
formed on the addition of ZnSO 4 did not have the absorbance 
maximum at 345 nm exhibited by TSC1. Clhelates were not formed on 
the addition of MgCl 2' Ca C12 . NaCl or KC1. Chelate formation was 
followed by the addition of MhSO 4' cuso 4 and ZnSO 4 to TSC1. and 
following the absorbance change at the above wavelengths. These 
ill 
results are given in Figures 9-11 respectively. They suggest 
that chelates were formed with equimolar concentrations of TSC1 
and transition metal. The spectra of TSC1, and of its copper, 
manganese and zinc chelates are given in Figure 12. These chelates 
were stable, as judged by spectral properties, on the addition of 
an excess of another transition metal and on the addition of thiol- 
containing compounds. The effect of thiol-containing compounds on 
chelate formation was not investigated. 
A comparison was made of the structures and antitrichomonal 
activities of a series of thiosemicarbazones, (including some 
thiosemicarbazone chelates), and their ability to form chelates 
(Table XVIII). It was found that in general compounds able to 
fo: rm chelates were more potent trichomonacides than similar 
compounds that could not. It was seen, also, that the chelates 
had greater antitrichomonal activity than the parent thiosemicarba- 
zone. 
3.6-3. Effect on proteinase activity 
2_nalis cell-free homogenate The proteinase activities of T. vaLi 
at pH 6.0 and PH 7.5# with and without added DTT, are given in 
Table XIX. Activity was enhanced by the addition of DTT in both 
cases and was greater at the lower pH. 1. vaL=alis proteinase 
activity at a range of pH's is given in Table XX. The activity 
increased with the increasing acidity of the assay conditions. 
T. vaginalis proteine-e activity was found to be inhibited 
by TSC2, leupeptin and antipain, as shown in Figure 13.90% (190) W 
and 50% (150) proteinase inhibition was achieved at inhibitor 
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cancentrations of 76 and 24 ug/ml (TSC2). 42 and 2.4 ug/ml (leupeptin), 
100 and 14 ; ag/ml (antipain) respectively. TSC1 had no effect on 
the proteinase activity at concentrations of up to 100, ug/ml. 
Despite their potent proteinase inhibitor activity, neither 
antipain nor leupeptin were trichomonacidal (Table XXI), unlike TSC2. 
The effect of a range of thiol-containing compounds on the 
inhibition by TSC2 of T, vaZinalis proteinase are given in Table 
XXII. It was found that the addition of DTT, glutathione, homocysteine 
or cysteine antagonised the inhibitory effect of TSC2 to a great extent, 
whereas the addition of mehionine or thioglycolate had much less 
effect. 
3.6-4. Effect on glycolytic kinases 
The hexokinase, pyruvate kinase and phosphofractokinase 
activities of T. vag-inalis clone G3 cell-free homogenates were 
assayed under anaerobic conditions to avoid interference from 
trichomonal NAM and NADPH oxidases. Under aerobic conditions 
the NAIE oxidase present in the homogenate oxidised the NAIE 
presentA the assay mixes of pyruvate kinase and phosphofructokinase, 
and NADPH oxidase oxidised the NADPH produced in the hexokinase 
assay. This made it impossible to measure the activities of the 
above kinases aerobically. In each assay, all the constitutents 
described in the materials and methods section were fo-und to be 
necessaxy for the reaction to proceed. The specific activities 
in cell-free homogenates of T. vagýnalis of hexokinase, pyruvate 
kinase and ph-osphofructokinase are given in Table XXIII. All 
three enzymes were present with high activity. 
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The sensitivity of T. vaginalis clone G3 to three arsenical 
compounds is given in Table XXIV. Rather high concentrations of 
these compounds were required to kill the parasite, the trivalent 
arsenical melarsen oxide (A2) having the greatest trichomonacidal 
activity. 
The effects of the thiosemicarbazone TSC1 and its chelate 
TSC2. and the three arsenicals upon yeasto mouse liver and 
. 
1. va&L-nalis hexokinase aotivities is given in Table XXV. Compounds 
A2 (melarsen oxide), A3 (Mel B) and TSC1 all inhibited hexokinase 
from yeast, compound A2 inhibited mouse liver hexokinasel whereas 
only TSC1 inhibited T. va alis hexokinase. The inhibition by 
TSC1 of hexokinase from yeast was significantly greater than for 
the T. vaginalis enzyme. 
'The effects of different concentrations of compounds A2, A3 
and TSC1 on the hexokinases from yeast, mouse liver and T. yýýZinalis 
are given in Figures 14, 15 and 16 respectively. In each case the 
190 was greater than 100 uM. The 150's for yeast hexokinase were 
2 )iM (A2), 43 UM W) 9 50 uM 
(TSC1 ), for mouse liver hexokinase, 
38 tuM 
(A2) and for T. vaeinalis hexokinase, 97 um (TSCl), 
The inhibitions of pyruvate kinase purified from rabbit muscle, 
pyravate kinase in mouse liver cell-free homogenate supernatent and 
the enzyme in T. vaginalis cell-free homogenate by thiosemicarbazones 
and arsenicals is given in Table XXVI. Only compounds Al (melarsen) 
and A2 inhibited rabbit muscle pyruvate kinase, and then only slightly. 
Compounds A2 and TSC1 at 100 uM inhibited mause liver pyruvate kinase 
to a great extent, whereas compound A3 (Mel B) inhibited slightly. 
Py-l-avate kinase activity from T. vaginalis was inhibited very 
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significantly by TSC2, but was unaffected by the other compounds. 
The concentration dependences of the inhibition of mouse 
liver pyruvate kinase by compounds A2 and TSC1. and of T. va&Lnalis 
pyravate kinase by TSC2 are given in Figures 17 and 18 respectively. 
The J90's for compounds A2 and TSC1 were both greater than 100, UM- 
Compound A2 was more active than TSC19 however, with the 150s: being 
37)aM and 86, uM respectively. The 190 of TSC2 against T. vaginalis 
pyruvate kinase was 100 pM. and the 150 was 32, uM. 
The inhibition of phosphfractokinase purified from rabbit 
muscle and phosphofxuctokinase from T. vaLinalis clone G3 cell- 
free homogenate by thiosemicarbazones and arsenicals is given in 
Table XXVII, The only inhibition observed was with TSC2, which 
inhibited T. vaginalis phosphofractokinase slightly. 
The effect of thiol-containing compouzids and methionine on 
the inhibition of T. vaainalis hexokinase by TSC1 and pyravate 
kinase by TSC2 is given in Table XXVIII. The addition of the thiol- 
containing compounds antagonised the inhibition in all cases. 
However, the addition of methionine had no effect on the inhibition 
of hexokinase by TSC1 and only a slight effect on the inhibition of 
pyruvate kinase by TSC2. 
3.6-5. Effect on the thiol content of T., vaginalis 
'The results described in section 3.6.1. suggested that thiols 
were involved in some way in the antitrichomonal activity of 
thiosemicarbazones. It was postulated that the addition of thio- 
semicarbazones to a parasite culture could have affected the non- 
2_nalis, through the direct protein bound thiol content of T. vagi 
binding of the drug to free thiols in the cell. 
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ks a prerequisite to investigating this possibility, paxasites 
were incubated with thiosemicarbazones (TSC1 and TSC2) to determine 
the time taken to kill the parasites. This was necessary information 
as I wished to measure the thiol content of T. vaginalis after 
incubation with thiosemicarbazones, and this had to be carried 
out with live cells. The progressive killing effect of the two 
thiosemicarbazones (TSC1 and TSC2) on T. vaginalls is given in 
Table XXIX. TSC2 had a greater trichomonacidal activity than 
TS01 over the period of this study. 
The total soluble thiol content of T. vaginalis was found to 
be 5.2 nmoles/10 
6 
cells (approximately equal to 1.6, umoles/g 
wet weight), (mean of 3 experiments) with a range of 3-4-6.6110 
6 
cells. The total glutathione content was found to be 1.1 nraoles/ 
10 
6 
cells (mean of 3 experiments (approximately 0-34 ýmoles/g wet 
wt. ), with a range of 0.8-1-5 nmoles/10 
6 
cells. Glutathione was 
approximately 21Y6 of the total soluble thiol of the cell. 
The effects of TSC1 and TSC2 on the thiol content of T. vaginalis 
are shown in Table XXX. In all cases it was found that there was 
an initial decrease in the total thiol content, but with some 
subsequent recovery. In the case of the lower thiosemicarbazone 
concentration, the initial thiol loss from the cells was approximately 
equimolar to the total drug present (50 nmoles). This relationship 
was not t: rue for the higher thiosemicarbazone concentrationv however, 
where the initial thiol loss was similar to the loss with the lower 
thiosemicarbazone concentration, i. e. only approximately one fifth 
of the high drug concentration. There was no obvious correlation 
between the loss of total free thiol and cell death. 
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TABLE II. Sensitivity of T. vaEinalis to a range of compounds 
using Bashby's medium 
Compound Type Compound Aerobic 
MIC (uM) 
Line 965691 
4-nitrodiazole 1 4 (2-8) 
2 300 
3 63 
nitrofuran 4 19 
thiosemicarbazone TSC3 14 
TSC1 0.2 (0-1-0-4) 
TSC10 0.2 (0-1-0-4) 
iso-thiazole 5 21 
6 19 
7 11 
Quinone 8 63 
9 26 
10 19 
11 20 
The figures given are the mean results of two experiments with 
the ranges given in paxentheses where there was variation between 
experiments. 
119 
TABLE III. Sensitivity of T. vaainalis clone G3 and line 
965691 to compounds 7 and TSC10 using different 
test conditions 
Test method/compo-und 
MIC (UM) 
Culture medium 
Compound 7 Cell line GTM Bushby's 
Test tubes G3 >100 45 
965691 ý>100 45 
Aerobic G3 100 43 
microtitre plate 965691 -ý:,. 100 10 
Anaerobic G3 100 13 
microtitre plate 965691 100 26 
TSC10 
Test tubes G3 23 <3 
965691 45 <3 
Aerobic G3 40 N. P. 
microtitre plate 965691 40 5 
Anaerobic G3 100 5 
microtitre plate 965691 100 5 
N. P. Experiment not performed. 
The figures given are the results from a single experiment. 
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TABLE IV. Effect of the culture media on the MIC of trichomon- 
acidal compounds 
Anaerobic MIC (um) line 965691 
Culture Medium Compound 7 TSC10 
GTM 100 100 
Bushby's + 12.7 mM ascorbate 35 5 
Bushby's + 2.7 mM ascorbate 55 5 
Bushby's + 12.7 mM cysteine 55 20 
Bushby's + 2.7 mM cysteine 55 5 
Bushby's + 12.7 mM (cysteine 
and 12.7 mM ascorbate) 60 20 
Bushby's 30 5 
The figures given are the results from a single experiment. 
TABLE V. Metronidazole sensitivity of Trichomonas vaULnalis 
'Parasite MIC (um) 
line Aerobic Anaerobic 
G3 10 (6) 7-5-12.5 5 (4) 5.0-7-5 
IR78 >580 (5 ý' 5 (5) 2-5-5-0 
LRS (2.0) 40 (6) 35-42-5 20 (4) 17-5-20.0 
Boston 350 (3) 5 (3) 
Fall River 560 (2) 5 (2) 
Albany 470 (2) 5 (2) 
The figu-res are the median results from the number of experiments 
given in parentheses, with ranges where there was variation between 
experiments. 
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TABLE VI. Metronidazole reduction, NADH oxidase and NADPH 
oxidase activities of Trichomonas vaginalis 
homogenates 
Cl one G3 Line IR78 Line LR. S (2.0) 
a Metronidazole red-action + 65L 9 (6) 91ý18 (5) 19ý 3 (6) 
NAIE oxidase 
b 570 + 87 (10) 413-+55 (10) 507ý153 (9) 
c NADPH oxidase 3.89ý: 101 (12) 127+42 (7) 559±123 (6) 
The figares are the means + one standard deviation from the 
number of experiments given in parentheses. 
protein. 
Units -. rmoles/min/mg 
a. Rates with clone G3 and line IR78 are significantly 
different from that with the line LRS (2.0) at p=0.01. 
b. Activity of clone G3 -*-. s significantly different from 
line IR78 at p=0.05. 
CO Activities of clone G3 and line LRS (2.0) are significantly 
different from that of line IR78 at p=0.05. 
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TABLE VIII. Effect of methionine, DTT and glutathione on 
growth of Trichomonas vaginalis clone G3 under 
aerobic conditions in the absence of cysteine 
Culture medium No. of parasites/ml Yo of control 
GTM 3-8 x 10 
6 100 2 
GTM-cysteine s. 6 x 105 23 3 
GTM-eysteine + 12.7 mM methionine 1.9 x 10 
6 
50 2 
GTM-cysteine + 6.4 mM glutathione 1.8 x 10 
6 
47 3 
GTM-cysteine + 6.4 mM dithiothreitol 1.1 x 10 
6 
30 3 
The results given are the parasite densities after 24 hr (in4; tio*-t 
6ell density 1x 105/m, ) and the cell density expressed as 
Ia% 
of 
the growth in GTM medium. The figures are the mean range) 
from 2 experiments. 
TABLE IX. Effect of p1l and added salts upon the trichomonacidal 
activity of metronidazole 
C'ulture conditions MIC Oam) 
Aerobic Anaerobic 
GTM &H 6.0) 10 (15) 5 (11) 
GTM (PH 5.2) 10 (2) 5 (2) 
GTM &H 4.6) 10 (2) 5 (2) 
GTM +5 mM lactate 80 (6) 5 (4) 
GTM +5 mM acetate 80 (6) 5 (4) 
GTM +5 mM succinate 10 (3) 5 (2) 
GTF, +5 mM pyruvate 10 (4) 5 (2) 
The figures are the median results from the number of experiments 
given in parentheses. T. vaginalis clone G3 was used. 
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TABLE X. Effect of different concentrations of lactate and 
acetate upon the metronidazole sensitivity of 
1. vaginalis clone G3 
Tactate/Acetate Aerobic MIC (uM) 
concentration (mM) Lactate Acetate 
0 10 (16) (5-10) 10 (16) (5-10) 
0.25 10 (2) 10 (2) 
0.5 10 (2) 10 (2) 
1.0 20 (2) 20 (2) 
2.0 45 (2) 45 (2) 
5.0 80 (6) (60-80) 80 (6) (60-80) 
10 80 (3) 80 (3) 
The figures are the median results from the number of experiments 
given in parentheses with ranges where there was variation between 
experiments. 
TABLE XI. Effect of lactate and acetate on the activity of NADH 
oxidaseo NADPII oxidase and the rate of metronidazole 
reduction by T. vaginalis clone G3 homogenates 
Cells grown in GTM 
Alone +5 mM Lactate +5 mM Acetate 
Metronidazole reduction 73 11 (3) 78 21 (3) 65 14 (3) 
NAIE oxidase, 603 55 (4) 625 106 (3) 592 78 (3) 
NADPH oxidase 376 26 (3) 426 100 (3) 404 63 (3) 
The figures are the mean results - one standard deviation of the 
number of experiments given in parentheses. 
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TABLE XII* -M-P Effect of added lactate to medium upon the 
excretion of lactate by Trichomonas vaginalis 
clone G3 
Calture medium Lactate produced (mM) 
GTM 13.2 0.5 (3) 
GTM +5 mM Lactate 9.64 0.38 (3) 
The figures are the mean results ± one standard deviation of 
the number of experiments given in parentheses. 
Initial parasite density 1x 105 cells/ml. 
Final parasite density: Control (GTM) 1.69 x 10 
6+1.1 
x 105 cells/ml 
X 10 
6+1.2 
x 105 Experimental (+Lactate) 1.56 - cells/ml 
24 hr inciabation growth in bijo-u bottle cultures of 5 ml medium. 
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TABLE XIV. SensitiVitY of T. vaginalis line 965691 to azobenzener 
nitrobenzene and two of their mammalian metabolites. 
Compound 
MIC 
(PM) 
nitrobenzene 50 400 
azobenzene 50 275 
aniline 50 540 
p-nitrophenol 50 360 
The figures are the mean results of two experiments. 
TABLE XV. The Rf values of azobenzene, nitrobenzene and their 
main mammalian metabolites by thin layer chromatography 
using three solvent systems. 
Rf value 
Comound 
I 
Solvent I Solvent II Solvent III 
nitrobenzene 0.92 (1) N. D. 0.93 (1) 
aniline N. D. N. D. N. D. 
2 -aminophenol 0.78 
+ 0.05 (3) 0.90 
+ 0.01 (2) 0.20 
+ 0.02 (3) 
3-aminophenol 0.75 
+ 0.03 (3) 0.87 
+ 0.02 (2) 0.18 
+ 0.01 (3) 
4-aminophenol 0.68 
+ 0.04 (3) 0.88 0.01 (2) 0.06 
+ 0.02 (3) 
2-nitrophenol N. D. 0.86 
+ 0.01 (2) N. D. 
3-nitrophenol 0.81 
+ 0.01 (2) 0.84 
+ 0.03 (3) 0.57 + 9.03 (2) 
4-nitrophenol 0.80 0.01 (2) 0.89 
+ 0.03 (3) 0.56 0.04 (3) 
azobenzene 0.92 
+ 0.01 (2) 0.84 0.01 (2) 0.93 
+ 0.01 (2) 
hydrazobenzene 0.93 0.02 (2) 0.85 0.01 (2) 0.90 0.02 (2) 
benzidine, 0.68 
+ 0.01 (2) 0.82 
L 
+ 0.02 (2) 
I 
0.18 0.02 (2) I 
The figures given are the means one standard deviation or range) 
from the number of experiments given in parentheses. N. D. Not detectable. 
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TABLE XIX. Proteinase activity of Trichomonas vaginalis clone G3 
homogenates. 
Assay Conditions Activity 
pH 6.0 6.7 0.9 (9) 
pH 6.0 (+ 1.3 mM DTT) 10.1 0.4 (3) 
pH 7.5 4.0 
+ 1.0 (6) 
pH 7.5 (+ 1.3 mM-DTT) 5.7 0.2 (3) 
The figures are the mean results standard deviation) from the 
number of experiments given in parentheses. Units: mU/m-g protein. 
TABLE XX. Proteinase activity of Trichomonas vaginalis clone G3 
at a range of pH. 
pH Activity 
5.0 8.5 0.2 (2) 
5.5 7.6 t 0.1 (2) 
6.0 7.3 't 0.3 (2) 
6.5 7.0 t 0.1 (2) 
7.0 6.4 0.2 (2) 
7.5 4.7 0.1 (2) 
8.0 1.9 0 (2) 
The figures are the mean results and range from the numbers of 
experiments given in parentheses. No DTT was present. 
Units: mU/mq protein. 
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TABLE XXI. Sensitivity of Trichomonas va2inalis clone G3 to 
antipain and leupeptin. 
Compound RIC (; ig/ml) 
antipain 100 (2) 
leupeptin 100 (2) 
TSC1 0.05 (2) 
TSC2 0.03 (2) 
The fi. gures are the median results of two experiments. 
TABLE XXII. Effect of thiol containing compounds on the inhibition 
of T. vaginalis proteinase by TSC2. 
% Inhibition 
Control 0 (2) 
* 100 uM TSC2 71 1 (2) 
* 100 pM TSC2 + 6.4 mM DTT 5 1 (2) 
* 100 PM TSC2 +12.7 mM cysteine 20 
+ 2 (2) 
* 100 'um TSC2 +12.7 MM glutathione 
13 + 1 (2) 
* 100 pm TSC2 + 6.4 MM homocysteine 5 1 (2) 
* 100 )IM TSC2 +12.7 mM methionine 50 2 (2) 
* 100 pm TSC2 +12.7 MM thioglycolate 32 (1) 
The figures given are the means and ranges from the number of 
experiments given in parentheses. 
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TABLE XXIII. Hetokinaser Pyruvate kinase and phosphofructo 
kinase activities of Trichomonas va2inal-is 
clone G3 homogenates. 
Activity 
Hexokinase 124 
+ 12 (9) 
pyruvate kinase 123 
+ 19 (10) 
phosphofructo kinase 95 
+6 (4) 
The figures are the mean results one standard deviation from the 
number of experiments given in parentheses. 
protein. 
units: nmols/min/mg 
TABLE XXIV. Sensitivity of Trichomonas va inalis clone G3 to 
arsenicals. 
MIC (pm) 
Melarsen (Al) 300 (4) 
Melarsen oxide (A2) 100 (4) 
Mel. B. (A3) 300 (4) 
The figures are the median results of the number of experiments 
given in parentheses. 
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TABLE XXVIII. Effect of thiol compounds on the inhibition of 
hexokinase by TSC1 and pyruvate kinase by TSC2. 
% Activity 
Hexokinase Pyruvate kinase 
+ 10 0 pM TSC1 + 100 pM TSC2 
Control (no TSC1/TSC2) 100 100 
Drug + 3 mM cysteine 82 ( 81- 83) 95 (95- 96) 
Drug + 3 mM DTT 88 ( 84- 92) 96 (92-100) 
Drug + 3 mM glutathione 71 ( 67- 74) 87 (86- 88) 
Drug + 3 mM thioglycolate 93 ( 85-100) 64 (60- 67) 
Drug + 3 mM homocysteine 106 (105-107) 98 (96-100) 
Drug + 3 mM methionine 44 ( 43- 45) 40 (35- 45) 
Drug only 44 ( 42- 46) 23 (20- 26) 
The figures given are the the mean results and ranges of two 
experiments. 
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TABLE XXIX. Trichomonacidal. activity of thiosemicarbazone TSC1 
and its copper chelate, TSC2. 
% Parasite survival 
120 min 210 min 
Contr ol 100 100 
1 pm Tý(- 1 90 87 
5 UM -rcc- 1 86 69 
1 
'UM 
Tse- -1 90 70 
5 pM 78 32 
The figures given are the mean results 
+ 
one standard deviation of 
three experiments. 
TABLE XXX. Effect of thiosemicarbazones on the soluble thiol 
content of T. vaginalis. 
Time of Total thiol loss (nmole) 
Incubation 
witb drug TSC1 added TSC2 added 
(min) 50 nmoles 250 nmoles 50 nmoles 250 nmoles 
0 0 0 0 0 
30 44 49 36 53 
60 51 47 42 31 
120 22 17 0 29 
210 0 N. D. + 29 N. D. 
The figures given are the mean results of two experiments. The 
initial thiol content of each parasite culture was 120 nmoles, the 
7 
thiol content in 2.4 x 10 cells. N. D. ' = Not determined. 
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I AgLLres 1-4 Grcwth of Trichomonas vaE. _Lalis 
in GTM medium 
containing different eysteine and ascorbate concentrations. 
IP. arasite riumbers are given as the number of motile 
parasites/ml medium. Me figures are the means and 
range of 2 aerobic aund 2 anaerobic experiments. Anaerobic 
conditions were achieved by passing argon over the cultures 
prior to incubation), 
IFJI. g Ur e1. Clone G3 -under aiiaerobic conditions 
A gure 2. ClIone G3 under aerobic conditions 
Agi. xre 3. Idne IR78 under anaerobic conditions 
Figure 4. Line IR78 under aerobic conditions 
Key foi 1-4: cysteine -ind ý-,,, c, -, rbrate concentrr-Aionrs (PA) I- 
* (12.7 and 21.0, conccntral. iorl in GTFI medium respectively); 
/I 10 ana 16 . 8) 
(7 . 6,1 ',, . 
6) 1 and 8 . 4) li, 
(2-5 
4.2) an (1 2-1 ir 9 zý', (0 
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119ures 5 and 6 Effect of gaseous conditions upon the growth 
of Trictiomonas vadnalis. Growth medium: G-TVI without 
cysteine and ascorbate. Gaseous conditicns: 
* 5% C021 95% argon; N argon; A 2% 02' 98% argon; 
5Yo 021 95yo argon; 0 909/6 argon; 0 15% 02' 85Yo 66 109/ 02' 
argon; Zý 20Yo 02,80% argon. Parasite numbers are 
expressed as the number of motile parasites/ml medium. 
The figures are the means (+ standard deviation or range) 
of three (clone G3) and two (line IR78) experiments. 
Figuxe 5. Clone G3 
Figixre 6, Idne IR78 
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EFFECTS OF GASEOUS CONDITIONS UPON THE 
GROWTH OF T. VAGINALIS CLONE G3 
FIGURE 5 
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XPIA-gures 7 and 8 Growth of Itichomonas vaginalils under aerobic 
conditions in medium containing different concentrations of 
lactate or acetate. Parasite numbers are given as the 
number of motile parasites/ml medium. The figures are 
the means and range from two experiments. Key for Figs. 
and 8: Iactate or acetate concentrations (mM) in GTM 
medium; A 10; b, 5; A 2.5; a)-0; 0 0. 
gur e7- Growth, of T. vaginalis clone G3 in medi-um containing 
different lactate concentrations. A-&. 
Tigure 6. Growth of T. vaginalis clone G3 in medium containing 
different acetate concentrations. 
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2 
GROWTH OF T. VAGINALIS CLONE G3 UNDER AEROBIC 
CONDITIONS IN MEDIUM WITH DIFFERENT LACTATE 
CONCENTRATIONS FIGURE 7 
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GROWTH OF T. VAGINALIS CLONE G3 UNDER AEROBIC 
CONDITIONS IN MEDIUM WITH DIFFERENT ACETATE 
CONCENTRATIONS FIGURE 8 
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gure Titration of 500 uM TSC1 against MnSO The figures) 
are the mean of two experiments. 
Figure 10. Titration of 100 uM TSC1 against CuSO 
are the mean of two experiments. 
The figLures 
FIgure 11. Titration of 10 uM TSC1 against ZnSO 4' The figures 
are the mean of two experiments. 
Agure 12. Spectra of TSC1 and its copper, zinc and manganese 
chelates from 288 rm to 575 nm. 
1. SpectrLm of 10 uM TSC1. 
2. Spectrum of zinc chelate produced from 10 uM TSC1 and 
loum ZrIso 4' 
3- Spectrum of 500 uh TSC1. 
Spectrum of manganese chelate produced from 500 uM TSC1 
and 500 UM MhS04' 
5. Spectrum of copper chelate produced from 100 uM TSC1 
and 100 uM CuSO 4* 
Spectnm of solvent (50yo ethanol). 
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FIGURE 10 
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TITRATION OF 10ýJM TSC 1 AGAINST ZnS04 
FIGURE 11 
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'Ngwre 13. Inhibition of proteinase frm Tridiomonas vadnalis 
by TSC2, leupeptin and antipain. The figures are the means 
(+ one standard deviation) of three experiments. 
FigLLve 14. Inhibition of purified yeast hexokinase by A2 
(melarsen oxide), A3 kMel B) and TSC 1. The figures are 
the means (+ one standard deviation) of three experiments. 
14gure 15. Inhibition of mouse liver hexokinase by A2 
(melarsen oxide). The figures are the means (+ one 
standard deviation) of three experiments, 
Idgure 16. Inhibition of Trichomonas vaginalis clone G3 
hexokinase by TSC1. The figures are the means (+ one 
standard deviation) of three experiments. 
Figure 17. Inhibition of mouse liver py-ruvate kinase by A2 
(melarsen oxide) and TSC1, The figures are the means 
(± one standard deviation) of three experiments, 
Figure 18. Inhibition of Trichomonas vaElpalis pyruvate kinase 
by TSC2. The figures are the means (+ one standard deviation) 
of three experiments. 
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DIFFERENT METHODS OF ASSESSING ANTITRICHOMONAL ACTIVITY 
Metronidazole has been used in the treatment of trichomonal 
vaginitis for over 20 years and is still the drug of choice. 
Unfortunately, resistance to the drug has been reported recently 
(Meingassner and Thurner, 1979; MuMer, Meingassner, Miller and 
Ledger, 1980). Since resistance to metronidazole is likely to 
become more prevalent as the drug continues to be used on a wide 
scale, it is of importance to discover and develop new antitrichomonal 
compounds which may eventually replace metronidazole. An important 
step in this process is the design and use of a reliable and 
sensitive method to assess the antitrichomonal activity of potentially 
useful comoounds. 
Using the microtitre plate method developed, three lines of 
Trichomonas vaginalis were found to be sensitive to a range of 
compounds, including some known to have, and some similar to 
compounds which have, antitrichomonal activity (Table I). The 
5-nitroimidazole metronidazole was first reported to have 
antitrichomonal activity in 1959 (Cosar and Julou, 1959), and its 
use as an antitrichomonal agent has been well documented (Rees, 1960; 
Porapakkham, 1967). Although metronidazole is the preferred compound 
in use against trichomonal vaginitis, a range of other nitroimidazole 
derivatives have been tested for antitrichomonal activity (Meingassner 
and Mieth, 1976; Ray, Chatterjee and Tendulkar, 1982). The anti- 
trichomonal activity of metronidazole against T. vaginalis clone G3 
165 
was similar to that reported by other authors (Jennison, Stenton 
and Watt, 1961; Edwards, Dye and Carne, 1975; Lindmark and Muller, 
1976) for several other lines. The sensitivity of line IR78 to 
metronidazole, although similar to that of clone G3 under anaerobic 
conditions, was much less under aerobic conditions. This loss of 
sensitivity to metronidazole under aerobic conditions has been 
previously reported by Meingassner and Thurner (1979). This result 
suggested that oxygen is involved in the resistance of this line 
to metronidazole. The metronidazole sensitivity of line LRS (0.6)f 
a laboratory produced stra4n grown under in vitro drug pressure 
until it was cultured in medium containing 0.6 pg metronidazole Per 
ml, was slightly lower under both aerobic and anaerobic conditions 
than that of clone G3, and no effect of the presence of oxygen 
similar to that observed with line IR78 was found. These results 
suggested that lines IR78 and LRS fO. 6) have different modes of 
resistance to metronidazole. The activity and mode of action of 
metronidazole to several lines of T. vaginalis is discussed more 
fully in section 4.2. 
Meingassner and Mieth (1976) showed that a metronidazole- 
resistant line of Tritrichomonas foetus exhibited cross-resistance 
to a range of other nitroimidazole derivatives, both in vitro 
and in vivo. Although the activity of other nitroimidazoles was 
not tested in this study, the activity of other nitro-compounds 
(nitrodiazoles and nitrofurans) was investigated. The nitrodiazoles 
were less active than metronidazole against Trichomonas vaginalis 
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clone G3 and although line IR78 was relatively resistant to these 
compounds, this was so in both aerobic and anaerobic conditions 
suggesting that oxygen was not involved. These results suggest 
that cross-resistance between 5-nitroimidazoles and other nitro- 
cyclic compounds may not occur and that these different nitro- 
compounds act differently. No overall picture of the sensitivity of 
line LRS (0.6) to nitrodiazoles emerged from this study. Both 
nitrofurans were active against all three lines of T. vaginali . 
This is of interest as it suggests that nitrofurans (such as 
compound 41 may be effective in treating infections resistant to 
metronidazole. This would, of course, need to be tested in vivo. 
in addition, it confirms that 5-nitroimidazoles and nitrofurans 
have different modes of action. Nitrofurans have previously been 
suggested as useful antitrichomonal comDounds (Caviert Chemtob, 
Rene and Royer, 1979) and have been shown to have antitrypariosomal 
(Gugliotta, ranowitz, Wittner and Soeiro, 1980) and antibacterial 
1ý 41 11 
(Ebringer, Jurasek, Kada, KroSýka and Foltinova, 1972) activity. 
Of the three thiosem. icarbazones tested using the microtitre 
plate method, none appeared to be of especial interest as an 
antitrichomonal compound. The one compound that was active (TSC3), 
was equally so against line IR78 and clone G3, suggesting that such 
compounds act in a different way to 5-nitroimidazoles. Drugs 
developed from them therefore should be useful against metronidazole- 
resistant lines, like IR78, when metronidazole treatment fails. A 
group of thiosemicarbazones (2-acetylpyridine thiosemicarbazones) 
have been shown to have antimalarial (Klayman, Bartosevich, Griffin, 
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Mason and Scovill, 1979) and antit-/anosome (Wilson, Revankar and V 
Tolman, 1974) activity. The compounds tested in this study however, 
were not in this group of thiosemicarbazones. 
It is of interest to note that apart from one thiosemicarbazone 
(TSC3), only nitro-compounds were found to be active against 
T. va! 1: 1nalis at low concentrations using the microtitre olate method. 
Since it is known that the activity of 5-nitroimidazoles requires 
the reduction of -the nitro-group (O'Brien and Morris, 1972) and this 
is also thought to be the case for nitrofurans, the activity of 
the nitrodiazoles may be dependant upon their reduction also. All 
these nitro-compounds may therefore be activated in a similar manner, 
although as the activity profiles of the drugs against the 3 lines 
of T. vaginalis differ markedly, it is probable that either different 
enzymes are involved in the nitro-reduction, or the subsequent 
tarqets are not the same. 
The importance of the method of assessing antitrichomonal 
activity was illustrated when the activity of the same compounds 
was measured using a tube method (Table II). With most compounds, 
the results obtained using this method were similar to those obtained 
in the microtitre plate method, considering that a different cell 
line and medium was used. However, the thiosemicarbazones (TSC1 
and TSC10), which were apparently inactive when assessed using the 
microtitre plate method, were found to be highly active using this 
method. These differences in observed activity could have been due 
to one or more of several factors: differences between the cell lines; 
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differences between the culture media; differences in other aspects 
of the two drug-screening methods. Upon testing, it was found that 
it was the culture media, and not the cell lines that was crucial. 
The main difference between the two media was the presence of high 
concentrations of cysteine (12.7 mM) and ascorbate (21.0 mM) in GTM 
medium, and their absence in Bushby's medium (See section 2.1.2. ). 
The low activity of the thiosemicarbazone (TSC 10) in GTM medium 
was due, to a large extent, to the presence of cysteine. Ascorbate 
apparently had only a small effect. The antitrichomonal activity 
of thiosemicarbazones will be discussed in more detail in section 
4.5. As well as the thiosemicarazones, a difference in activity of 
compound 7 (an isothiazole) was observed with the two methods. In 
this case the low activity of compound 7 in GTM medium may be due 
to the highly reducing conditions present, rather than to cysteine 
or ascorbate themselves. 
The differences in the sensitivites of the two lines, using 
the two culture media, are of some importance, as they illustrate 
a shortcoming in the in vitro drug-screening methods used. If GTM 
medium alone had been used in these tests, then the thiosemicarbazones 
(TSC1 and TSC10) would not have been considered as-potentially useful 
antitrichomonal compounds, whereas by using Bushby's medium they were 
shown to be very highly active. This demonstrates that the type of 
drug screening method used can affect the results and in particular 
may produce falsely negative results, allowing potentially useful 
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antitrichomonal compounds to be passed over. This danger has been 
reported previously. In 1978, Meingassner, Mieth, Czok, Lindmark 
and Muller showed that the MLC (Minimal lethal concentration) of 
metronidazole against a line of Tritrichomonas foetus (Kv 1 
/M 
100 
) 
differed markedly depending upon the medium in which it was grown 
and tested. This line of T. foetus was metronidazole resistant in 
an aerobic tray test if most culture media were used. If CACH 
(Mýller and Gottschalk, 1970) or TTYS + 0.1% (w/v) ascorbic acid 
(Diamond,, 1968) were used, however, then this line was normally 
sensitive, there being no difference in MLC when compared to a 
reference strain. The simplest method of circumventing the problem 
outlined above is to test the activity of each compound in a range 
of media. 
4.2. SENSITIVITY OF TRICHOMONAS VAGINALIS TO METRONIDAZOLE 
Mechanisms of resistance to metronidazole 
The results given in Table V confirm the involvement of oxygen 
in the metronidazole-resistance of T. vaginalis lines IR78, Boston, 
Fall River and Albany, that has been previously reported 
(Meingassner and Thurner, 1979; MU"ller, Meingassner, Miller and 
Ledger, 1980; M611er, 1982)0 and show that the lower sensitivity of 
line LRS (2.0) is independant of oxygen. Although the mode of action 
of metronidazole is not fully understood, it has been shown that 
metronidazole inhibits hydrogen produCtion (O'Brien and Morris, 
1972; Coombs, 1976), not by directly inhibiting hydrogenase, but by 
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acting as an electron acceptor for the pyruvate: ferredoxin 
oxidoreductase system. This action involves the reduction of the 
nitro-group of metronidazole (Edwards, Dye and Carne, 1973; Coombs, 
1976; Lindmark and M61ler, 1976), a reduction that was inhibited 
s in vitro by Oxygen (MU'ller, Lindmark and McLaughlin, 1976; 
Peterson, Masonf Hovespian and Holtzman, 1979). 
Cytoplasmic NADH oxidase and NADPH oxidase (MUller and Lindmark, 
1973; Tanabe, 1979) probably reduce the oxygen that enters T. vaginalis 
and so could be responsible for maintaining the anaerobic nature of 
the hydrogenosomes in living cells. It is in these organelles that 
metronidazole is reduced. The lower activities of NADH oxidase and 
NADPH oxidase in line IR78 compared with clone G3 (Table VI) suggests 
that drug resistance in this line may be due to significant amounts 
of the oxygen entering the parasite permeating unmetabolised to the 
hydrogenosomes, where it would interfere with the reductive 
activation of the drug. Beaulieu, McLafferty, Koch and Goldman (1981) 
reported that under aerobic, but not anaerobic, conditions line IR78 
formed acetamide, a reduction product of metronidazole, at a lower 
rate than a metronidazole-sensitive line. This suggests that the 
oxygen present was inhibiting the reduction of metronidazole in line 
IR78 and this did not occur, or occurred to a much lesser extent, in 
the metronidazole-sensitive line. This correlates well with the 
findings presented above. However, MU'ller (1982) reported that the 
NAr'H oxidase activity of line IR78 was greater (830 nmoles/min, /mg 
protein) than those of four metronidazole-sensitive reference lines, 
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ATC 30001, NYH 209, NYH 272 and NYH 286 (20,370,550 and 380 nmoles/ 
min/mg protein) respectively. This is contrary to the findings of 
this study. The NADH oxidase activities of Muller's reference lines 
(except ATC 30001) were broadly similar to that of clone G3, 
indicating that the methods used by this author were comparable to 
the methods used in this study. There is, as yet, no explanation 
for the difference in NADH oxidase activities reported for line 
IR78. The low NADH oxidase activity reported for the line ATC 30001 
suggests that the metronidazole activity exhibited by this line 
should be highly sensitive to oxygenp however Muller did not find 
this. This could perhaps be due to the protective effects of a high 
NADPH oxidase activity in this line. Clearly, further investigation 
will be necessary to determine the exact mechanism of metronidazole- 
resistance of these lines. It may be that the level of oxygen 
available is important and studies of enzyme activity under reduced 
oxygen tension could be a useful approach. 
The growth of Trichomonas species (Mack and MuAler, 1978) and 
another protozoan Entamoeba histolytica (Band and Cirrito, 1979; 
Gillin and Diamond, 1980) have been shown to be sensitive to oxygen 
and to the concentration of reducing agents in the medium (Gillin and 
Diamond, 1981 a, b). GTM medium contains high concentrations of 
cy. ýteine (12.7 mM) and ascorbate (21.0 mM). These compounds produce 
a highly reducing environment in the medium and the lowering of 
their concentrations would result in the greater availability of 
oxygen. The observed adverse effects of such conditions upon the 
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growth of both clone G3 and line IR78 (Figures 2 and 4) support 
the suggestion that Trichomonas va2Lnalis is an anaerobia. Gillin 
and Diamond (1981b) showed that cysteine and ascorbate delayed the 
killing effect of oxygen on Entamoeba histolytica and Giardia 
lamblia. However, with Trichomonas vaginalis, although both 
cysteine and ascorbate protected the parasites from the killing 
effects of oxygen, cysteine gave markedly greater protection (Table 
VII). It was also shown with Entamoeba histolytica and Giardia 
lamblia that cysteine itself was a required nutrient. Other reducing 
agents did not support survival as well, and in the absence of cysteine 
the parasites did not grow, even under anaerobic conditions. This was 
not the case with Trichomonas vaginalis. Under anaerobic conditions, 
growth of T.. vaginalis occurred in media lacking both cysteine and 
ascorbate, although at a reduced rate (Figures 1 and 3). The addition 
of other reducing agents as cysteine substitutes enhanced growth, but 
it was still less than when cysteine was present (Table VIII). 
Gillin and Diamond (1981b) reported that 1-cystine protected 
Entamoeba histolytica from oxygen. This was unexpected, as this 
amino acid lacks the thiol reducing group of cysteine, They 
suggested that E. histolytica may have the enzymatic capacity tc) 
reduce 1-cystine to cysteine. Cystine reductase has been demonstrated 
in Histoplasma capsulatum (Maresca, Jacobson, Madoff and Kobajashi, 
1978) and glutathione reductase in Entamoeba histolytica (Weinbach, 
Claggett and Singer (unpublished data). L-cystinc was not tested 
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with Trichomonas vaLinalis as a suitable solvent could not be found. 
Attempts were made to dissolve this compound in distilled water, 
ethanol, methanol and ethylene glycol, but only low micromolar 
concentrations could be obtained. The attempt to investigate this 
compound was hindered by the lack of experimental methods provided 
by Gillin and Diamond. 
The greater effect of lowering cysteine and ascorbate 
concentrations in the medium upon the growth under aerobic conditions 
of line IR78 compared with clone G3, suggested that the former line 
was less capable of handling oxygen entering the cell than was clone 
G3. This correlated well with line IR78's lower NADH oxidase and 
NADPH oxidase activities. The low activities of these enzymes may 
also account for the relatively poor growth, even in GTM medium, 
of this line under aerobic conditions (Figures 5 and 6). 
Mack and Maller (1978) showed that the presence of CO 2 
did not 
affect the generation time of T. vaginalis in an anaerobic 
environment. In -tAtý3 
'AAýý 
, however, growth of clone G3 and line 
IR78 were markedly enhanced by the addition of 5% CO 2 to anaerobic 
cultures (Figures 5 and 6). CO 2 
is an endproduct of the parasite's 
metabolism and carboxylation, reactions are not thought to be of 
major significance to T. vaginalis unlike Tritrichomonas foetus. 
The enhanced growth was not due to a lowering of the -pH of the medium 
by CO 2 
in solution, as such a change did not enhance growth. The 
presence of high CO 2 concentrations 
in the medium may have inhibited 
the activity of pyruvate: ferredoxin oxidoreductase and therefore of 
174 
acetate formation. There could have been a concomitant increase in 
the production of malate from pyruvate and phosphoenol pyruvate, and 
of pyruvate excretion. It is difficUlt-to see how'this would increase 
parasite growth, however, as the changes outlined would tend to 
lower the total amount of high energy phosphates produced per 
molecule of glucose. It would be of interest to investigate endproduct 
production in the presence and absence of CO 2' to 
determine whether 
acetate production was lowered and malate and pyruvate production 
and excretion increased. However, the differences in the findings 
given by Mack and Muller (1978) and those presented in this study may 
be related to the different media and parasite lines used. 
In contrast to line IR78, line LRS (2.0) possessed similar levels 
of NADH oxidase and NADPH oxidase to clone G3. Cell-free homogenates 
of line LRS (2.0), however, anaerobically reduced the nitro-group 
of metronidazole at a significantly lower rate than similar homogenates 
of clone G3. This may be an expression of lower pyruvate: ferredoxin 
oxidoreductase activity. Such a difference in vivo could result in 
a slower rate of activation of the drug. This could account for 
the lower sensitivity of this line, compared with clone G3, to 
metronidazole. A similar mechanism of resistance has been reported 
with Bacteroides frýLgilis (Britz, 1981; Dý611er, 1982). Since a 
slower rate of drug activation would tend to lessen the concentration 
gradient of unreduced drug entering the parasite, it would be of 
interest to see if metronidazole uptake by Trichomonas vaginalis 
175 
line LRS (2.0) and these Bacteroides fragilis lines was less than 
uptake in metronidazole-sensitive reference lines. 
In conclusion, two mechanisms of resistance to metronidazole 
have been postulated. It is suggested that the relatively low NADH 
oxidase and NADPH oxidase activities of Trichomonas vaginalis line 
IR78 may allow molecular o-.. ygen to permeate unmetabolised to the 
hydrogenosomes in which it inhibits the reductive activation of 
metronidazole. The reduced drug sensitivity of line LRS (2.0) may 
be due to this line's diminished level of the enzyme activity 
responsible for reductively activating metronidazole. 
4.2.2. The antagonistic effects of lactate and acetate 
In 1981, Mahood and Wilson reported that lactate enhanced the 
killing activity of metronidazole against hypoxic Chinese hamster 
ovary cells. They postulated that this effect may be due to one 
of several possibilities: an increased activation of the drug 
through the formation of NADH and a general raising of the reduction 
potential of the cell; an increase in the levels of lactate dehydro- 
genase (LDH) and its related enzyme complex sensitive to attack by 
drug free radicals; or a decrease in the intracellular pH at critical 
sites. 
The antagonism of lactate to the trichomonacidal activity of 
metronidazole (Table IX) contrasts with the above result. None of 
the mechanisms suggested for the effect reported by Mahood and 
Wilson (1981) appear to be involved in this phenomenon, as the 
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antagonism was not simply a result of the low pH of the medium 
produced by the acids (Table IX). It is possibly significant 
that of the acids tested, only those that were end products of 
T. vaginalis metabolism had an antagonistic effect. It was shown 
to be unlikely that either lactate or acetate were antagonistic to 
the trichomonacidal activity of metronidazole through a direct 
effect, either inhibition or repression, of parasite pyruvate: 
ferredoxin oxidoreductase (Table XI). It is this enzyme that is 
thought to be mainly responsible, through its generation of reduced 
ferredoxin, for the reductive activation of metronidazole (Coombs, 
1973; Edwards, Dye and Carne, 1973). Acetate could affect the 
enzyme indirectly by decreasing, through product inhibition, the 
rate of catabolism of acetyl CoA in the parasite. This could 
cause an accumulation of acetyl CoA which would be likely to inhibit 
pyruvate: ferredoxin oxidoreductase, for which it is one endproduct. 
It would be anticipated, however, that such an effect would occur 
under both aerobic and anaerobic conditions, whereas the antagonism 
was dependant upon the presence of oxygen. 
The enhancement of the parasite lactate dehydrogenase (LDH) 
activity, assayed in the direction of lactate production, upon the 
addition of lactate to the growth medium was surprising. The 
explanation of this higher activity, whether enzyme activation or 
synthesis, is unclear. This result may be significant, however, as 
it is feasible that the antagonistic effect of lactate could be due 
to stimulation of LDH activity resulting in a greater percentage of 
the pyruvate produced by the glycolytic pathway being metabolised to 
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lactate, and so less being available to generate reduced ferredoxin 
and so lead to the activation of metronidazole. Again, however, 
it would be expected that this would occur under both aerobic and 
anaerobic conditions. The lower concentration of lactate produced 
by parasites grown in medium containing lactate (Table XII) is in 
contrast to the enhancement of LDH activity by lactate. The decrease 
in lactate production, however, may have been due to the inhibition 
of one or more enzymes prior to LDH in the glycolytic pathwaye 
although this might have been expected to cause growth inhibition, which 
did not occur. Thus, the significance of the enhancement of LDH by 
lactate to the growing parasite is unclear. 
The dependance upon oxygen for the antagonistic effect of 
acetate and lactate on the toxic effect of metronidazole, suggested 
that the acids may have impaired, in some way, the parasites ability 
to metabolise oxygen. If some of the gas permeated unreduced to 
the hydrogenosomes it could have inhibited the reductive activation 
of the drug (Muller and Lindmark, 1976). As discussed previously, 
the cytosolic enzymes NADH oxidase and NADPH oxidase (Brugerolle and 
Metenier, 1973; Mu"ller, 1973; Tanabe, 1979) are thought to be mainly 
responsible for metabolising the oxygen entering the cell, and may 
in this way keep the hydrogenosomes anaerobic. However, in this study 
it was shown that neither lactate nor acetate directly inhibited 
either of these enzymes (Table XI), nor did it affect the level of 
the enzymes in the cells. It is feasible, but not supported by data 
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on lactate production, that the increased levels of lactate 
dehydrogenase in parasites grown in the presence of lactate could 
have caused a depletion in the NADH concentration in the parasite 
and consequently a lower rate of oxygen reduction catalysed by 
NADH oxidase. It is likely, however, that a reduction in the 
activity of NADH oxidase (or NADPH oxidase or pyruvate: ferredoxin 
oxidoreductase) would have adversely affected the growth of the 
parasite, but neither acetate nor lactate had this effect (Figures 
7 and 8) (Britz and Wilkinson, 1979). 
Although the mechanisms whereby acetate and lactate exert their 
antagonistic effects are not understood, these pehonomena could have 
some bearing on the treatment of trichomoniesis. The failure of 
metronidazole treatment on T. vaginalis infections has been reported 
intermittantly during the two decades it has been in clinical use 
(Squires and McFadzean, 1962) and several causes of treatment failure, 
including metronidazole resistance and concomitent infection with 
lmetronidazole-inactivating' bacteria (Edwards, Dye and Carne, 1979), 
have been postulated. The results suggest a third possible cause, 
since not only will the excretions of T. vaginalis themselves tend 
to counter the drugs action, but other organisms present could have 
similar effects. The antagonistic action of acetate and lactate 
was observed only when the acids were present at relatively high 
concentrations (Table X), however, there is little information 
available on the levels of metabolites that can occur in the 
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microenvironment of T. vaginalis in the vagina. Lactate is 
present in the uninfected vagina (Stamey, Fair, Timothy and Chung, 
1968). The predominant bacterial inhabitant of the uninfected 
vagina (Doderlein's bacilli) produces lactate in quantity such 
that the environmental pH is reduced to approximately pH 4.5 
(Stamey and Kaufman, 1975). During infection with T. vaginalis, 
however, usually the pH rises to about pH 6.0 (Parsons, Lofland 
and Mulholland, 1977) and the Doderleins Bacilli are virtually 
eliminated (Pfau and Sacks, 1981). In the infected vagina, the 
predominant microbial flora is gram-negative, mainly Escherichia 
coli, often in conjunction with a heavy colonization by colonic 
organisms such as streptococcus faecalis (Parsons, Lofland and 
Mulholland, 1977). More information on the microenvironment of 
the parasite (and especially those causing infection insensitive 
to the drug) would be helpful in elucidating the relevance of the 
present findings to the causes of metronidazole--insensitive 
trichomoniasis. 
4.3. ANTITRICHOMONAL ACTIVITY OF COMPOUNDS THAT AFFECT DNA 
AND ITS REPAIR. 
The potentiation of the antitrichomonal activity of DMS by 
the four benzamides tested (Table XIII) suggested that poly (ADP- 
ribose) polymerase may required in this protozoan parasite in a 
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similar way to that reported for mammalian cells (Durkacz, 
Omidijii, Gray and Shall, 1980). There is at present no direct 
evidence on how the benzamides exerted this effect against 
Trichomonas vaginalis. Indeed, there is no explanation on how 
benzamides inhibit poly (ADP-ribose) polymerase in mammalian cells. 
However, as a product of the reaction catalysed by this enzyme in 
the mammal, is nicotinamide, and nicotinamide is a potent inhibitor 
of this enzyme (Clark, Ferris and Pinder, 1971), this compound 
could act by competitive inhibition. Benzamide is closely related to 
nicotinamide and it is feasible that it acts in a similar manner. 
The extent of the synergism of the benzamides with Dimethyl sulphate 
(DMS), which was much greater than that reported for mammalian cells 
(albeit from studies involving different experimental conditions), 
suggested that drug combinations acting in a similar way could have 
potential as antitrichomonal agents. 
The lack of antitrichomonal activity and synergism of benzamides 
with ethidium bromide suggests two possibilities. Either the 
mechanism of action of this compound differs from that of DMS to such 
an extent that a different DNA repair mechanism is active, or that 
ethidium bromide was not able to enter the parasite in a concen- 
tration sufficiently high to do significant damage. The latter 
suggestion is perfectly feasible, as the anti-DNA activity of 
ethidium bromide has usually been studied using permeabilised cells 
(Mattern and Painter, 1979), and indeed probable, as no antitri- 
chomonal activity from it was detectable. 
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The lack of synergism between metronidazole and the benzamides 
against T. vaginalis suggested that the mechanism of antitrichomonal 
activity of metronidazole and DMS were not identical. It does not 
exclude the possibility that activated metronidazole damages DNA, 
albeit in a different way to DMS. 
The antitrichomonal activity of the thiosemicarbazone (TSCl) 
shows that this compound enters the cell without difficulty, but 
the lack of synergism between this compound and the benzamides 
gives no evidence that TSC1 affects DNA in a similar manner to DMS. 
4.4. THE METABOLISM OF XENOBIOTICS BY TRICHOMONAS VAGINALIS 
The metabolism of nitrobenzene and azobenzene in the mammal 
is now well documented (Robinsont Smith and Williams, 1951a; Parke, 
1956). In the case of nitrobenzene, aniline is the only purely 
reductive metabolite, and in the case of azobenzene, aniline, 
hydraxobenzene and benzidine are purely reductive metabolites. 
All the other metabolites (See section 1.4.3. ) involve oxidative 
steps in their production. As T. vaginalis is an anaerobe, it 
was of interest to investigate its ability to metabolise compounds 
which undergo oxidative metabolism in the mammal, with a view to 
elucidating some of the metabolic capabilities of the parasite. 
Nitrobenzene and azobenzene were investigated because of the wide 
range of metabolic pathways related to these compounds in the mammal 
and the depth of the literature concerning their metabolism. 
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The MIC of both compounds, and of aniline and p-nitrophenol 
(Table XIV), show that these compounds are toxic to T. vaginalis, 
but only at relatively high concentrations. This is interesting 
as nitrobenzene, azobenzene and aniline are toxic to mammals. 
Nitrobenzene was used in shoe polish, perfume, dyes, inks and 
furniture polish, and there were many cases of poisoning due to the 
nitrobenzene in these products (Steens, 1928; Chapman and Fox, 1945; 
Nabarro, 1948; Parkes and Neill, 1953). Nitrobenezene poisoning 
causes nausea, vomiting, cyanosis, coma and in some cases, death. 
Other nitrobenzene derivatives, such as dinitrobenzene, have also 
been shown to be toxic to mammals (Cody, Witherup, Hastings, 
Stemmar and Christian, 1981). The lack of toxicity of the compounds 
to T.. vaginalis may be due to a lack of uptake of them by the parasite 
or to the different metabolism of them in T. vaginalis and man. it 
was important to assess the toxicity of nitrobenzene and azobenzene 
to T. vaginalis so that sub-inhibitory concýeAtrations of each compound 
could be added to cell cultures in experiments to study the metabolism 
of these compounds by the parasite. 
The reduction of the nitro-group of nitrobenzene and of the 
azo-group of azobenzene probably occurred by the same ferredoxin- 
linked system involved in the reduction of 5-nitroimidazoles such 
as metronidazole. The reduction of the nitro-group of nitrobenzene 
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and metronidazole, and of the azo-group of azobenzene, all were 
inhibited by oxygen, required pyruvate as a substrate, coenzyme A 
as a cofactor, and were enhanced by the addition of methyl viologen. 
In 1975, Douch reported that the azoreductases of Moniezia 
expasa and Ascaris lumbricoides var suum were insensitive to 
4.4 
oxygen, but that mammalian azo-reductase enzymesAere oxygen- 
sensitive. The results presented in this study show that the 
azo reductase system found in Trichomonas vaginalis is not similar 
to that found in these helminths. 
The lack of detection of any metabolites of either nitrobenzene 
or azobenzene by TLC could have been due to the solvents used in 
this method. Aniline, the only purely reductive metabolite of 
nitrobenzene in the mammal, and the most likely product of T. vaginalis, 
could not be detected using these solvents. Hydrazobenzene, the 
major reductive metabolite of azobenzene in the mammal, had a 
similar Rf value (Table XV) to that of azobenzene in each of the 
three solvents, making distinguishing the two compounds impossible. 
Thus it turned out that the reductive metabolites of each compound 
could not be studied using these solvents. The solvents used in 
this method clearly were not ideal for the investigation undertaken. 
Aminophenols and nitrophenols, mammalian metabolites produced in 
oxidative steps, could be separated from parent compounds and 
identified using these solvents. However, they were not detected, 
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suggesting they were not produced. It may well be that reductive 
pathways are the only ones available to T. vaginalis, and that 
they can occur was demonstrated by the observed reduction of the 
parent compounds using T. vaginalis cell-free homogenate. 
The analytical methods available in the past for the 
detection and quantitation of nitrobenzene, azobenzene and their 
mammalian metabolites often required multi-ole extractions at 
alkaline ', OH, and subsequent chemical conversion to a more spectro- 
photometrically sensitive derivative (Boyland and Nery, 1964). 
fluorimetry (Sternson and Stewart, 1973) and isotopic techniques 
(Gang, Lieber and Rubin, 1972) at the final data, read out. The 
analysis of nitrobenzene, azobenzene and their mammalian metabolites 
by high-performance liquid chromatography (HPLC) was developed by 
Sternson and DeWitte (1977), who separated nanomole quantities of 
aniline, o- and p-aminophenol, nitrobenzene and azobenzene by 
reversed-phase chromatography. Methanol-water (15: 85) or (50: 50) 
was used as the mobile phase. This method is very similar to 
that used in the present study (section 2.4.3. ) even including the 
mobile phase. The compound retention times are given in Table XIV. 
The method used in the present study was equally sensitive to that 
used by Sternson and DeWitte (1977)f detecting nanomole quantities 
of the compounds, and was a marked improvement over earlier methods, 
such as the TLC method used in this study. Despite the greater 
sensitivity of the method, no metabolites of nitrobenzene 
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t, >&, s detected using HPLC. However, in control samples, 
lacking T. vaginalis cell-free homogenate, parent compound 
(nitrdbenzene) recovery was 70% whereas in experimental samples, 
with homogenate, only 30% of the parent compound was recovered. 
The only difference between these samples was the presence of 
homogenate. These results suggest that nitrobenzene was metabolised 
but that the metabolite (or metabolites) were undetected by this 
method. The loss of parent compound occurred only if pyruvate, 
coenzyme A and methyl viologen were included in the incubation mix 
along with nitrobenzene and extract. These are the compounds 
required for nitrobenzene reduction to take place in cell-free 
homogenates of T. vaginalis. Thus it appears that the reduction 
of nitrobenzene was occurring, but that the metabolite (or 
metabolites) were not being detected. The extraction and subse- 
quent detection of nitrobenzene standards showed that 70% of the 
nitrobenzene was detected, the same amount as was recovered in 
control samples. This suggested that the smaller recovery of 
nitrobenzene in experimental samples was not due to the method used, 
but to its disappearance during the incubation when 3-aminophenol 
and aniline standards were similarly tested, 70% of the former was 
detected, whilst no aniline was found. The inability to detect 
aniline after extraction correlates well with the thoery that the 
reduction of nitrobenzene is responsible for the lower recovery of 
parent compound in experimental samples, and that its major product 
(which can't be detected) was aniline. The lack of 3-aminophenol 
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suggests that none was produced, that is, hydroxylation did not 
take place. 
Hydrazobenzene was identified by cochrom&tography as a 
metabolite of azobenzene. This only occurred however, if pyruvate, 
coenzyme A and methyl viologen were present in the incubation mix 
along with azobenzene and cell-free homogenate. The lower azobenzene 
recovery rate in experimental samples (40%) compared with that in 
control samples (75%) could not all be accounted for by the 
hydrazobenzene present (15%). There was approximately 20% of the 
parent compound unaccounted for. This could have been converted 
to aniline which was not detected due to its loss in the extraction 
procedure. 
The loss of aniline in the evaporation of the extract during 
the extraction procedure was a major drawback of this HPLC method. 
Aniline is a highly volatile substance and the combination of 
low pressure and high temperature (50*C) may have caused the loss 
of this compound. An improvement to this procedure would be 
the evaporation of the extract under vacuum at room temperature, 
which should improve aniline recovery. 
The lack of direct evidence for nitrobenzene metabolites and 
the inability of the techniques used to detect aniline after 
extraction, means that further investigation is required to quantify 
the reductive metabolites of nitrobenzene and azobenzene. 
The lack of any metabolites, of nitrobenzene or azobenzene, 
whose production involves oxidative steps, howeverr confirms the 
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anaerobic nature of T. vaginalis, and suggests that the ability 
of this organism to utilise oxygen, even when available, is limited. 
In addition, this may also explain the low toxicity of nitrobenzene 
and azobenzene to T. vaginalis, as the oxidative metabolism of these 
compounds is involved in their toxicity to mammals. The lack of 
oxidative metabolism of xenobiotics may provide a possible target 
for chemotherapeutic attack. Compounds normally detoxified by 
Man by oxidation may be selectively toxic to T. vaginalis. 
4.5. ANTITRICHOMONAL ACTIVITY OF THIOSEMICARBAZONES 
4.5.1. Involvement of chelates 
The trichomonacidal activity of a range of thiosemicarbazones 
and some of their chelates are given in Table XVIII. Compounds 
unable to form chelates were much less active than compounds able to 
form chelates. Chelates were slightly more active than their parent 
compounds. In particular, TSC1 and TSC2f a thiosemicarbazone and 
its copper chelate, were highly active against T. vaginalis. 
The ability of thiosemicarbazones to form chelates with 
transition metals has been known for some time, and metal ions have 
often been implicated in the activity of thiosemicarbazones (Venton, 
Chan, Passor Racine and Morris, 1977; Ankel and Petering, 1980; 
Stunzi, 1982). Although thiosemicarbazones of the type used in 
this study have not been investigated previously, these results 
(Figures 9,10 and 11) show that TSC1 is also an avid chelator of 
transition metals, which may be of importance to the mode of action 
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of this compound. The copper chelate (TSC2) was stable in the 
presence of excess transition metals. This suggests that 
chelation is not the mode of action of the killing activity of 
these compounds. Since only chelates, and compounds with the 
ability to form chelates, were highly active, and chelation 
itself was not the cause of cell death, then the chelate or a 
metabolic product of the chelate must be the forms active against 
the parasite. 
4.5.2. Antagonism by thiol agents 
The antagonistic effect of cysteine upon the trichomonacidal 
activity of a thiosemicarbazone (TSCIO) has been reported (section 
3.2. ) and discussed (section 4.1. ) in the context of the alteration 
of killing activity by culture medium components. This effect was 
also found with two other thiosemicarbazones (TSC1 and TSC2) but 
did not occur with a third (TSC3) (Table XVII). It is possible 
that TSC3 was not affected by cysteine because it lacks the CS group 
11 
S 
in the lower chain to which the cysteine could bind (See diagram I 
for this mechanism. ) Alternatively, the lack of antagonism by 
cysteine upon the action of TSC3 may be related to this thiosemi- 
carbozone beinq unable to form a chela. te. In either case, the 
results suggest that this thiosemicarbazone exerts its (albeit 
rather limited) antitrichomonal activity in a different way from 
thiosemicarbazones TSC1 and TSC2. 
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The antagonistic activity of some thiol-containing compounds 
against the killing activity of TSC1 and TSC2 with T. vaginalis, 
and of TSC1 with Leishmania mexicana mexicana is of interest, as 
it may help to elucidate the mode of action of these compounds. 
All the thiol-containing compounds found to antagonise 
thiosemicarbazones had an -SH group and an -NH or -NH group NH2 2 
1 
(e. g. cysteine: HSCH 2 CHCOOH), except 
for dithiothreitol (DTT) 
(HSCII 
2 (CHOH) 2 
CH 
2 
SH) which has two -SH groups. The two compounds 
tested which did not exhibit antagonistic activity (methionine 
and thioglycolate) lack an -SH group (HOOCCHCH 2 
CH 
2 SCH 3) and an I 
-NH group (HSCH 3 COOH) respectively. 
NH 2 
The thiol compounds interfered with the antitrichomonal 
activities of both chelate and non-chelate, suggesting that they 
do not act by inhibiting chelation, although this only holds if 
both thiosemicarbazone and chelate act by the same mechanism. 
There are several ways in which thiol compounds could act 
with thiosemicarbazones and chelates. Cysteine might react with 
TSC1 to give a compound unable to form a chelate (Diagram 1). 
However, if this did occur, then the antitrichomonal activity of 
the chelate should not be affected, which it is. In addition, the 
lack of antagonistic activity of thioglycolate on the killing activity 
of TSC1 cannot be explained by this process, for it too should react 
with TSC1 in a similar way to cysteine. 
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Diagram 1. The possible effect of cysteine upon the structure of 
a thiosemicarbazone (TSCl). 
CH 
3 N. NHCSNH(CH 2)2 N(CH 3)2 
CH 
3 
("N. 
NHCSCH 3 y 
CH 
3 N. NHCSNH(CH 2)2 
N(CH 3)2 
COOH 
CH N. NHCSCH CH 3 11 -2 s NH 2 
+ HSCH 3 
Chelates could react with cysteine in three possible ways 
(see diagram 2): The dative bonds between the copper and the 
nitrogen (position 1) could be broken; the covalent bonds between 
Diagram 2. The possible effect of cysteine upon the structure of a 
thiosemicarbazone: copper chelate (TSC2). 
CH 
3 
N-N CNH (CH 2)2N 
(CH 3)2 
2s 
1 Cu 
CH 3 
ý. %N-N U- SCH 3 
the copper and the sulphur atoms (position 2) could be broken; both 
the above reactions could occur, probably resulting in the breakdown 
of the chelate. Thioglycolate is a non-nitrogen thiol, and therefore 
may be expected to breakdown the covalent bonds between the sulphur 
NH COOH 
HSCH CHCOOH CH N. NHCSCH CH 23 11- 2 
s NH 2 
and copper of TSC2 (position 2). Thioglycolate does not exhibit 
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antagonistic activity to the trichomonacidal activity of TSC2, 
suggesting that breakage of these bonds alone is not sufficient 
for antagonistic activity. Methionine has no -SH group, but 
Contains an -NH group, and is likely to affect the chelate at 
position (1). It also does not exhibit antagonism against the 
antitrichomonal activity of TSC2 however, suggesting that breakage 
of the dative bonds to the nitrogens is not sufficient for antago- 
nistic activity. All the other thiol-containing compounds (except 
DTT) contain both a thiol group and an -NH group, and have 
antagonistic activity. This suggests that only compounds able to 
hydrolyse at positions (1) and (2) antagonise the activity of TSC2 
and that they do so by interfering with the structure of the chelate. 
The results obtained with DTT do not fit in with this hypothesis. 
Unlike thioglycolate however, DTT contains two thiol groups and this 
may affect its reaction with TSC2, so that it has the same effect 
as thiol- and amine-containing compounds such as cysteine. 
These interactions of thiols with thiosemicarbazones and chelates 
however are only theoretical, and whether they occur has not been 
experimentally studied in detail. Attempts were made to see if the 
chelate was broken down upon the addition of cysteine, by looking 
for changes in the absorption spectrum, but none was observed. 
Thus it is feasible that the thiols do not react directly on the 
chelate but rather exert their effect by interferance with its action 
against cellular components. It is possible that it is the 
192 
effectiveness of the compounds at maintaining host enzyme thiol 
groups reduced that is the most important characteristic of the 
antagonists. 
The antagonistic effect of cysteine upon the killing activity 
of TSC1 with Leishmania mexicana mexicana shows that the thiol- 
antagonism exhibited with Trichomonas vaginalis is not a function 
of this parasite, and that the mode of action of TSC1 in Leishmania 
mexicana mexicana may be the same as in Trichomonas vaginalis, and 
probably involves chelation of TSC1 to a transition metal chelate. 
However, there is no evidence to suggest whether the chelate itself 
is the active agent or whether the metabolic action of the parasite 
upon the chelate produces a toxic substance. 
In conclusion, the antitrichomonal activity of thiosemicarbazones 
appears to involve the formation of chelates. Thiol- and amine- 
containing compounds antagonise the antitrichomonal activity of the 
thiosemicarbazones and chelates. It is unlikely that this is due 
to them interfering with the formation of the chelate, but it is 
possible that they affect the structural integrity of the chelate 
itself. Structure-activity analysis of the antagonists suggests 
that the ability to break the dative bonds from the nitrogens of 
the chelate and of the bonds from the metal to the disulphide bridge 
between the upper and lower chains of the thiosemicarbazone: copper 
chelate appears to be necessary for antagonistic activity. There 
is no experimental evidence that the thiol compounds cause the 
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breakdown of the chelate however, and it is quite possible that 
they antagonise its activity in some other way, such as interference 
with its action against cellular components. 
4.5.3. Effect on proteinase activity 
Proteinases are highly important enzymes, whose presence has 
been noted in a wide variety of prokaryotic and eukaryotic organisms 
(North, 1983). Proteinases are implicated in protein degradation 
and cell turnover. 
Thiol proteinase activity has been previously reported in 
T. vaginalis (Coombs, 1982) and Tritrichomonas. foetus (McLaughlin and 
ýt Muller, 1979). The proteinase activity of Trichomonas vaginalis 
clone G3 is given in Table XIX. The enhancement of activity on 
the addition of dithiothreitol (DTT) has been previously reported 
(Coombs, 1982; Coombs and North, 1983) and confirms the thiol- 
dependant nature of at least some of the enzymes. The proteinase 
activity was not maximal between pH 5.0 and pH 8.0 (Table XX), but 
the activity increased with increasing acidity. This is unlike the 
enzyme found in Tritrichomonas foetus, which had a pH 7.0 optimum, 
but is more like the mammalian thiol proteinase cathepsin B, which 
has a OH optimum between pH 3.5 and pH 5.0 (Otto, 1971). It must 
be remembered however, that it is likely that there were several 
trichomonal proteinases detected using azocasein, and so the results 
reflect their combined activities. 
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Proteinase assays were carried out at pH 6.0 and pH 7.5 
(Table XIX). These pH's were used for several reasons: 
1. The proteinase activity did not have an optimum between pH 5.0 
and pH 8.0. 
2. pH 6.0 is the initial pH of Trichomonas vaginalis culture 
medium and may be similar to its normal environment. 
3. pH 7.5 is likely to be similar to the physiological pH within 
the cytosol of the parasite. 
4. Coombs (1982) used similar conditions and a comparison could 
be made with the results of that study. 
The results obtained for T. vaginalis proteinase activity in 
this study were similar to those reported by Coombs (1982) and 
confirm that the proteinase activity of this species is very high 
compared with those of many other flagellate protozoa. The exception 
is the proteinase activity of Leishmania mexicana mexicana amastigotes, 
which at pH 6.0 was approximately five-fold greater than that of 
Trichomonas vaginalis (Coombs, 1982). Leishmania mexicana mexicana 
however, lives in the potentially lethal environment of the parasi- 
trophorous vacuole of the host macrophage, and the high proteinase 
activity of this parasite may reflect the role these enzymes play 
in the survival of this parasite. A thiol-proteinase similar to 
cathepsin B also has been found in the anaerobe Entamoeba histolytica 
(McLaughlin and Faubert, 1977). although this enzyme was found to 
have an optimum pH of 6.0-6.3. 
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The function of the proteinase found in Trichomonas vaginalis 
is not yet understood. In other organisms, such as Schistosoma 
mansoni, proteolytic activity is believed to be associated with 
the palstites ability to peietrate the skin of the definative host A 
(Dresden and Asch, 1972), and a thiol proteinase found in Trypanosoma 
cruzi may assist this organism to penetrate host cells (Bongeretz 
and Hungerer, 1978). Since Trichomonas vaginalis is not an 
intracellular parasite, cell penetration is unlikely to be a function 
of the thiol proteinase reported here. The proteinase reported in 
Tritrichomonas foetus (McLaughlin and Muller, 1979) was associated 
with, a population of' lysosome-like, posteriorly positional particles, 
and it was suggested that this proteinase is involved in the 
breakdown of macromolecules or organisms by the parasite, and 
perhaps assists in autophagy. Trichomonas vaginalis infections are 
associated with inflammation of the vaginal mucosa, and in culture 
T. vaginalis causes degenerative changes in Hela cells and inhibits 
cell division in fibroblasts (Honigberg and King, 1964). Proteinases 
secreted by the parasite may be responsible for these manifestations, 
although there is, as yet, no direct evidence for this. 
Leupeptin is a proteinase inhibitor which was first isolated 
from Streptomyces_spp. in culture (Aoyagi, Takeuchi, Matsuzaki, 
Kawamura, Kondo, Hamada, Maeda and Umezawa, 1969). Leupeptin is 
now well known to inhibit thiol proteinases, and has been shown to 
inhibit protein degredation (Ward, Chua, Li. Morgan and Mortimore, 
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1979; Hopgood, Clark and Ballard, 1977). The screening of 
actinomyces culture filtrates for papain inhibition led to the 
discovery of another compound, antipain'(Suda,, Aoyagi, Hamada, 
Takeuchi and Umezawa, 1972) which is structurally related to 
leupeptin. Antipain has been shown to inhibit cathepsin A and B, 
and through this proteolytic degredation (Leake and Peters, 1981). 
Leupeptin and antipain were potent inhibitors of Trichomonas vaýLinalis 
proteinases (Figure 13), but neither exhibited great trichomonacidal 
activity, even at concentrations which inhibited proteinase activity 
by 90% (Table XXI). The insensitivity of T. vaginalis to these 
compounds suggests that they do not reach the enzymes within the cell. 
As the trichomonacidal activity of TSC1 and TSC2 was inhibited 
by compounds containing thiol groups, and thiol-containing compounds 
could bind to these drugs (section 4.5.2. ), and thiol proteinases 
are dependant upon thiol groups for activity and exhibit enhanced 
activity in the presence of thiol-containing compounds such as 
DTTr it was considered that TSC1 and TSC2 could be interfering with 
thiol proteinases in the parasite. If this occurred, the lack of 
thiol proteinase activity may well kill the parasite, or at least 
be a contributing factor in its death. The chelate (TSC2) was found 
to inhibit trichomonal proteinases (Table XXI). The concentration 
of the drug required to give 90% proteinase inhibition, however, was 
apr---oximately 250 fold greater than that required to kill the 
parasite. it is possible that the chelate is only poorly taken in to 
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the parasite, nevertheless these results suggest that thi. ol 
proteinase inhibition is unlikely to be the mode of action of the 
trichomonacidal activity of this compound. 
The lack of inhibitory activity by TSC1 against the proteinases 
reinforces the suggestion given in section 4.5.2. that TSCI does 
not bind to thiol-containing compounds. 
Since thiol compounds affect the trichomonacidal activity of 
these thiosemicarbazones, the anatagonism of thiol-containing 
compounds upon the inhibition of thiol proteinase activity by TSC2 
was a distinct possibility. All the thiol-containing compounds 
tested were found to be antagonistic in this way except for thio- 
glycolate (Table XXII). Methionine also did not antaqonise the 
inhibition. It is of interest to note that all the thiol-containing 
compounds and methionine, enhanced the thiol-proteinase activity, 
although thioglycolate and methionine had the least effect. This 
fits in with the previous observation (section 4.5.2. ) that both 
on -NH and --SH group are necessary for maximal antagonism of the 
chelate, but in addition does show that compounds such as thioglycolate 
anck methionine have some effect upon the chelate. This was not 
detected using trichomonacidal activity as a parameter (Table XVII), 
presumably because growth inhibition was a less sensitive measure 
and minor effects were less readily detected than with the method 
involving enzyme inhibition. The results do not distinguish between 
whether the thiol. reagents exert their effect by directly reacting 
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with the chelate or by binding to the enzymes and so protecting 
them from interferance by the chelate. Clearly however, reaction 
with the enzymes is possible, as is shown by the stimulating affect 
of the thiols on the enzyme activity. 
4.5.4. Effect on, glycolytic kinases 
Thiosemicarbazones have not previously been tested for 
activity against glycolytic kinases. Most reported work is on the 
effect of thiosemicarbazones on ribonucleoside diphosphate reductase 
(Sartorelli, Agrawal and Moore, 1971). The antagonistic activity 
of thiols on the inhibition of this enzyme from Sarcoma 180 ascites 
cells as reported by Sartorelli, Agrawal, Tsiftsoglou and Moore (1977) 
is analagous to the antagonistic effect of thiols upon the trichomona- 
cidal activity of the thiosemicarbazones (TSC1 and TSC2) observed 
in this study. In 1977, Sartorelli et al., noted that ribonucleoside 
diphosphate reductase inhibition was more pronounced at low thiol 
levels and suggested that the thiosemicarbazone binds at, or near to, 
the site on the enzyme normally occupied by the thiol. This seems 
a reasonable suggestion, but many enzymes have associated thiol 
groups and the thiosemicarbazone may have some effect on these also. 
Thy glycolytic kinases have been known to have associated 
thiol groups for some time (Peters and Wakelin, 1946; Ernest and 
Drobnica, 1980), the thiol groups being essential for these enzymes 
to function. It has been shown that arsenical compounds inhibit 
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pyruvate kinase both in vitro and in vivo (Peters, Sinclair and 
Thompson, 1946) and it has been suggested that the arsenical combines 
with the enzyme by reacting with its thiol groups (Stocken and 
Thompson, 1946a). It has also been shown that the addition of thiol 
compounds protects the pyruvate kinase system from the effect of 
arsenicals (Stocken and Thompson, 1946b). Antitrypanosomal arsenicals 
are thought to act through inhibition of the trypanosome pyruvate 
kinase (Flynn and Bowman, 1974). It therefore seemed reasonable to 
postulate that thiosemicarbazones, which react with thiol groups, 
may have a similar effect to arsenicals on the activity of pyruvate 
kinase and other glycolytic kinases. 
The specific activities of hexokinase, pyruvate kinase and 
phosphofructokinase from T. vaginalis clone G3 cell-free homogenates 
are given in Table XXIII. All three enzymes were assayed under 
anaerobic conditions in order to avoid interference from the 
parasite. NADH oxidase activity. The activities of all three 
kinases were of the same order and greater than the metronidazole 
reduction rate of this parasite line (Table VI). This was not 
unexpected as the metronidazole reduction activity is a measure of 
the parasite pyruvate: ferredoxin oxidored. uctase activity. The flux 
through this enzyme must be lower than, or equal to, that through 
the glycolytic Pathway if carbohydrate is the major energy substrate. 
Although enzyme specific activities are only general indications of 
metabolic fluxes in vivo, in this case they apparently correlate 
quite well with the relative fluxes as judged from considerations of 
the fate of catabolised glucose. 
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The glycolytic kinase activities observed in this study were 
somewhat lower than those -eported by Arese and Cappuccinelli (1974). 
However, these authors assessed enzyme activity in 100,000 9 
supernatants of T. vaginalis homogenates, under anaerobic conditions. 
This procedure would remove a lot of the protein from the parasite 
extract, but as these enzymes are soluble, they would remain in the 
supernatant. Thus the apparent specific activity in such samples 
would be greater than that in the homogenate. No reference to 
the specific activities of these enzymes in T. vaginalis cell-free 
homogenate could be found in the literature, and so the results 
presented constitute the first report of T. va2inalis glycolytic 
kinase specific activities. 
The inhibition of pyruvate kinase by arsenical compounds 
reported by Peter-sSinclair and Thompson (1946) suggested that 
these compounds may be of interest as antitrichomonal agents. 
Arsenical compounds have been used in the treatment of trichomoniasis 
in the past (Michaels, 1968). However, the three arsenical compounds, 
melarsen (Al ), melarsen oxide (A2) and Mel B. (A3) tested in 
this study, showed poor trichomonacidal activity (Table XXIV). 
The likely explanations were that either these compounds were non- 
inhibitory to the parasite kinases or they did not freely enter the 
cell. A low permeability to arsenicals appears to be the mechanism 
responsible for several microorganisms being non-susceptible to 
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those compounds, as well as accounting for resistance of normally 
sensitive lines e. g. Escherichia coli mutants resistant to arsenate 
(Bennett and Malamy, 1970) and arsenite-resistant Pseudomonas 
pseudomollei (Arima and Beppu, 1964). In addition, an arsenite- 
resist, -Ace mechanism involving increased thiol-group concentrations 
was reported by Herington (1959) in the blue tick, and although this 
method is not postulated here, it again serves to confirm the 
antagonistic effect of thiols on arsenical activity, and the apparent 
similarity of the toxic effects of thiosemicarbazones, and arsenicals. 
Arsenicals are known to have a wide spectrum of activity against 
glycolytic kinases, from microorganisms to man, thus the lack 
of inhibition of any of the glycolytic kinases of Trichomonas vaginalis 
by the arsenicals used was unexpected, but did explain the low toxicity 
of these compounds to this parasite. This lack of sensitivity of 
trichomonal enzymes to trivalent arsenicals makes them unusual. 
Although the molecular basis of the different sensitivities is not 
known,, it is feasible that other inhibitors could be specific for 
the trichomonal enzymes and so have potential as antitrichomonal 
drugs. 
In contrast to TI. vaginalis, enzymes, the trivalent arsenical 
melarsen oxide (A2) inhibited hexokinase and pyruvate kinase from 
mouse liver supernatant, but had no activity on purified pyruvate 
kinase from rabbit muscle, confirming the finding of Flynn and 
Bowman (1974). The lack of activity of the pentavalent arsenical 
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(compound Al), which did not inhibit any of the glycolytic kinases 
tested, can be explained as pentavalent arsenicals have no 
affinity with thiols. Flynn and Bowman (1974) suggested that the 
in vivo trypanocidal effects of pentavalent arsenicals lies 
in their activation by reduction, as originally postulated by 
Crawford (1947). This reductive activation does not take place 
in cell-free homogenates, which accounts for the lack of 
inhibitory activity exhibited by melarsen against the glycolytic 
kinases, as found in this study and by Flynn and Bowman (1974). 
The difference in the inhibitory activity of mel B. (A3) 
between yeast and mammalian hexokinase suggests differences between 
the enzymes from the two sources, although similar degrees of 
inhibition of these enzymes by melarsen oxide (A2) would suggest 
that these differences may not be due simply to the thiols associated 
with the enzymes. It is possible that the two arsenicals require 
slightly different conditions at their enzyme binding sites and 
that these sites differ in the enzymes from the two sources. 
The inhibitory activity of the thiosemicarbazone TSC1 on 
hexokinase from yeast and T. vaginalis (Table XXV and Figures 14 
and 16) is not surprising, but the lack of inhibitory activity of 
the thiosemicarbazone: copper chelate (TSC2) suggests that the 
trichomonacidal activity of these thiosemicarbazones as described 
in section 4.5.1., (that is, TSC1 forms a chelate with a transition 
metal and it is the chelate that is active) is not mediated through 
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inhibition of this enzyme. The action of TSC1 against hexokinase 
probably is due to binding of the drug to the thiols associated 
with this enzyme. The lack of inhibitory activity of TSC1 with 
mouse liver hexokinase (Table XXVI) suggests that hexokinase from 
T. vaginalis and from yeast are more similar (at least at their 
thiol binding sites) to each other than either is to the mammalian 
enzyme. This confirms the suggestions made above, when discussing 
lack of activity of arsenicals. The inhibition by TSC2 of T. vaginalis 
pyruvate kinase and by TSC1 of mouse liver pyruvate kinase, whereas 
neither affected the other enzyme nor rabbit muscle pyruvate kinase, 
also indicates differences between trichomonal and mammalian 
pyruvate kinases. However, the differences in the inhibitors 
activities against the two mammalian pyruvate kinases suggests that 
the activity of TSC1 and TSC2 is highly dependant upon the structural 
conformation of the thiol binding site. If this is so, minor 
alterations in this site may change dramatically the effectiveness 
of an inhibitor. Such a situation holdspromise for the design of 
specific antiparasite enzyme inhibitors. 
The lack of inhibitory activity of both thiosemicarbazones 
against phosphofructokinase is similar to the situation with 
arsenicals. This suggests that either this enzyme is less dependant 
upon thiol groups for activity, although the low activity of TSC2 
with T. vaginalis phosphofructokinase suggests that this enzyme 
requires thiols, or that stereo hinderance at the thiol binding site 
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stops these compounds inhibiting the enzyme. 
The antagonism of thiol compounds to the inhibitory activity 
of TSC1 and TSC2 on T. vaqinalis hexokinase and pyruvate kinase 
respectively (Table XXVIII), confirms the mode of action of these 
compounds with the kinases. The only compound tested that did not 
antagonise the inhibitory activity was methionine, which does not 
have a free -SH group. 
The speed of the cell death of T. vaginalis in the presence 
of low concentrations of the thiosemicarbazones (Table XXIX) indicates 
that they may be inhibiting a system upon which the cell depends on 
a minute to minute basis. It seems unlikely that inhibition of DNA 
synthesis, although fatal in the longer term, would kill so rapidly. 
The concentration of thiosemicarbazone required to achieve a 
significant level of kinase inhibition was high, although a similar 
concentration of the trivalent arsenical melarsen oxide (A2) was 
required for the inhibition of mammalian hexokinase (Figure 15) and 
pyruvate kinase (Figure 17), in addition, Flynn and Bowman (1974) 
reported that similarly high concentrations of melarsen oxide and 
other trivalent arsenicals were required to inhibit Trypanosoma 
brucei and Trypanosoma rhodesiense pyruvate kinase, which is thought 
to be the primary target of arsenicals in trypanosomes. Quite high 
concentrations of A2 are required to kill tryponosomes in vitro 
however (Flynn and Bowman, 1974). Nevertheless, recently it has 
been postulated that thiosemicarbazones suppress energy production 
(Emery, Stancato,, Brown, Prichard and Wolfe, 1982) and glycolytic 
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kinase inhibition would fulfill this role. However, the MIC of 
TSC1 and TSC2 were approximately 100 fold lower than the 1 50% 
of TSC1 for hexokinase and of the 1 90% of TSC2 for pyruvate kinase, 
which indicates that inhibition of glycolytic kinases are unlikely 
to be the primary site of action of these thiosemicarbazones. 
4.5.5. Effect of thiol content 
The involvement of thiol groups with the activity of thiosemi- 
carbazones and their possible interactions was discussed in sections 
4.4.2. and 4.4.4. The total soluble thiol content of T. vaginalis 
was similar to that found in various bacteria (Fahey, Brown, 
Adams and Worsham, 1978). The affinity of thiosemicarba'zones for 
thiol groups was illustrated by the drop in thiol content of 
T. va2inalis cultures incubated with TSC1 and TSC2 (Table XXX). 
This drop in soluble thiol was transient, however, with the thiol 
level returning to the control level after 210 minutes in the presence 
of 50 nmoles TSC1 or TSC2. That this loss was similar to the 
concentration of TSC1 or TSC2 added to the culture could have been 
sic, nificant, suggesting a 1: 1 relationship between thiol and 
thiosemicarbazone. The initial loss of thiol however, was approx- 
imately similar irrespective of whether 50 nmoles or 250 nmoles of 
TSCI or TSC2 was added to the culture. In each case thiol levels 
recovered after this initial loss. Thus, the apparent 1: 1 
relationship between thiol drop and thiosemicarbazone concentration 
may simply have been a coincidence. 
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The transient nature of the loss in thiol content suggests that 
the parasite can overcome this aspect of the activity of thiosemi- 
carbazones if the drug is at a low concentration. The thiol lost 
presumably reflects the time taken for the cell to react to the 
presence of thiosemicarbazone, and produce more thiols. In the 
experiments carried out, significant numbers of parasites were 
killed within 210 minutes at the higher (5 pM) drug concentration. 
However, it was not possible to show a direct relationship between 
cell death and thiol level. Indeed, it is of interest to note 
(Table XXX) that after this time period the thiol content of one of 
the parasite cultures had increased significantly (by 58%) compared 
to the control culture, perhaps on indication of a parasite defence 
mechanism against the activity of the thiosemicarbazone. It has been 
shown that thiols protect the parasite itself from the effects Of 
the thiosemicarbazone, as'lell as antagonising their effect on 
proteinase (section 4.5.3. ) and glycolytic kinase (section 4.5.4. ) 
activities. 
Thus the loss of thiol probably does not in itself kill the 
parasite. Nevertheless it may play a part in the toxic action of 
thiosemicarbazones. It has been shown that glutathione deficient 
r 
mutants of Escherichia coli are moe susceptible to a wide range of A 
chemical agents than their parent strains (Apontoweil and Berends, 
1975) and these authors oostulated that glutathione plays a part in 
the integrity of the cell membrane. Lowering the soluble thiol 
content of Trichomonas vaginalis may similarly make the parasite more 
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Susceptible to the toxicity of thiosemicarbazones towards other 
aspects of cellular metabolism. 
4.5.6. Conclusions un the modes of action of antitrichomonal 
thiosemicarbazones 
The antitrichomonal activity of thiosemicarbazones appear to 
be associated with chelation, as only chelates and compounds 
capable of forming chelates are highly toxic to T. vaginalis. 
Thiol compounds antagonise the toxic activity of the thiosemicarbazones, 
but whether they act by directly interfering with the chelate or by 
interfering with its action against cellular components have not been 
elucidated. 
The chelate inhibited thiol proteinase activity; and thiol 
compounds antagonise the inhibition. The anti-proteinase activity 
of the chelate (TSC2) was observed only at concentrations significantly 
greater than those required to kill the parasite, and this suggests 
that thiol proteinase inhibition is unlikely to be responsible for 
the trichomonacidal effect. 
Thiosemicarbazones also inhibited glycolytic kinases and again 
their activity was antagonised by thiol compounds. The concentrations 
of the thiosemicarbazones necessary to kill T. vaginalis were 
significantly lower than those required to inhibit the glycolytic 
kinases however, suggesting that the inhibition of glycolytic kinase 
is not the primary mode of action of these compounds. 
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Incubation of the parasite cultures with both thiosemi- 
carbazones and chelate caused a transient drop in the total soluble 
thiol level in the parasites, but this could not be correlated to 
parasite death. 
Thiosemicarbazones and their chelates are highly toxic 
to T. yaginalis, and exert their effect rapidly. The primary mode 
of action of these compounds appears to involve thiol groups, but 
is still to be fully elucidated. Nevertheless, the results indicate 
that Lhey have potential as antitrichomonal compounds. 
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